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Abstract 
Human pluripotent stem cells (hPSCs) can be differentiated into retinal organoids to study 
inherited and age related retinal dystrophies, to screen new drugs and to use them as 
replacement tissues. Published evidence suggests that retinal pigmented epithelium (RPE) and 
decellularised extracellular matrix (ECM) from RPE and neural retina contain several ECM 
molecules that are important for retinal development and synaptic formation between various 
cell types. To date, there has been limited detailed analysis of ECM components distribution 
during human retinal ontogenesis and the functional importance of several components is 
poorly understood. In this study, the expression of key ECM components in adult mouse and 
monkey retina, developing and adult human retina and hPSC-derived retinal organoids was 
studied. The results demonstrate that different ECM components have distinct distribution 
patterns throughout the adult retina of different species and a well conserved expression 
pattern between adult and developing human retinae. Furthermore, the expression of ECM 
components examined in retinal organoids was found to recapitulate at large human retinal 
development in vivo. The functional role of ECM on the differentiation of hPSC-derived 
retinal organoids was investigated either via blocking the action of two ECMs: cluster of 
differentiation 44 (CD44) and interphotoreceptor matrix proteoglycan 1 (IMPG1) in the 
organoids or via supplementation of culture media with RPE conditioned medium, 
decellularised ECM of neural retina or RPE. The findings indicate that IMPG1 and CD44 
play an important role on photoreceptor development, their inner and outer segments, 
connecting cilia and IPM formation; with IMPG1 acting earlier and having more significant 
effect than CD44. All three supplements enhanced the light response in retinal organoids 
suggesting a beneficial effect of ECM on the development and function of hPSC-derived 
retinal organoids. Together, the study highlights a conserved expression of ECMs between 
human adult and developing retinae and retinal organoids as well as an important role for 
ECM in retinal development in vitro. 
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 Introduction Chapter 1.
 
1.1. The extracellular matrix (ECM) 
 
1.1.1. The ECM at a glance 
The ECM is the non-cellular component of all tissues and organs. It consists of 
proteins, water and polysaccharides (Frantz et al., 2010) and each tissue has a distinctive 
ECM composition (Frantz et al., 2010). The ECM acts as a structural support that facilities 
cell adhesion via integrins and other adhesion molecules which mediate various signalling 
pathways such as the serine/threonine kinase  pathway known as protein kinase B (Akt/PKB) 
and the extracellular signal-regulated kinase (Erk) pathway (Streuli, 2009; Moreno-Layseca 
and Streuli, 2014) that are essential for cell proliferation (Streuli, 2009; Fournier et al., 2012; 
Moreno-Layseca and Streuli, 2014). More than 150 components have been recognised to 
interact at integrins adhesion sites, forming an adhesion complex identified as “adhesome” 
(Harburger and Calderwood, 2009; Moreno-Layseca and Streuli, 2014). Adhesion complex 
molecules involve cytoskeletal components, adaptor proteins and enzymes that regulate cell 
behaviour including cell migration, ECM expression, differentiation, apoptosis and 
proliferation (Humphries et al., 2006; Berrier and Yamada, 2007; Leitinger and Hohenester, 
2007; Harburger and Calderwood, 2009; Streuli, 2009; Frantz et al., 2010; Schmidt and Friedl, 
2010; Xian et al., 2010; Moreno-Layseca and Streuli, 2014). ECM can regulate cell behaviour 
through harbouring growth factors or through ECM-cell interaction that mediate signalling 
pathways and alter the cellular response to growth factors (Streuli, 1999). The ECM is 
dynamic and changes throughout development (Hausman, 2007). It provides biochemical and 
biomechanical cues that are essential for tissue morphogenesis (Frantz et al., 2010).  
Many reports indicated the important role of different ECM components in animal 
models (Table 1-1). For example, mutation in aggrecan gene (ACAN, 7 bp deletion in exon 5) 
resulted in severely truncated aggrecan molecule which was a major cause of cartilage matrix 
deficiency in mice suggesting an important role of aggrecan in cartilage formation (Watanabe 
et al., 1994). Another example, transgene insertion mutation of versican gene inhibited the 
growth of the heart right ventricle (first segment) in heart defect mouse suggesting important 
role of versican in the development of the mouse heart (Mjaatvedt et al., 1998). Similarly, 
disrupting the Has2 gene, a major source for hyaluronic acid, resulted in sever cardiac defect 
and death of embryos in Has2–/–  mice suggesting that hyaluronic acid plays important role in 
the migration ant transformation of endothelial-cell in AV canal morphogenesis in mouse 
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(Camenisch et al., 2000). In addition, mutations in the ECM genes were reported in several 
human diseases (Table 1-2). For example, A splice mutation in the Versican gene (VCAN, 
heterozygous c.9265 + 1G > A nucleotide change in intron 8) was reported in Wagner 
syndrome patients with retinal detachment (Rothschild et al., 2013). Interphotoreceptor matrix 
proteoglycan 1 (IMPG1) gene mutations were reported in Vitelliform macular dystrophies 
(characterised by the accumulation of yellow deposits of lipofuscin pigment at the centre of 
the macula) leading to impaired metabolism of the interphotoreceptor matrix (IPM) and the 
accumulation of Vitelliform deposits in the sub-retinal space (Manes et al., 2013), whilst 
mutations in interphotoreceptor matrix proteoglycan 2 gene (IMPG2) cause progressive 
degeneration of the photoreceptors, leading to autosomal dominant retinitis pigmentosa (an 
inherited retinal dystrophy characterised by progressive degeneration of the photoreceptors 
(Bandah-Rozenfeld et al., 2010; Manes et al., 2013). 
Proteoglycans (PGs) and glycoproteins are the main macromolecules of the ECM 
(Frantz et al., 2010; Kwan, 2014; Reinhard et al., 2015). There are two main types of ECM 
that differ according to their location and arrangement: the basement membrane, which 
separates the epithelium from the surrounding stroma; and the interstitial connective tissue 
matrix, which surround cells and offers structural scaffolding for tissues (Bonnans et al., 
2014).     
Table 1-1: Role of different ECM components in animal models 
ECM Phenotypes References 
Aggrecan 
Mutation in Aggrecan gene (ACAN, 7 bp deletion in 
exon 5) resulted in severely truncated aggrecan 
molecule which was a major cause of cartilage matrix 
deficiency in mice. 
(Watanabe et al., 
1994; Rozario 
and DeSimone, 
2010) 
Brevican 
Brevican-null mice displayed alterations in the 
expression of neurocan and less prominent formation of 
Perineuronal nets surrounding neurons than in wild-type 
mice brain suggesting structural and functional roles of 
Brevican in the development of mouse brain. 
(Brakebusch et 
al., 2002; 
Rozario and 
DeSimone, 
2010) 
Collagen  
IV 
Collagen IV-null mice displayed structural deficiencies 
(discontinuities or ruptures) in the basement membranes 
suggesting a fundamental role for collagen IV in for the 
maintenance of integrity and function of basement 
membranes in mice.  
(Poschl et al., 
2004; Rozario 
and DeSimone, 
2010) 
Fibronectin 
Fibronectin-mutant caused embryonic (E14.5) 
abnormalities such as deformed heart and embryonic 
vessels which caused lethality in mice suggesting that 
fibronectin is required for embryogenesis in mice.  
(George et al., 
1993; Rozario 
and DeSimone, 
2010) 
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Table 1-1: Role of different ECM components in animal models, continued. 
ECM Phenotypes References 
Hyaluronan  
Hyaluronan synthases, Has2–/– mouse embryos 
lack the characteristic transformation of cardiac 
endothelial cells into mesenchyme suggesting 
important role of Hyaluronan in the migration ant 
transformation of endothelial-cell in AV canal 
morphogenesis in mouse. 
(Camenisch et al., 
2000) 
Laminin 
Disruption of laminin lambc1 in zebrafish caused 
the expulsion of retinal cells through the retinal 
pigment epithelium RPE into the adjacent 
forebrain and lens and corneal malformations 
suggesting important role for lambc1 in eye 
development in zebrafish. 
(Gross et al., 2005; 
Rozario and 
DeSimone, 2010) 
Neurocan 
Mild defects in synaptic plasticity in Neurocan-
deficient mice suggesting important function of 
Neurocan subtle function in the development of 
mice brain. 
(Zhou et al., 2001; 
Rozario and 
DeSimone, 2010) 
Nidogen 
Nidogen-1 knockout mouse displayed interruptions 
in the inner limiting membrane that result in small 
retinal ectopias and small holes in the optic nerve 
suggesting important function for Nidogen-1 in the 
development of basement membranes.    
(May, 2012) 
Versican 
Transgene insertion mutation of versican gene 
inhibited the growth of right ventricle of the heart 
in heart defect mouse suggesting important role of 
versican in the development of the mouse heart. 
(Mjaatvedt et al., 
1998; Rozario and 
DeSimone, 2010) 
 
 
Table 1-2: Examples of mutations in ECM components reported in human diseases. 
ECM Human Disease Reference 
Aggrecan Spondyloepiphyseal dysplasia, Kimberley type (Bateman et al., 2009) 
Collagen IV Axenfeld-Rieger syndrome (Hausman, 2007) 
Collagen XVIII Knobloch syndrome type I 
(Hausman, 2007; 
Sarrazin et al., 
2011) 
Fibrillin-1 Marfan’s syndrome (Hausman, 2007) 
Perlecan Schwartz–Jampel syndrome (skeletal dysplasia) 
(Sarrazin et al., 
2011) 
Versican Wagner syndrome 
(Kloeckener-
Gruissem et al., 
2013) 
SPACR 
(IMPG1) Vitelliform Macular Dystrophies (Manes et al., 2013) 
SPACRCAN 
(IMPG2) Retinitis pigmentosa  
(Bandah-Rozenfeld 
et al., 2010) 
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1.1.2. Proteoglycans (PGs) 
PGs include both ECM molecules and cell-surface PGs such as syndecans and 
glypicans (Figure 1-1) (Schaefer and Schaefer, 2010). PGs consist of one core protein and 
one or several glycosaminoglycans (GAG) which are long, negatively charged, linear chains 
of disaccharide repeats with the exception of hyaluronan (HA) which is only polysaccharide 
and lacks a protein core (Hausman, 2007; Frantz et al., 2010; Clark et al., 2011; Keenan et al., 
2012; Mouw et al., 2014; Reinhard et al., 2015).        
  Based on their sulphated and non-sulphated GAG chains, PGs are classified into 
heparan sulphates (HSPGs), chondroitin sulphates (CSPGs), dermatan sulphates (DSPGs), 
keratan sulphates (KSPGs) and HA (Clark et al., 2011; Reinhard et al., 2015). The GAG 
chains of HSPGs, CSPGs and DSPGs are composed of repeated region of disaccharide that 
contain acetylated amino sugar moieties (N-acetyl-glucosamine or N-acetylgalactosamine) 
and mostly uronic acid (L-iduronic acid or D-glucoronic acid) (Schaefer and Schaefer, 2010). 
HSPGs, CSPGs and DSPGs sulphated chains are connected to their core proteins via serine 
residues (Schaefer and Schaefer, 2010). In contrast, the GAG chains of KSPGs are made of 
repeating disaccharide containing galactose (−4 N-acetyl-glucosamine-β1,3-galactose-β1) and 
have a different linkage regions from other GAGs because their chains can be synthesised on 
serine/threonine O-linked oligosaccharides and on N-linked oligosaccharides  (Schaefer and 
Schaefer, 2010). Alternatively, based on  their location and binding, PGs can be classified into 
three main families: 1) small leucine-rich PGs (SLRPs) such as decorin), 2) modular PGs that 
can be divided into hyalectans (hyaluronan-binding PGs including versican, aggrecan, 
neurocan, and brevican) and non-hyaluronan-binding PGs of the basement membrane such as 
agrin and perlecan (both are HSPGs) (Bix and Iozzo, 2008; Schaefer and Schaefer, 2010).  
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 Figure 1-1: Main classification of PGs (adapted from reference (Schaefer and Schaefer, 
2010)).  
Based on their location and binding, PGs can be classified into three families including 
SLRPs, modular PGs (hyaluronan- and non-hyaluronan-binding PGs) and cell-surface PGs 
(Schaefer and Schaefer, 2010). 
 
1.1.3. Glycoproteins 
ECM glycoproteins are fibrous proteins that have structural and adhesive functions 
and include collagens, elastin, tenascins, fibronectins, laminins and entactin (nidogen) 
(Hausman, 2007; Frantz et al., 2010; Rozario and DeSimone, 2010). ECM glycoproteins 
contain less sugar residues in the heterosaccharide than PGs (Margolis and Margolis, 1983). 
Glycoproteins are involved in ECM assembly and act as reservoir of growth factors (Bonnans 
et al., 2014). For example, the amount of collagen IV in the basement membrane modulates 
the assembly of fibronectin (FN) via confining cell-FN interaction (Groulx et al., 2011). 
Collagens are the most abundant proteins in the interstitial ECM (Rozario and DeSimone, 
2010) and comprise up to 30% of the total protein mass in animals (Frantz et al., 2010). 
Collagens form the structural part of the ECM and provide tensile strength to a tissue (Frantz 
et al., 2010; Rozario and DeSimone, 2010). There are 28 discovered collagens resulting from 
49 gene products of collagen α-chain (Gordon and Hahn, 2010). Collagens are mainly 
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classified into fibril and non-fibril forms that can be arranged into sheets or reticular networks 
(Rozario and DeSimone, 2010). Elastin fibres allow recoil to tissue that undergo frequent 
stretch (Frantz et al., 2010) and are mainly covered by fibrillins (glycoprotein microfibrils) 
that are important for elastin fiber integrity (Wise and Weiss, 2009). FN is a fibrous 
glycoprotein that mediates cell attachment and function (Frantz et al., 2010). It can stretch 
various times over its length via cellular traction forces and act as mechano-regulator (Smith 
et al., 2007; Frantz et al., 2010). Moreover, FN is essential for cell migration during 
development such as directing the migration of myocardial precursor in zebrafish heart 
organogenesis (Matsui et al., 2007). 
 
1.1.4. Cellular receptors for ECM 
The major receptors for the ECM are the integrins (Hynes and Naba, 2012) but other 
ECM receptors also exist such as dystroglycan (that binds to laminin, agrin, and perlecan in 
the basement membrane), CD44 (which binds to hyaluronan), the discoidin domain receptor 
(DDR) and tyrosine-kinases which are the receptors for collagen (Hynes and Naba, 2012). 
These ECM receptors act as transmembrane link to the cytoskeleton and to signal transduction 
pathways (Hynes and Naba, 2012). Integrins regulate the extracellular affinity of other 
receptors (Hynes and Naba, 2012).     
Integrins are widely expressed transmembrane glycoprotein receptors that facilitate 
cell-cell adhesion and cell-ECM adhesion (Harburger and Calderwood, 2009; Barczyk et al., 
2010; Moreno-Layseca and Streuli, 2014; Walters and Gentleman, 2015). Different subunits 
of integrins are expressed in several layers of the adult human retina (Table 1-3) (Brem et al., 
1994), and in embryonic and adult stem cells (Table 1-4) (Prowse et al., 2011). Integrin 
heterodimers consist of non-covalently associated α and β subunits (Harburger and 
Calderwood, 2009; Barczyk et al., 2010).  
Table 1-3: Expression of integrins in adult retina of  human eyes (Brem et al., 1994). 
Integrins RPE Rods Cones OLM ONL OPL INL IPL GCL NFL ILM 
β1 - - - - - - - - - - + 
β2 +/- + + + + + +/++ + + + + 
β3 - - - - - - - - - +/- - 
α2 - + + - +/++ + +/++ + +/++ + +/- 
α3 - - - +/- + + + + + + +/- 
α4 + + + + + + + + + + - 
α5 - +/- +/- + +/- +/- + +/- +/- - - 
α6 - - - - - - - - - - - 
αv - - - - - - - - - - - 
RPE = retinal pigment epithelial cells; OLM = outer limiting membrane; ONL = outer nuclear 
layer; OPL = outer plexiform layer; INL = inner nuclear layer; IPL = inner plexiform layer; 
GCL = ganglion cell layer; NFL = nerve fiber layer; ILM = inner limiting membrane. 
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Table 1-4: The expression of integrins in embryonic and adult stem cells (Prowse et al., 
2011). 
Cell 
Type 
Integrin subunit 
α
1 
α
2 
α
3 
α
4 
α
5 
α
V 
α
6 
α
7 
α
8 
α
9 
α 
10 
α 
11 
α
M 
α
X 
α
L 
α
E 
β
1 
β
2 
β
3 
β
4 
β
5 
β
6 
β
7 
β
8 
MSC +/- 
+
/- + 
+
/- + 
+
/- 
+
/- -   
+ 
/- + - + + - + 
+
/
- 
+
/
- 
+ 
+
/
- 
+
/
- 
+ + 
hESC +/- 
+
/- + - + + + + - - - +    + + + 
+
/
- 
- + -   
HSC - - - + +  + + - + - -     + +       
NSC - +/- + - 
+
/-  + +         +   -     
MSC; mesenchymal stem cell. hESC; human embryonic stem cells. HSC; haematopoietic 
stem cell or CD34+ haematopoietic progenitor. NSC; neural stem cell. “+” shows an 
identified integrin (Prowse et al., 2011). “-“ shows the integrin subunit was investigated but 
not detected and “+/-“ shows positive and negative testing for the subunit in different 
publications (Prowse et al., 2011). No information has been found for the remaining stem 
cells and integrin subunit pairs (Prowse et al., 2011). 
 
 In human, there are 18 α and 8 β subunits that can assemble into 24 possible 
confirmations (Table 1-5) (Johnson et al., 2009; Barczyk et al., 2010; Walters and Gentleman, 
2015). Each subunit contains a large extracellular domain and short cytoplasmic domain (50aa 
sequence, except for β4 which has around 1000aa sequence in its cytoplasmic domain), 
creating a typical type I transmembrane subunit (Hynes, 2002; Prowse et al., 2011). On the 
extracellular side, integrins bind to various ECM components by recognising specific amino 
acid sequence such as Arg-Gly-Asp (RGD) in fibronectin, vitronectin and fibrinogen; Gly-
Phe-Hyp-Gly-Glu-Arg (GFOGER) in collagens; and Leu-Asp-Val (LDV) in alternatively 
spliced region of fibronectin (Barczyk et al., 2010; Walters and Gentleman, 2015). Moreover, 
integrins can bind to surface receptors on other cells by direct interaction with membrane 
bound proteins including intracellular- or vascular- cell adhesion molecules (ICAM and 
VCAM), or through linker molecules such as von Willebrand factor (Figure 1-2) (Prowse et 
al., 2011). Inside the cell, integrins attach to the cytoskeleton via several linker proteins 
(Walters and Gentleman, 2015). As a result, integrins act as mechanosensors and bidirectional 
signalling receptors that transmit environmental information into the cell (outside-in 
signalling) and intracellular information to the ECM (inside-out signalling) (Walters and 
Gentleman, 2015).   
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Table 1-5: Integrins and their ligands 
Integrin Ligands Recognition Sequence References 
α1β1 Collagens, semaphoring 7A GFOGER 
(Johnson et 
al., 2009; 
Barczyk et 
al., 2010) 
α2β1 Collagens, tenascin C, E-cadherin, endorepellin GFOGER 
α3β1 Laminins  
α4β1 Fibronectin, VCAM  
α5β1 Fibronectin RGD 
α6β1 Laminins, ADAMs  
α7β1 Laminins  
α8β1 Fibronectin, vitronectin, tenascin C, RGD 
α9β1 Tenascin C, osteopontin, ADAMs, factor XIII, VCAM, VEGF-C, VEGF-D  
α10β1 Collagens GFOGER 
α11β1 Collagens GFOGER 
αLβ2 ICAM  
αMβ2 ICAM, VCAM, iC3b, factor X, fibrinogen  
αXβ2 Fibrinogen, plasminogen, heparin, iC3b  
αDβ2 ICAM, VCAM  
αIIBβ3 Fibrinogen, fibronectin, vitronectin RGD 
α6β4 Laminins  
αvβ1 Fibronectin, vitronectin RGD 
αvβ3 Fibrinogen, fibronectin, vitronectin, tenascin C, tumstatin, MMP-2 RGD 
αvβ5 Vitronectin RGD 
αvβ6 Fibronectin, TGF-β-LAP RGD 
αvβ8 Vitronectin, TGF-β-LAP RGD 
αEβ7 E-cadherin  
α4 β7 Fibronectin, VCAM, MadCaM  
ADAM= a disintegrin and metalloproteinase; GFOGER= Gly-Phe-Hyp-Gly-Glu-Arg; iC3b= 
inactivated complement component 3b; ICAM= intercellular adhesion molecule; MadCaM= 
mucosal vascular addressin cell adhesion molecule; MMP-2= matrix metalloproteinase-2; 
RGD= Arg-Gly-Asp; TGF-β-LAP= transforming growth factor beta- Latency associated 
peptide; VCAM= vascular cell adhesion molecule; VEGF= vascular endothelial growth 
factor.   
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Figure 1-2: Integrins functions (adapted from reference (Prowse et al., 2011)).  
A diagram of main integrins interactions in Cell-ECM adhesion, Cell-Cell adhesion and 
integrins-growth factor cross-talk. ECM, extracellular matrix; GF, growth factor; GFR, 
growth factor receptor; VCAM, vascular cell adhesion molecule. 
 
 
1.1.5. Integrin activation and inside-out signalling 
Integrins exist in a compact bent conformation that represents the inactive form of 
integrins (Barczyk et al., 2010). Inside-out signalling is initiated by the binding of talin to 
integrins β cytoplasmic tail via phosphotyrosine binding domain (PTB) (Ginsberg et al., 
2005). Talin is one of the actin binding proteins that connect integrins to the actin 
cytoskeleton (Ginsberg et al., 2005). The head domain of talin disrupts the salt bridge 
between the α and β cytoplasmic tails causing their separation and the activation of integrins 
(Ginsberg et al., 2005). Integrin activation can be inhibited by binding of integrins to proteins 
containing (PTB)-domain such as docking protein 1 (Dok1) and integrin-cytoplasmic-
domain-associated protein 1 (ICAP1) that compete with talin binding to β integrin and impair 
activation (Harburger and Calderwood, 2009).        
1.1.6. Outside-in signalling (focal adhesion formation) 
On the extracellular side, the binding of the integrin receptors to the ECM ligands 
initiates cell-ECM interaction (Walters and Gentleman, 2015). The interaction of integrins 
receptors with the ECM mediate outside-in signalling through the formation of integrin 
clusters known as focal adhesion sites (Prowse et al., 2011). Several types of adhesion 
structures are formed due to cell-ECM interaction including focal complexes, focal adhesions 
and fibrillar adhesions (Berrier and Yamada, 2007). Focal complexes are small and transient 
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adhesion structures that are formed during early cell attachment to the matrix (Berrier and 
Yamada, 2007). Focal adhesions (FAs) are large elongated structures in which binding of 
clustered integrins to the ECM fibrils occurs on the outside of the cell and connect on the 
inside to the actin cytoskeleton via actin binding proteins (ABPs) such as tensin, paxillin, 
vinculin, talin and zyxin (Figure 1-3) (Olberding et al., 2010; Schwartz, 2010; Ciobanasu et 
al., 2013). If the focal complexes stabilised they will form focal adhesions that can convert 
into fibrillar adhesion (Berrier and Yamada, 2007). 
 
Figure 1-3: Comparison between focal and fibrillar adhesions, adapted from reference 
(Berrier and Yamada, 2007).  
 
Signalling proteins must be recruited to regulate adhesion-dependant processes due to the lack 
of intrinsic enzymatic activity in the integrins receptors (Berrier and Yamada, 2007). Three 
main classes of proteins aggregate to the cell-ECM adhesion: (1) integrin-binding proteins 
that bind directly to integrin cytoplasmic domains such as talin; (2) adaptors proteins lacking 
enzymatic activity such as vinculin, paxillin and α-actinin; (3) enzymes that effect integrins 
downstream signalling and regulate cytoskeletal remodelling, cell migration, survival and 
gene regulation such as tyrosine kinases, serine/threonine kinases and tyrosine phosphatases 
(Berrier and Yamada, 2007; Prowse et al., 2011). 
1.1.7. Focal adhesion - function 
FAs sense and respond to variations in the components and properties of the ECM and in 
force generated by different actin network and adapt cell-matrix adhesion via activation of 
several pathways that control cellular behaviours (Figure 1-4) such as actomyosin-integrin-
ABP-ECM pathway (Ciobanasu et al., 2013), extracellular signal-related-kinase/ mitogen-
activated protein kinase (ERK/MAPK) pathway and Rho associated protein kinase pathway 
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(RhoA/ROCK) (Walters and Gentleman, 2015). ERK/MAPK pathway plays important role in 
cell growth control via connecting the activation of growth factor receptors to the machinery 
of cell-cycle (Huang and Ingber, 1999). The activation of ERK/MAPK causes the induction of 
cyclin D1 and triggers a series of nuclear events that leads the cell to pass through the late-G1 
restriction point and enter the S phase (Huang and Ingber, 1999). Rho/ROCK pathway is 
important for the organisation of the actin cytoskeleton and promotes specialised actin 
structures (stress fibres) that are essential for cell polarity and migration (Brakebusch and 
Fassler, 2003).    
 
Figure 1-4: A diagram of integrin-mediated cell-ECM adhesion, adapted from reference 
(Berrier and Yamada, 2007).  
Cell-ECM adhesion causes integrin clusters and aggregation of several types of proteins that 
control various cellular behaviors (Berrier and Yamada, 2007).   
 
  1.1.8. ECM remodelling 
The ECM is a dynamic structure that constantly changes its composition (remodelled) 
to control tissue homeostasis (Reinhard et al., 2015). During development, ECM remodelling 
is an effective mechanism to regulate various cellular functions such as cell shape, 
12 | P a g e  
 
proliferation and migration that are important for tissue morphogenesis (Bonnans et al., 2014). 
The main process during ECM remodelling is the cleavage of ECM components, which 
regulates ECM abundance, composition and structure as well as releasing biologically active 
molecules such as growth factors including fibroblast growth factor (FGF), epidermal growth 
factor (EGF) and different signalling molecules such as WNTs, amphiregulin and 
transforming growth factor-β (TGFβ) (Bonnans et al., 2014). Several families of proteases are 
involved in ECM cleavage including matrix metalloproteinases (MMPs) and adamalysins 
(Table 1-6) (Bonnans et al., 2014).  
 
Around 23 human MMPs have been discovered and these are the main enzymes that 
degrade ECM (Bonnans et al., 2014). All MMPs share a self-inhibitory prodomain at the 
amino terminus, and a catalytic domain, flexible hinge motif and hemopexin domain at the 
carboxyl terminus (Lu et al., 2011). Most of the MMPs contain the basic three-domain 
structure with certain variations in some enzymes such as MMP-2 and MMP-9 contain 
fibronectin type II repeats found in the catalytic domain to mediate collagen binding (Lu et al., 
2011). Most of the MMPs are secreted molecules except the membrane-type MMPs (MT-
MMPs), MMP-14, -15, -23, and -24 that have a transmembrane domain and a short 
cytoplasmic tail, while MMP-17 and -25 have glycosylphosphatidylinositol (GPI) linkages 
(Lu et al., 2011). MMPs enzymatic activity is low under normal states but increases during 
the processes of repair or remodelling as well as in inflamed or diseased tissues (Bonnans et 
al., 2014). They are activated by proteolytic cleavage (by serine proteases or other MMPs) or 
via the modification of the thiol group by oxidation (Bonnans et al., 2014). MMPs proteolytic 
activity on ECM plays crucial roles in organogenesis and branching morphogenesis (Bonnans 
et al., 2014). MMPs target a broad spectrum of ECM molecules such as MMP-1 targeting 
collagen III and entactin, whereas MMP-3 and MMP-10 target aggrecan, fibronectin and 
laminin (Lu et al., 2011). Meprins are part of the astacin family of MMPs and consist of two 
subunits (α and β) (Bonnans et al., 2014). They can cleave ECM proteins such as collagen IV, 
nidogen, fibronectin and laminin, and indirectly control ECM remodelling by activating other 
MMPs (Bonnans et al., 2014). For instance, the activation of MMP9 can be accelerated by 
meprin-β cleaving ADAM10, and by meprin-α and meprin-β promoting the cleavage of pro-
MMP9 by MMP3 (Bonnans et al., 2014). In addition to ECM cleavage, MMPs play important 
role in cell signalling by proteolytically activating cytokines such as transforming growth 
factor-β (TGF-β) by MMP-9 (Sivak and Fini, 2002). Several MMPs have been reported in 
human vitreous and interphotoreceptor matrix  including MMPs 1, 2, 3 and 9 (Sivak and Fini, 
2002). Up-regulation of MMPs has been observed with a number of diseases such as age-
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related macular degeneration and proliferative diabetic retinopathy (Sivak and Fini, 2002). 
However, up-regulation of MMPs has also a positive impact on the cell behaviour. For 
example, up-regulation of MMP-2 has also a beneficiary effect on inhibiting neurocan, an 
extracellular matrix component which increases the cell mortality and promotes cells 
migration and integration of retinal progenitor cells into host retina (Jiang et al., 2010).    
Table 1-6: Different proteases and their ECM substrates (Lu et al., 2011; Bonnans et al., 
2014). 
Enzyme  ECM and other substrates 
MMP7  Collagen IV, gelatin, fibronectin, laminin, elastin, aggrecan, tenascin, decorin 
MMP26 Collagen IV, fibrinogen, fibronectin, gelatin, pro-MMP9 
MMP1 Collagens, entactin, aggrecan, entactin, tenascin, perlecan, ovostatin, MMP2, MMP9, pro-MMP9 
MMP3 Collagens, gelatin, aggrecan, laminin, elastin, casein, osteonectin, fibronectin, ovostatin, entactin, plasminogen, pro-MMP9 
MMP8 Collagens, fibronectin, aggrecan 
MMP10 Collagens, gelatin, casein, elastin, fibronectin 
MMP12 Collagen IV, elastin, gelatin, casein, fibronectin, vitronectin, laminin, entactin, fibrinogen 
MMP13 Collagens, tenascin, plasminogen, aggrecan, fibronectin, osteonectin, MMP9 
MMP19 Collagen I and IV, gelatin, fibronectin, laminin 
MMP20 Amelogenin 
MMP11 Collagens, laminin, elastin, fibronectin, casein, aggrecan 
MMP21 N.D. 
MMP28 Casein 
MMP2 Collagens (IV, V, VII, X), gelatin, elastin, fibronectin 
MMP9 Collagens (IV, V, VII, X), gelatin, elastin, fibronectin 
MMP17 Gelatin, fibrinogen, pro-MMP2 
MMP25 Collagen IV, gelatin, fibronectin, pro-MMP2, pro-MMPp 
MMP14 Collagens, gelatin, fibronectin, laminin, vibronectin, entactin,pro-MMP2 
MMP15 Fibronectin, gelatin, vibronectin, entactin, laminin, pro-MMP2 
MMP16 Collagen III, gelatin, casein, fibronectin, pro-MMP2 
MMP24 Fibronectin, pro-MMP2, fibrin, gelatin 
MMP23A 
MMP23B Gelatin 
ADAM9 Fibronectin, gelatin 
ADAM12 Collagen IV, gelatin, fibronectin 
ADAM15 Collagen IV, gelatin 
ADAM10 Collagen IV, gelatin, meprin β 
ADAMTs Aggrecan, versican, brevican, decorin, fibronectin, pro-collagens 
Meprin α Collagen IV, nidogen 1, fibronectin, laminin 111, laminin 332, pro-collagen I, pro-collagen III 
Meprin β Collagen IV, nidogen 1, fibronectin, laminin 111, laminin 332, pro-collagen I, pro-collagen III, pro ADAM10 
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Adamalysins family include ADAMs (a disintegrin and metalloproteinases) and 
ADAMs with a thrombospondin motif (ADAMTS)  (Bonnans et al., 2014). ADAMs have a 
disintegrin domain, a cysteine-rich region and a series of epidermal growth factor (EGF)-like 
repeats (Lu et al., 2011; Khokha et al., 2013; Bonnans et al., 2014). They  cleave 
transmembrane ectodomains that are adjacent to the cell membrane which release cytokines, 
growth factors, receptors and adhesion molecules (Bonnans et al., 2014). ADAMs bind 
integrins through the disintegrin domains that mediate cell-ECM interactions (Lu et al., 2011), 
and interact with HS through Cys-rich domains (Bonnans et al., 2014). Unlike ADAMs, 
ADAMTS are secreted proteinases that contain thrombospondin type-I repeats in their 
carboxyl terminus (Lu et al., 2011; Bonnans et al., 2014). ADAMTS cleave PGs, collagens 
and von Willebrand factor (Bonnans et al., 2014). 
 
There are other enzymes that contribute in ECM modeling such as serine protease 
plasmin that degrade fibrin, fibrinogen and laminin (Lu et al., 2011; Bonnans et al., 2014). In 
addition, heparanases and sulphatases can target ECM PGs and modulate their properties (Lu 
et al., 2011; Bonnans et al., 2014). Sulphatase 1 and 2 are secreted endosulphatases that 
remove 6-O-sulphate from HS and alter HS binding to several cytokines and growth factors 
including FGF, vascular endothelial growth factor (VEGF) and Wnt (Lu et al., 2011; Bonnans 
et al., 2014). Heparanases present in several developmental processes and alter the structure 
of ECM by cleaving HS that release HS-bound growth factors, cytokines and bioactive 
saccharide fragments (Lu et al., 2011; Bonnans et al., 2014).   
 
Firm regulation of ECM proteolysis is required to avoid excessive and deleterious 
tissue degradation (Bonnans et al., 2014). The tissue inhibitor of metalloproteinases (TIMP) 
family is composed of four members (TIMP1-TIMP4) that reversibly inhibit the activities of 
MMPs, ADAMs and ADAMs except meprins (Bonnans et al., 2014). TIMPs contain two 
domains: an amino-terminal domain of around 125 amino acid residues that contain most of 
the MMP inhibitor activity, and carboxy-terminal domain of about 65 residues that facilitates 
the binding between TIMPs and MMPs (Lu et al., 2011; Khokha et al., 2013).  TIMPs bind to 
MMPs at a 1:1 ratio which regulates their proteolytic activity and each TIMP has special 
MMP-binding specificity (Lu et al., 2011; Bonnans et al., 2014). TIMPs 12 and 4 are present 
in soluble form in vivo whereas TIMP3 is sequestered in the ECM and the main inhibitor of 
ADAMs and ADAMTS (Bonnans et al., 2014). In addition, meprins have been found to be 
naturally inhibited by Cystatin C, elafin and fetuin (Bonnans et al., 2014). Fetuin is a plasma 
protein that is strongly expressed in developing epithelial and contains three domains 
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including two N-terminal cystatin-like domain and one C-terminal domain (Hedrich et al., 
2010). Cystatin C is a protein that is structurally close to fetuin and both inhibit α-meprin 
(Hedrich et al., 2010).   
 
1.1.9. ECM and growth factor interaction 
ECM interacts with growth factors by binding directly through their domain or cross-
talk between integrins and growth factor receptors (GFR) (Taipale and Keski-Oja, 1997). 
Integrins regulate the activity of GFR either by recruiting adaptor proteins through integrins 
cytoplasmic domain and concentrating them towards GFR, or by changing their localisation 
through focal adhesion (Alam et al., 2007). For example, β1A  forms a complex with the 
receptors of insulin growth factor-I (IGF-IR) promoting cellular proliferation while β1C 
reduces cells proliferation by inhibiting auto-phosphorylation of IGF-IR (Goel et al., 2005). 
Moreover, ECM acts as a reservoir that retains various growth factors which can be released 
proteolytically (von der Mark et al., 2010; Kim et al., 2011; Lu et al., 2011; Bonnans et al., 
2014).  For instance, the PG, perlecan, which is present in basement membranes can bind 
fibroblast growth factors (FGFs) (von der Mark et al., 2010) which can be cleaved by 
heparanase and are released as soluble ligands (Kim et al., 2011). HSPGs in the ECM 
commonly participate in binding, transporting and activating developmental control factors 
such as Wnt factor and Indian hedgehog (Ihh)(von der Mark et al., 2010). Moreover, 
fibronectin, vitronectin and HSPGs can bind to hepatocyte growth factor (HGF) and create 
complexes with Met (HGF receptor) and integrin which positively or negatively control the 
functions of the diffusible morphogen HGF and promote cell migration (Taipale and Keski-
Oja, 1997; Hynes, 2009; Kim et al., 2011). Endothelial growth factor EGF-like motif 
embedded in several ECM components including laminin, tenascin and fibrillins (Brizzi et al., 
2012). The binding of ECM to growth factors usually through specific domains that results in 
modulation of signalling activities (Kim et al., 2011). For example, fibronectin and tenascin-C 
bind to vascular endothelial growth factors (VEGF) through FnIII domains and initiate 
VEGF-mediated signalling through its receptor VEGFR2 and enhance cell proliferation 
(Hynes, 2009; Kim et al., 2011). In addition, some growth factors depend on heparan sulfate 
as a cofactor to bind to their signalling receptors (Hynes, 2009). For example, the binding of 
FGF to FGFR requires heparan sulfate chain that plays crucial role in signalling by acting as a 
solid-phase ligand (Hynes, 2009).  
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1.2. Retinal development and the role of ECM components 
1.2.1. Structure and function of the human retina 
The human eye is a remarkable organ that possesses the ability to perceive vision 
including shapes, colours, motions and different intensities of light (Sung and Chuang, 2010). 
The lens transmits and focuses light onto the neural retina which collects and amplifies the 
signal information before it is transmitted to the midbrain through the optic nerve (Figure 1-
5A) (Sung and Chuang, 2010). The retina is central nervous tissue (CNS) approximately 0.2 
mm thick and it is the first component of the visual system to carry out image processing 
through the circuits of five main types of cells including the light-sensitive photoreceptors 
(rods and cones), horizontal, bipolar, amacrine and ganglion cells (Sung and Chuang, 2010).  
These five cell types are organised in three main layers; the outer nuclear layer (ONL), inner 
nuclear layer (INL) and ganglion cell layer (GCL) (Figure 1-5B) (Nag and Wadhwa, 2006). 
In addition to these types of cell, Müller cells, specilasied radial glia that spread between the 
cells through the entire retina from the outer to the inner limiting membrane (Nag and 
Wadhwa, 2006). Photoreceptors form the outer part of the retina, their cell bodies forming the 
ONL (Sung and Chuang, 2010) whilst their inner and outer segments reside in the 
photoreceptor layer (Sung and Chuang, 2010). The retinal pigment epithelium (RPE) lies 
behind the photoreceptors and captures scattered light and unabsorbed light (Sung and 
Chuang, 2010). The RPE also has other functions that support the normal function of the 
photoreceptors including epithelial transport, phagocytosis, visual cycle, immune modulation 
and secretion (Strauss, 2005). In addition, Bruch’s membrane (BrM) is an important 
pentalaminar structure found between the RPE and the choroidal capillaries of the eye (Booij 
et al., 2010). BrM plays a crucial role in regulating the exchange of the oxygen, biomolecules, 
nutrients, fluids and metabolic waste products between the retina and the general circulation 
as well as cellular communication, differentiation, proliferation or migration (Booij et al., 
2010). 
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Figure 1-5: (A) Diagram of the human eye with fovea enlarged (Sung and Chuang, 2010). 
The fovea is a specialised anatomical area of the human retina, around 500 µm in diameter, 
where the number of photoreceptors (cones) and associated bipolar and ganglion cells are 
higher than the other parts of the retina (Nag and Wadhwa, 2006). The retina constitutes the 
inner lining of the posterior part of the eye (Sung and Chuang, 2010). The RPE is located 
between the retina and the choroid, a vascular connective tissue (Sung and Chuang, 2010). (B) 
Diagram shows the laminated structure of the retina (Swaroop et al., 2010). The ONL 
contains the somas (cell bodies) of the photoreceptors (R, rods and C, cones) and the INL 
contains the somas of the horizontal (H), amacrine (A), bipolar (B) and Müller glial (M) cells 
(Sung and Chuang, 2010; Swaroop et al., 2010).  The somas of the ganglion cells constitute 
the GCL (Sung and Chuang, 2010), and their axons extend toward and form the optic nerve 
which transmits visual signals to the brain (Swaroop et al., 2010). The processes and synaptic 
terminals of the photoreceptors, bipolar and horizontal cells are found in the outer plexiform 
layer (OPL) (Sung and Chuang, 2010; Swaroop et al., 2010). The processes and synaptic 
terminals of the amacrine, bipolar and ganglion cells are located in the inner plexiform layer 
(IPL) (Sung and Chuang, 2010; Swaroop et al., 2010). The terminals of the Müller glial cells 
form the inner and outer limiting membranes (Swaroop et al., 2010). 
 
1.2.2. Development of the human retina  
The eye morphogenesis and pattering is highly conserved in vertebrates (Sasai et al., 
2012). In human, the eye derived from four tissues in the embryo: the neural ectoderm, the 
optic neural crest, the surface ectoderm and the mesoderm (O'Rahilly, 1975). The neural 
ectoderm gives rise to the retina, RPE, optic nerve, ciliary body and iris (O'Rahilly, 1975). 
The surface ectoderm gives rise to the lens, corneal epithelium and eyelid skin (O'Rahilly, 
1975). The neural crest gives rise to the sclera and cornea (endothelium) while the mesoderm 
gives rise to the vitreous, cornea (stroma) and blood vessels (O'Rahilly, 1975). At 3 weeks of 
gestations (WG), the neural folds and the optic primordium and optic sulcus appear in the fold 
of each side of the forebrain at around 22 days of gestation (O'Rahilly, 1975). The optic 
B A 
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sulcus will become the optic vesicle 2 days later (O'Rahilly, 1975) in which retinal 
neuroepithelium evaginates (expands outwards) bilaterally from the diencephalic wall 
forming the optic vesicles (Figure 1-6) (Sasai et al., 2012). At around 28 days of gestation, 
the retinal disc appears on in the wall of the optic vesicle (O'Rahilly, 1975; Nag and Wadhwa, 
2006). The distal part of the vesicle (in contact with the surface ectoderm) invaginates (folds 
inward) to produce the bilayered optic cup (Sasai et al., 2012), and the lens are formed once 
the contact with the surface ectoderm has occurred (O'Rahilly, 1975). The outer layer of the 
optic cup develops into RPE and the inner layer becomes the neural retina (Sasai et al., 2012). 
Several major developmental signalling pathways such as FGF, Wnt, TGF-β, Shh, Notch and 
IGF-1 are essential for the adoption of optic cup to its precise gene expression before the 
onset of neurogenesis (Kwan, 2014; Mellough et al., 2014).  
 
Figure 1-6: Schematic diagram of optic cup morphogenesis (Mellough et al., 2014).  
 
In humans, neural differentiation in the central retina and fovea begins at 6 weeks of 
gestation and is complete by 19-21 weeks of gestation (midgestation), while neural 
differentiation in peripheral retina continues until 30 weeks of gestation (Hendrickson and 
Drucker, 1992; Nag and Wadhwa, 2006). By birth, all neurons and retinal layers become fully 
mature except in the foveal region where the differentiation of the photoreceptors continues 
for up to 5 months after birth (Nag and Wadhwa, 2006; Hendrickson and Zhang, 2017). The 
retina continue to increase in size until the 6th postnatal year (Nag and Wadhwa, 2006). 
During different stages of differentiation, retinal cells express a wide range of markers such as 
calcium-binding proteins, amino acid neurotransmitters, nitric oxide, neuropeptides and 
proteins of the phototransduction pathways (Nag and Wadhwa, 2006; Hoshino et al., 2017).  
 
The functional development of photoreceptor precursors (giving rise to cones and rods) 
varies between species (Swaroop et al., 2010). For example, the development of 
19 | P a g e  
 
photoreceptors is less advanced in mouse than human at birth (Swaroop et al., 2010). All 
photoreceptors are generated prenatally in human, whereas in mice they are generated pre- 
and postnatally (Swaroop et al., 2010). There are also significant differences between the two 
species in term of the number, ratio and distribution of the photoreceptors (Saghizadeh et al., 
2011). The human retina has a larger amount of cone cells (~5%) than the mouse retinal 
photoreceptors (~3% cone cells) (Fu and Yau, 2007) and it contains the fovea which is not 
present in the mouse (Sung and Chuang, 2010; Saghizadeh et al., 2011). Moreover, human 
retina is trichromatic (has three types of cone photoreceptors), whereas mouse retina is 
dichromatic (Saghizadeh et al., 2011). Therefore, it is important to study the developmental 
stages of human eye rather than other species in retinal research.  
 
1.2.3. Formation of retinal layers and neurons  
Different types of cells are generated at different stages of development (Jean et al., 
1998). Retinal ganglion cells are the first cells that appear (Jean et al., 1998). During the early 
development of the human embryonic eye, the retina starts to differentiate at 6 WG forming 
its inner neuroblastic zone (INZ) and ganglion cells (GCs) (Nag and Wadhwa, 2006). In 
addition, the RPE appears in the external layer of the optic cup at 6 WG (O'Rahilly, 1975).  
Around 7-8 WG, Müller cells appear and are located with the GCs in the INZ (O'Rahilly, 
1975; Nag and Wadhwa, 2006). Moreover, horizontal cells appears at this time point in the 
incipient fovea (Nag and Wadhwa, 2006). The outer neuroblastic zone (ONZ) appears at 9 
WG and composed of a heterogeneous population of undifferentiated neuroblasts (Nag and 
Wadhwa, 2006). ONZ is separated from the INZ by Chievitz layer, a transient fiber layer 
which will become the IPL (Figure 1-7A) (O'Rahilly, 1975; Nag and Wadhwa, 2006; 
Hendrickson, 2016). Before 9 WG, Ki-67 immuno-labelling shows that the central retina is 
more proliferative than the peripheral retina (Bozanic and Saraga-Babic, 2004; Nag and 
Wadhwa, 2006). Ki-67 is a nuclear protein used as a proliferation marker due to its expression 
in all cell cycle phases except the resting phase (G0) (Bozanic and Saraga-Babic, 2004). The 
INL starts to differentiate from the ONZ forming amacrine cells at around 11 WG (Rhodes, 
1979; Nag and Wadhwa, 2006) and bipolar cells at 15-16 WG (Nag and Wadhwa, 2006). The 
photoreceptors differentiate from the outer rows of the ONZ, cones born first at 10 WG and 
rods born at 12 WG (Rhodes, 1979; Nag and Wadhwa, 2006; Hendrickson and Zhang, 2017). 
The OPL starts to differentiate in the central retina at 11-12 WG and becomes prominent in 
the central to midperipheral area of the fetal retina by 16 WG (Figure 1-7B) (Nag and 
Wadhwa, 2006; Hendrickson, 2016). The differentiation of most retinal neurons proceeds in a 
central to peripheral direction and is attained by midgestation (20-21 WG) (Figure 1-7C) 
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(Nag and Wadhwa, 2006; Hendrickson, 2016). At this period, the connection to the visual 
centers is partially formed via the axons of retinal GCs (Hevner, 2000; Nag and Wadhwa, 
2006).            
 
Figure 1-7: Light micrographs of the human fetal retina at different gestational periods 
(Nag and Wadhwa, 2006). 
 At 11 WG (a), the RPE and the retina which is composed of ONZ and INZ, separated by the 
IPL (Nag and Wadhwa, 2006). At 16 WG (b), the OPL and GCL are prominent in the central 
retina while the neurons in the INL are still differentiating (Nag and Wadhwa, 2006). At 20 
WG (c), all retinal layers are established (Scale bar: 50µm) (Nag and Wadhwa, 2006).  
 
1.2.4. Photoreceptor differentiation 
At 15 WG, the cilium develops as a small projection from the apical end of the cone 
inner segments (Nag and Wadhwa, 2006; Hendrickson and Zhang, 2017). The cone inner 
segments will be arranged into mosaic patterns at 18-19 WG, where few large cone inner 
A 
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segments (blue cones) standing out from the mosaic of several small cone inner segments 
(red/green cones) (Narayanan and Wadhwa, 1998). They elongate and convert from spherical 
to an oval shape between 19 and 25 WG (Nag and Wadhwa, 2006). The rod inner segments 
are recognised and show ciliary outgrowths at 18-19 WG (Nag and Wadhwa, 2006). At 24 
WG, the rod outer segments start to develop from the distal part of cilia (Narayanan and 
Wadhwa, 1998; Nag and Wadhwa, 2006).  In Fovea, cones start to differentiate in the putative 
fovea at 13 WG (Yuodelis and Hendrickson, 1986; Nag and Wadhwa, 2006) while rods are 
not present until 15 WG (Nag and Wadhwa, 2006). Several markers start to be expressed at 
several time points during the development of the photoreceptors in the human fetal retina 
that could be critical in their differentiation and maturation (Table 1-7) (Nag and Wadhwa, 
2006).  
Table 1-7: Markers for photoreceptors in developing human retina until birth (Nag and 
Wadhwa, 2006; Hoshino et al., 2017). 
Photoreceptors 
Markers 
Expression starts at 
gestational week 
(GW) 
Retinal Location 
IRBP 9 foveal, peripheral 
TULP 9 foveal, peripheral 
Phosphodiesterase β 10 foveal 
AIPL 1 11 foveal 
Short opsin 11 foveal 
Long/medium opsin 14 foveal 
Taurine 18 central to peripheral 
Heat shock protein 70 20 midperipheral 
PEDF 21 foveal 
Calbindin 24 foveal 
Nrl 10 foveal edge, peripheral 
S-antigen 13 central, RT 
Rod opsin 15 RT, foveal 
IRBP = Interphotoreceptor retinal binding protein; TULP = Tubby-like protein-1; AIPL 1 = 
Leber congenital amaurosis protein; PEDF = pigment epithelium-derived factor; Crx = Cone-
rod homeobox; Nrl = Neural retina leucine zipper; RT = Retinal transplant. 
 
1.2.5. The role of ECM on formation of laminated retina during development 
In retina, the ECM divided into two distinct entities including the interphotoreceptor 
matrix (IPM) and the retinal ECM that surround other cells in the retina (Ishikawa et al., 
2015). The IPM surrounds the inner and outer segments of the photoreceptors and plays a 
significant role in retinal adhesion to the RPE (Hollyfield, 1999), retinoid transport 
(Hollyfield, 1999), photoreceptor differentiation (Karakousis et al., 2001) and intercellular 
communication (Beuckmann et al., 1996). During retinal development, the ECM plays major 
roles in numerous processes including cellular differentiation, proliferation, migration, 
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maturation, adhesion, guidance and axonal growth (Reinhard et al., 2015). For example, in 
chick embryos, removing the surface ectoderm and disrupting the surrounding ECM with 
collagenase resulted in the curvature of the optic vesicle at early stages of invagination and 
inhibition of subsequent invagination and optic cup formation (Oltean et al., 2016). Another 
study has demonstrated that blocking the interaction of rat retinal progenitor cells with 
laminin β2 in vitro reduced the fraction of cells that express rhodopsin, suggesting that this 
laminin could be important for rod photoreceptor differentiation (Hunter et al., 1992). 
Knockdown of laminin β2 also results in abnormal elongation of photoreceptor outer 
segments, abnormal electroretinogram, and atypical synaptic formation of rod photoreceptors 
and apoptosis in mice (Libby et al., 1999). Double knockout of laminin β2 and laminin γ3 in 
mice resulted in disruption of inner limiting membrane (ILM) and retinal dysplasia (Pinzon-
Duarte et al., 2010). 
Several ECM components have been studied in the mature and developing retina of 
many species including rat, mouse, and chicken as well as human adult retina (Table 1-8) 
(Popp et al., 2004; Hausman, 2007; Inoue et al., 2009; Clark et al., 2011; Keenan et al., 2012; 
Kwan, 2014). The localisation of ECM molecules varies between developmental stages 
(Keenan et al., 2012) and species (Clark et al., 2011). For example, versican has been 
identified in the nerve fibres and the inner plexiform layer of the embryonic chicken retina, 
while in adult chicken it has been found in photoreceptor layer and BrM (Keenan et al., 2012).  
HA is found only in the photoreceptor layer in the adult retina of chicken (Inoue et al., 2009) 
but in adult human retina HA is widely distributed throughout the whole retina (Clark et al., 
2011).  
Aggrecan, brevican, versican and neurocan are members of the CS family that plays 
an important role in maintaining adhesion between the RPE and neurosensory retina as well 
as BrM (Keenan et al., 2012). Moreover, they bind to HA from their N-terminal region and 
are involved in the development of the central nervous system (Popp et al., 2004). HA is 
another component of the ECM that has a vital role in tissue remodelling during development 
and normal tissue homeostasis as well as disease (Inoue et al., 2009). HA is expressed in the 
IPM and creates a scaffold that fills the matrix as well as binding to several proteins of the 
IPM such as versican, Interphotoreceptor Matrix Proteoglycan 1 (IMPG1) and 
sialoproteoglycan associated with cones and rods (IMPG2) (Inoue et al., 2009; Mellough et 
al., 2014). In addition, hyaluronan-binding motifs provide a structural link between the RPE 
and the neural retina (Ishikawa et al., 2015). HA is secreted from the apical side of the RPE 
(de et al., 2001) and has a binding affinity to PEDF which is  also secreted apically from the 
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RPE (Becerra et al., 2008; Ishikawa et al., 2015). PEDF is required for avascularity of the 
IPM and survival of photoreceptors (Becerra, 2006; Broadhead et al., 2010; Ishikawa et al., 
2015). Abnormal localisation of HA might result in IPM degeneration, consequently affecting 
photoreceptor survival (LaVail et al., 1981; Ishikawa et al., 2015). 
Table 1-8: Key ECM components 
ECM Protein 
Tissue Expressed Developmental Stage 
Species 
Studied  Note 
Reference/
s 
Family Class based on GAGs  Component 
Proteoglycan
s (PGs) 
Chondroitin 
Sulphate (CS)  
Aggrecan 
Throughout the 
retina Adult  Human - 
(Popp et al., 
2004; 
Hausman, 
2007; 
Keenan et 
al., 2012) 
Inner retinal 
layer of the optic 
cup 
Embryo (day 
16)  Rat - 
Ganglion cell and 
plexiform layers Adult  Rat 
Weak in nuclear 
layers 
Ganglion cell and 
nuclear layers Adult  Mouse 
Weak in inner 
plexiform and 
photoreceptor 
layers 
Brevican 
- Throughout the 
retina e.g. Nerve 
fiber layer & 
Inner plexiform 
layer 
- Bruch’s 
membrane 
- Choroid 
- Sclera 
Adult  Human 
Not studied in 
perinatal or adult 
retinal tissues of 
any vertebrate 
animal 
(Keenan et 
al., 2012) 
Versican 
Bruch’s 
membrane Adult Human 
Detected in 
Bruch’s/choroid 
complex 
(Popp et al., 
2004; 
Hausman, 
2007; 
Keenan et 
al., 2012) 
Nerve fiber and 
inner plexiform 
layers 
Embryo (day 
14)  
Chicke
n - 
photoreceptor 
layer and Bruch’s 
membrane 
Adult Chicken - 
Inner retinal 
Layers of the 
optic cup 
Embryo 
(day16) Rat - 
Ganglion cell and 
plexiform layers Adult Rat 
Weak in nuclear 
layers 
Neurocan 
Inner plexiform 
and ganglion cell 
layers. 
Neonate Rat - 
(Popp et al., 
2004; 
Hausman, 
2007) 
SPARC 
Macroglial Muller 
cells: INL, IPL, 
ILM 
Adult Rat - (Gilbert et al., 1999) 
IMPG1 Interphotoreceptor matrix Adult Human Binds to HA 
(Kuehn and 
Hageman, 
1999) 
IMPG2 
Bruch’s 
membrane/choroi
d complex 
Adult Human 
Binds to HA 
(Chen et 
al., 2003; 
Clark et al., 
2011) Interphotoreceptor matrix 
Embryo (day 
15- mouse 
only) and adult 
Human 
and 
mouse 
Polysaccharid
es Hyaluronan Widely expressed Adult Human 
- Binds to 
Versican, SPACR 
and SPACRCAN 
- A major 
component of the 
interphotorecepto
r matrix 
 
(Hausman, 
2007; Inoue 
et al., 2009; 
Clark et al., 
2011; 
Mellough et 
al., 2014) 
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Table 1-8: Key ECM components, continued.  
ECM Protein Tissue 
Expressed 
Development
al Stage 
Species 
Studied  Note Reference/s 
Family Class based on GAGs  Component 
Glycoproteins 
Fibronectin 
Cornea, lens, 
sclera, trabecular, 
meshwork and 
vitreous 
Embryo 
Chicken, 
mouse 
and rat 
- 
(Hausman, 
2007; Kwan, 
2014) 
Collagen IV 
Bruch’s 
membrane 
 Inner limiting 
membrane 
Embryo 
Chicken, 
mouse 
and rat 
Present in the 
basement 
membrane 
meshwork 
(Hausman, 
2007; Kwan, 
2014) 
Laminins 
α1 
Bruch’s 
membrane 
Fetal (9-12 
WG) Human - 
(Bystrom et 
al., 2006) 
Laminin α5 IPM OPL adult 
Rat, 
Human - 
(Libby et al., 
2000) 
Laminin β1 Bruch’s membrane 
Fetal (9-20 
WG) Human - 
(Bystrom et 
al., 2006) 
Laminin β2 IPM OPL adult 
Rat, 
Human  
(Libby et al., 
2000) 
Laminin γ1 ILM adult Human - (Libby et al., 2000) 
Laminin γ2 IPM adult Rat, Human - 
(Libby et al., 
2000) 
 
 IMPG1 & IMPG2 are novel proteoglycans found in the IPM and shown to be 
involved in the development and maintenance of the photoreceptors, in mice and human 
(Acharya et al., 1998; Kuehn and Hageman, 1999; Chen et al., 2003). IMPG1 mutations were 
reported in Vitelliform macular dystrophies leading to impaired metabolism of the IPM and 
the accumulation of Vitelliform deposits in the sub-retinal space (Manes et al., 2013). IMPG2 
mRNA expression in the developing retina of rat shows that its detected first with time 
photoreceptors start to extend from the outer retinal surface, suggesting that IMPG2 may 
contribute in the maturation and maintenance of the photoreceptor outer segments (Foletta et 
al., 2001). Fibronectin and collagen IV are two mesh-forming glycoproteins of the ECM 
(Kwan, 2014). Fibronectin is a homodimer and interact with collagens to provide structural 
support for cell adhesion (Stenzel et al., 2011; Kwan, 2014). The functional importance of 
fibronectin has been highlighted by the injection of RGD peptides (block fibronectin-integrin 
interaction) resulting in severe disorganisation of the optic cup in chick (Kwan, 2014). 
Collagen IV, laminin and fibronectin are the main ECM components of the basement 
membranes including Bruch’s membrane and inner limiting membrane (ILM) (Hausman, 
2007; Kwan, 2014). Basement membranes are essential for structural support, cellular 
adhesion, differentiation, proliferation, migration and intercellular communication (LeBleu et 
al., 2007). In the case of BrM it is essential for the regulation of the bio-molecules diffusion 
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between RPE and choroid, RPE cellular adhesion, migration and differentiation, and acting as 
a division barrier to restrict choroidal and retinal cellular migration (Booij et al., 2010).  
The basement membranes of the retina include BrM and the ILM (Reinhard et al., 
2015). CSPGs have been found to play an important role in the regulation of synaptic 
plasticity in CNS and were speculated to have similar role in retinal tissues (Faissner et al., 
2010; Reinhard et al., 2015). Moreover, CSPGs are vital for the maintenance of the cellular 
adhesion between RPE and the neural retina (Lazarus et al., 1993). Lazarus and Hageman 
(1992) demonstrated that intravitreal injections of xyloside, an inhibitor of CSPG synthesis, in 
Yucatan micropigs perturb CSPG and induce the degeneration of the cone photoreceptor outer 
segment and shallow retinal detachment (Lazarus and Hageman, 1992; Ishikawa et al., 2015). 
This result suggests that adhesion between the PRE and neural retina is dependent on 
continuous synthesis of cone matrix sheath-associated PGs (Lazarus and Hageman, 1992; 
Ishikawa et al., 2015). Transmembrane cell-surface HSPGs such as syndecans and glypicans 
are also present in the retina (Reinhard et al., 2015). For instance, N-syndecan is highly 
expressed in retinal nerve fiber layer at the beginning of postnatal stage (P0-P14) in human, 
suggesting that N-syndecan play a role in the formation of the neural network of the retina 
(Inatani et al., 2002). The inhibition of decorin results in the loss of retinal progenitor 
polarisation and it serves as neurotrophic factor and participate in cellular differentiation 
during retinal development (Reinhard et al., 2015). Moreover, the laminins work as mediators 
of cellular differentiation such as laminins β2 chain that are essential for rod-bipolar cell 
differentiation and maintenance (Reinhard et al., 2015). In culture, exposing the cells to a 
laminin β2- rich matrix can promote the production of rods six fold and reduce the bipolar 
production by 66%, suggesting that laminins may control cells fate between rod 
photoreceptors and rod bipolar cells (Hunter and Brunken, 1997). Tenascin-C, an extracellular 
glycoprotein, inhibits cellular proliferation during retinal development (Reinhard et al., 2015). 
It is mainly expressed in the nerve fiber and plexiform layers of the adult retina (Reinhard et 
al., 2015). Tenascin-C modulates the responsiveness of growth factors (FGF2 or PDGF) in 
retinal stem/precursors and supports the de-differentiation ability of Müller glia (Besser et al., 
2012).     
There has been limited detailed analysis of ECM component distribution throughout 
retinal development in human and its functional importance is poorly understood (Reinhard et 
al., 2015). Therefore, studying the distribution of the key ECM component during human 
embryonic and foetal retinal ontogenesis as well as adult human retina will fill the knowledge 
gaps existing between the retinal developmental stages in human and other species and may 
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help to uncover the specific roles of different ECM components on retinal lamination and 
photoreceptor function in human which will be crucially important for optimising our in vitro 
differentiation protocols. Determining ECM components that expressed in the IPM of the 
human embryonic and fetal retina may help in selecting the best candidate for enhancing the 
differentiation of the OS from the hESCs and iPSCs.  
 
1.3. Human pluripotent stem cells 
Pluripotent stem cells are remarkable cells that have the ability to differentiate into 
multiple cell types with the capability of indefinite self-renewal in their undifferentiated form 
(Ramsden et al., 2013). They can be classified according to their potency which is the range 
of cell types they may differentiate into (Ramsden et al., 2013). Totipotent stem cells able to 
differentiate into embryonic and extra-embryonic tissue [ tissues that support the embryo such 
as the placenta and yolk sac (Wang et al., 2017)], pluripotent stem cells have the potential to 
differentiate into all cell types derived from the three germ layers of embryonic tissue 
(ectoderm, mesoderm and endoderm), and multipotent stem cells have the ability to 
differentiate into a limited number of cell types, controlled by the degree of previous 
differentiation (Ramsden et al., 2013). Pluripotency can be divided into two phases: naïve and 
primed (Nichols and Smith, 2009). Naïve pluripotent stem cells are embryonic stem cells 
(ESCs) that are derived from the inner cell mass of a pre-implantation blastocyst (Wu et al., 
2015). In human, ESCs are pluripotent cells that are harvested from the inner cell mass of the 
blastocyst of fresh or frozen embryos produced by in vitro fertilisation (IVF) for clinical 
purposes (Figure 1-8) (Thomson et al., 1998; Narsinh et al., 2011; Armstrong et al., 2012; 
Ramsden et al., 2013).  Epiblast stem cells (EpiSCs) are the in vitro counterparts of the 
primed epiblast that established from post-implantations (Nichols and Smith, 2009; Wu et al., 
2015). Although both are pluripotent, they have some differenced in term of colony 
morphology and efficiency, molecular signature, metabolic requirements and epigenetic 
features (Wu et al., 2015).  
 
 
27 | P a g e  
 
 Figure 1-8: Diagram of human embryonic stem cells derivation (Hynes, 2008).  
Embryonic Stem cells (ESCs) are harvested from the inner cell mas (ICM) of an early embryo 
(blastocyst) (Hynes, 2008). ESCs can continuously proliferate under appropriate cultural 
condition and differentiate into several cell types in vitro (Hynes, 2008).    
 
In 2006, Shinya Yamanaka and his group demonstrated that murine fibroblast could 
be reprogrammed into ESC-like pluripotent stem cells, named as induced pluripotent stem 
cells (iPSCs) (Takahashi and Yamanaka, 2006; Wiley et al., 2015). Forced expression of four 
transcription factors including Oct4, Sox2, Klf4 and c-Myc can reprogram differentiated 
somatic cells into iPSCs (Takahashi and Yamanaka, 2006; Ramsden et al., 2013). Soon after, 
Yamanaka demonstrated that this reprograming method could be repeated using human 
fibroblasts, thus making iPSCs relevant to human disease and potential resource for cellular 
transplantation research (Figure 1-9) (Takahashi et al., 2007; Wiley et al., 2015). Moreover, 
iPSCs derivation can be achieved by using different combinations of transcription factors 
including Oct4, Sox2, Nanog and Lin28 avoiding the use of c-Myc which is a known proto-
oncogene (Yu et al., 2007; Ramsden et al., 2013). Since then, several reprogramming 
techniques have been developed for iPSCs derivation (Table 1-9) (Robinton and Daley, 2012).     
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Figure 1-9: Diagram of iPSCs reprograming and their medical application (Robinton 
and Daley, 2012). 
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Table 1-9: Techniques for reprograming somatic cells to iPSCs (Robinton and Daley, 
2012). 
Vector type Cell types Factors Efficiency (%) 
Integrating 
Retroviral 
Fibroblasts, 
neural stem 
cells, stomach 
cells, liver cells, 
keratinocytes, 
amniotic cells, 
blood cells and 
adipose cells 
OSKM, OSK, 
OSK + VPA, or 
OS + VPA 
~0.001–1 
Lentiviral Fibroblasts and keratinocytes 
OSKM or 
miR302/367 
cluster + VPA 
~0.1–1.1 
Inducible 
lentiviral 
 
Fibroblasts, β 
cells, 
keratinocytes, 
blood cells and 
melanocytes 
OSKM or 
OSKMN ~0.1–2 
Excisable 
 
Transposon 
 Fibroblasts OSKM ~0.1 
loxP-flanked 
lentiviral 
 
Fibroblasts OSK ~0.1–1 
Non-
integrating 
 
Adenoviral 
 
Fibroblasts and 
liver cells OSKM ~0.001 
Plasmid Fibroblasts OSNL ~0.001 
DNA free 
 
Sendai virus 
 Fibroblasts OSKM ~1 
Protein 
 Fibroblasts OS ~0.001 
Modified 
mRNA 
 
Fibroblasts OSKM or OSKML + VPA ~1–4.4 
MicroRNA 
 
Adipose stromal 
cells and dermal 
fibroblasts 
miR-200c, miR-
302s or miR-
369s 
~0.1 
OSKM and similar names represent a group of reprogramming factors: K= KLF4; L= LIN28; 
M= c-MYC; N= NANOG; O= OCT4; S= SOX2; and VPA= valproic acid. 
 
1.3.1. hESCs and hiPSCs 
hESCs and hiPSCs share the important characteristics of self-renewal and 
pluripotency (Narsinh et al., 2011). hESCs are commonly recognised as a rich biological 
source of pluripotent cells, and hold an incredible therapeutic potential due to their capability 
to proliferate, self-renew and differentiate (Ghosh et al., 2010). However, the ethical issues of 
using human embryo and the limited supply of human embryos may delay the obtaining of 
hESCs (Narsinh et al., 2011; Armstrong et al., 2012). hiPSCs are a non-controversial different 
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source of pluripotent human cells that could overcome some of the hESCs difficulties related 
to immune rejection of the transplanted tissue (Ghosh et al., 2010). hESCs and hiPSCs are 
similar in term of morphology, surface marker expression and in vivo teratoma formation 
capability (Narsinh et al., 2011). However, they harbour subtle differences due to their origins 
and ways of derivation (Robinton and Daley, 2012). 
 
1.3.2. Disease modelling and clinical cell transplantation  
hESCs and hiPSCs hold great promises for disease modelling and transplantation 
studies (Ramsden et al., 2013; Wiley et al., 2015). Both cell types have been used in 
therapeutic application or studies of different retinal diseases such as age-related macular 
degeneration (AMD) (Ramsden et al., 2013). hESCs have been used to study AMD and 
propagate RPE-like cells that could replicate the morphology and function of indigenous 
tissue (Ramsden et al., 2013).  Protein and gene expression of hESC-derived RPE in vitro 
demonstrated the expression of RPE65, a specific marker to RPE cells (Ramsden et al., 2013). 
The derived RPE cells expressed PAX6 at a similar level to foetal RPE cells (Klimanskaya et 
al., 2004; Ramsden et al., 2013). In addition, hESCs-derived RPE cells show several 
characteristics of native RPE such as morphology, polarity, tight junction, phagocytosis and 
retinol cycling (Ramsden et al., 2013). After transplantation of the derived RPE tissue, these 
cells can rescue visual parameters and might be a potential source for cell therapy for AMD 
(Ramsden et al., 2013). Recently, transplantation of hESC-derived RPE in 12 Stargardt 
patients with macular degeneration resulted in subretinal hyperpigmentation indicated the 
survival of transplanted cells (Mehat et al., 2018).   
In advanced AMD, stem cell-choroidal endothelial cells are required in cellular 
transplantation in order to reconstruct the macula (Wiley et al., 2015). hiPSCs can be used to 
drive endothelial cells through co-culture with primary endothelial cell lines or conditioned 
media with endothelial cell-specific factors (Wiley et al., 2015). A recent study has shown the 
integration of iPSCs-derived endothelial cells with the host vasculature triggers a relatively 
modest immune response in a murine model of hindlimb ischemia (de Almeida et al., 2014; 
Wiley et al., 2015), suggesting that autologous endothelial cells may be well tolerated in the 
choroid (Wiley et al., 2015). Another group successfully transplanted hESC-derived RPE 
monolayer into the eye subretinal space of two patients with severe AMD which improved 
their visual acuity (clarity of vision) and reading ability based on letter chart (from being able 
to read only 10 letters to read 39 and from 8 to 29 letters, respectively) enabling them to read  
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29 and 21  more letters over 12 months suggesting the feasibility and safety of  hESC-derived 
RPE patch transplantation as a regenerative strategy (da Cruz et al., 2018). 
Singh et al. used patient specific hiPSCs to model Best disease, an autosomal 
dominant disorder of the RPE that causes degeneration of the photoreceptors (Singh et al., 
2013). Using transmission electron microscopy, all hiPSCs cell lines showed typical RPE 
features including apical microvilli, intracellular pigment granules and tight-junctional 
complexes (Singh et al., 2013). hiPSCs modelling of Best disease can provide a platform to 
explore its pathophysiological mechanism (Singh et al., 2013). Patient-specific hiPSCs have a 
potential to be as a tool for identification of disease causing mutations, drug screening and 
source for autologous retinal cell transplantation (Wiley et al., 2015). Recently, Foltz and 
Clegg reported a rapid (14 days) method to direct the differentiation of hESCs and hiPSCs 
into RPE with no or minimal dissection required which may provide a platform for 
pluripotent stem cells to model ocular disease and to generate RPE cells for transplantation 
(Foltz and Clegg, 2017).   
 
1.4. Human pluripotent stem cell differentiation to retinal lineages and the role of ECM 
1.4.1. Differentiations of human pluripotent stem cell into retinal lineages 
Researchers have used several growth factors and morphogens including insulin-like 
growth factor 1 (IGF-1), Wnt inhibitors, activin A and sonic hedgehog (Shh) to differentiate 
hESCs and hiPSCs as a monolayer (Lamba et al., 2006; Lund et al., 2006; Mellough et al., 
2014). However, two-dimensional (2D) culture might not be the ideal method to produce fully 
mature functional photoreceptors since hESCs-derived photoreceptors fail to develop outer 
segments (an important cell compartment for phototransduction) in vitro (Osakada et al., 2008; 
Hirami et al., 2009; Lamba et al., 2009), or integrate with low efficiency upon transplantation 
into adult Crx-/- mice with retinal degeneration (3000 cells Nr1+ of human cells) (Lamba et al., 
2009). Using three-dimensional (3D) culture system, a number of reports have shown that 
various aspects of the retinal development can be recapitulated in vitro through the 
differentiation of hESCs and hiPSCs (Rashid and Vallier, 2010; Meyer et al., 2011; Mellough 
et al., 2012; Nakano et al., 2012; Mellough et al., 2014; Zhong et al., 2014; Gonzalez-
Cordero et al., 2017; Welby et al., 2017) into retinal organoids  which contain the key retinal 
cells types and respond to electrophysiological cues. In 2012, Sasai’s group reported the 
generation of 3D optic cup containing typical three layered retinal statures including 
photoreceptors (Nakano et al., 2012). However, CRX+ photoreceptors formed 12-18% of the 
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total cell numbers at day 126 of the differentiation with some expression of other 
photoreceptor markers such as NRL (rod specific marker) and RXRγ (marker for cone 
precursors). Zhong et al. supplemented culture media with retinoic acid (RA) that promoted 
the differentiation of hiPSCs into of photoreceptors by increasing the expression of 
photoreceptor markers such as RHO, S-opsin and L/M-opsin (Zhong et al., 2014). The retinal 
organoids from Zhong et al. protocol were able to respond to light stimuli but they were from 
a limited number of photoreceptors (2 out of 13 randomly selected cells) (Zhong et al., 2014). 
Recently, Hallam et al. generated retinal organoids from different patient-specific hiPSCs 
lines that responded to light similarly to those recoded from neonatal mouse retina (Hallam et 
al., 2018). However, the differentiation of retinal organoids showed variable efficiency 
depending on nutrient availability suggesting a possible link between nutrient availability and 
cell fate (Hallam et al., 2018).   
 
1.4.2. The role of ECM on stem cell differentiation 
Stem cells reside in a specialised and dynamic microenvironment known as stem cell 
niche that provide extracellular cues that control stem cell survival, self-renewal and 
differentiation (Brizzi et al., 2012). ECM is a major component shaping the stem cell niche 
and maintain their homoeostasis through integrating signalling emanating from soluble and 
matrix-bound growth factors as well as cell-matrix interaction (Brizzi et al., 2012). Moreover, 
ECM regulates stem cell fate through integrin, mainly β1-integrin, that controls the 
orientation of mitotic spindle and influences symmetric and asymmetric division (Brizzi et al., 
2012). Culture conditions for stem cell differentiation might contain soluble factors such as 
Wnts and FGFs that regulate stem cell self-renewal, membrane associate proteins such as 
cadherins which form adherens junctions that participate in positioning and anchoring the 
cells, and integrins that bind to several components of ECM to facilitate cell adhesion and 
differentiation (Viswanathan et al., 2014). Engineered surfaces with specific ligand affinity 
and spatial arrangement of surface chemistry, topologies and matrix stiffness can generate 
cellular responses such as self-renewal and differentiation (Viswanathan et al., 2014).  
ECM proteins such as fibronectin and collagen IV can guide the differentiation of 
stem cell in vitro (Votteler et al., 2010). Fibronectin can induce the differentiation of 
myoblasts into skeletal muscle cells and the differentiation of adipose tissue-derived stem 
cells into endothelial cells within monolayer cultures (Lan et al., 2005; Heydarkhan-Hagvall 
et al., 2008; Votteler et al., 2010). In addition, culturing pluripotent stem cells on tissue 
culture ware coated with collagen IV enhance their differentiation into cardiovascular and 
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hematopoietic linages (Schenke-Layland et al., 2007; Schenke-Layland et al., 2008; Votteler 
et al., 2010). A recent study has shown that the addition of heparin to HS–competent ESCs 
significantly change the differentiation outcomes: the haemopoietic commitment was 
improved by ∼50% at very low level (10 ng/ml), while at high concentration (500 ng/ml) 
haemopoiesis was reduced (Holley et al., 2014). In contrast, the addition of related sugars CS 
and DS failed to influence differentiation, suggesting the specific importance of HS in stem 
cell differentiation (Holley et al., 2014).   
1.4.3. The role of ECM on pluripotent stem cell differentiation to laminated retinae 
In the human eye, the RPE is essential for normal development in vivo and to maintain 
correct morphogenesis of the neural retina (Gong et al., 2008). Most of the established 
protocols for the differentiation of hESC and iPSC into RPE cells involve the removal of 
growth factors from culture medium after the cells have reached confluence (Rowland et al., 
2013). Such protocols use animal-derived products including feeder cells (mainly mouse 
fibroblasts), gelatin and media containing fetal bovine serum (Rowland et al., 2013). Several 
reports have shown that hESC and iPSC can be differentiated into RPE using purified ECM 
components such as laminin (Gong et al., 2008; Rowland et al., 2013). In addition, neural 
progenitor cells can express photoreceptor markers after culture on confluent ARPE19 or 
laminin (Gong et al., 2008). A recent study has shown that the addition of ECM components 
to a fully-defined, feeder-free culture system assists the growth of iPSCs and the 
differentiation of pigmented areas from iPSCs and the maintenance of iPSC-RPE (Rowland et 
al., 2013). For example, the addition of Matrigel, a complex ECM which is rich in basement 
membrane components, to the media was shown to promote hESC self-organisation into 
retinal organoids under 3D culture conditions (Boucherie et al., 2013). Another example, 
hESC derived neural progenitors express RPE markers when cultured on Matrigel and 
photoreceptor markers when cultured on laminin coated surfaces respectively (Gong et al., 
2008). Matrigel and Laminin-111 also support the highest level of pigmentation frequency in 
iPSC-derived RPE cells (Rowland et al., 2013). Sasai et al. have demonstrated that the 
addition of laminin and entactin to 3D culture promoted the formation of self-organising optic 
cups from mouse ESCs (Eiraku et al., 2011; Kuwahara et al., 2015).  
Given that human retina develops largely in utero, it is imperative to understand the 
expression of ECM components during retinal ontogenesis, in order to use this knowledge to 
improve the differentiation of pluripotent stem cells into retinal organoids and understand the 
role of various ECM components in retinal development and disease (Clark et al., 2011; 
Keenan et al., 2012). 
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1.5. Aims of the study 
The aims of this project were to: 
• Investigate the expression of key ECM components in adult mouse, monkey and 
human retinae so that important ECM expressions in the IPM and BrM can be 
identified which may be important for outer retinal development, in vivo (Chapter 3). 
Due to the samples availability of adult human retinae and the ECM composition may 
change in retinae obtained from elderly as retinal changes occur with aging, there is a 
need to find animal models such as mouse and monkey that are similar to humans in 
term of ECM expression. Therefore, the ECM expression was studied in the retinae of 
the three species.    
 
• Determine the temporal and spatial expression of the ECM components during human 
retinal morphogenesis in order to identify components associated with the 
development of the outer retina that could potentially enhance the photoreceptor 
development, in vitro (Chapter 3). 
 
• Investigate the expression of key ECM components (Fibronectin, Collagen IV, 
Versican, Brevican, IMPG1 and IMPG2) and their functions in the development of 
retinal organoids generated from hESCs and hiPSCs (Chapter 4). 
 
• Examine the impact of culture supplementation with RPE CM, decellularised ECM 
from adult bovine neural retina (decel NR) and RPE (decel RPE) on the differentiation 
of pluripotent stem cells (PSCs) to retinal organoids in order to enhance the current 
differentiation protocol by manipulating the ECM microenvironment to improve the 
development of retinal organoids and their responses to electrophysiological stimuli, 
in vitro (Chapter 5). 
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Chapter 2 
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Chapter 2. Materials and Methods 
 
2.1. Tissue Preparation  
2.1.1. Preparation of retinal sections from mouse and macaque monkey 
Eyes were retrieved from post-mortem adult macaque monkeys (aged 9-10 years) 
which had undergone experiments under terminal anaesthesia as part of an unrelated study 
into the neural control of movement. That study was carried out under the approval of the 
Newcastle University Animal Welfare and Ethical Review Board, and appropriate licences 
from the UK Home Office. Mouse eyes were obtained from wild type mice (C57BL/6 
background, 7 months old) from the Functional Genetic Unit, Institute of Genetic Medicine, 
Newcastle University. Mice were sacrificed humanely via cervical dislocation. Mouse and 
monkey eyes were dissected from the orbit and immediately transferred to phosphate buffered 
saline (PBS; Sigma-Aldrich, UK). The anterior portion was removed using micro-scissors and 
forceps, and fixed in 4% (w/v) paraformaldehyde (PFA; Sigma-Aldrich, UK) at 4°C overnight. 
Eye fixation was followed by dehydration steps through increasing concentrations of ethanol 
(50%, 70%, 95% and 100%) before clearing in histo-clear (National Diagnostics, USA) and 
embedding in paraffin wax (pastillated Gurr wax, VWR, UK) (Hewitson and Darby, 2009). 6 
μm thick sections were cut on a microtome and collected onto slides (Superfrost Plus, Thermo 
Fisher Scientific, UK) then stored at room temperature (RT) and protected from light and dust. 
2.1.2. Preparation of retinal sections from adult human eyes 
Adult human eyes were obtained from Manchester Eye Bank, Manchester Royal Eye 
Hospital. Three eyes were collected from adult donors 48 hours after death (a female aged 84 
years and two males aged 67 and 88 years). The tissue was stored in organ culture medium at 
34°C for 7 days before screening for bacteria and fungi using blood agar plates and liquid 
microbiological media (Armitage et al., 2014). Organ culture medium was composed of 
Eagle’s Minimum Essential Medium (MEM) containing 26 mM sodium bicarbonate, 20 mM 
HEPES buffer, 2% Fetal Bovine Serum (FBS; Australian origin, Life Technology Ltd, UK), 2 
mM L-glutamine, penicillin (100 U/mL), streptomycin (0.1 mg/mL), and amphotericin B 
(0.25 mg/mL) (Armitage et al., 2014). All consumables used for storage were from (Sigma-
Aldrich, UK) except for FBS. Adult human eyes were fixed, dehydrated and embedded 
according to the method described above, before 8 μm thick sections were collected. 
2.1.3. Human Developmental Tissue 
Human embryonic and foetal specimens aged between 6-19 weeks of post-conception 
(PCW) were obtained from the MRC/Wellcome-Trust funded Human Developmental Biology 
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Resource at Newcastle University (HDBR; http://www.hdbr.org), with appropriate maternal 
written consent and approval from the Newcastle and North Tyneside NHS Health Authority 
Joint Ethics Committee. HDBR is regulated by the UK Human Tissue Authority (HTA; 
www.hta.gov.uk) and operates in accordance with the relevant HTA Codes of Practice. 
Ready-prepared 10µm paraffin wax sections were collected from the HDBR and stored at 4°C 
in slide boxes prior to immunostaining. 
 
2.2. Immunohistochemistry (IHC) 
2.2.1. IHC using paraffin sections (adult retina and human developing retina) 
Expression of ECM proteins was determined using immunohistochemistry (IHC). 
Tissue sections were dewaxed by two incubations in histo-clear, each 10 minutes at RT. 
Histo-clear was removed by placing the tissue in 100% ethanol that was changed every 5 
minutes 10 minutes. Then, the samples were rehydrated through several incubations in 
decreasing concentration of ethanol (90%, 70% and 50%), each 5 minutes. Rehydration of the 
samples was followed by two washing steps in PBS, each 5 minutes (Hewitson and Darby, 
2009). For antigen retrieval, the tissue was placed in citrate buffer (pH 6.3; Sigma-Aldrich, 
UK) and microwaved at 800 watts for 10 minutes. Afterward, the brim containing the sample 
was allowed to cool for 10 minutes at RT and for another 10 minutes under tap water. The 
tissue was rinsed in double-distilled water before being washed three times in PBS, each 5 
minutes. Non-specific epitope binding was blocked by incubation at RT for 45 minutes with 
PBS containing 10% FBS. The slides containing the sections were then placed in a dark 
humidified chamber before adding the primary antibody. 
Primary antibodies were diluted in PBS containing 2% FBS (Table 2-1), applied on 
tissue sections (150 μl/slide) and incubated overnight at 4°C. After several washing steps in 
PBS (3x5 minutes), appropriate fluorescently-labelled secondary antibodies (Table 2-2) 
diluted in PBS containing 2% FBS were added to each tissue section (150 μl/slide) and 
incubated at RT for 1.5 hours in a dark humidified chamber. To quench the sample auto-
fluorescence, tissue sections were incubated in 0.3 % (w/v) Sudan Black (Sigma-Aldrich, UK) 
(prepared in 70% ethanol) for 15 minutes at RT (Sun et al., 2011), washed in PBS (4x10 
minutes), then mounted with Vectashield (Vector Laboratories, UK) medium containing 
Hoechst (Life Technologies, UK) as a nuclear counter-stain. Cover-slip was applied on each 
slide, sealed with nail polish and left to dry in a dark box before storage at 4°C. 
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Table 2-1: List of antibodies used for labelling cells for immunohistological analysis. 
Antibody Tissue Cat. No. Host Antibody Isotype Source Dilution 
ACAN ECM - Rabbit IgG Gift from Prof Timothy Hardingham 1:100 
AP2α Amacrine cells sc-12726 Mouse IgG2b Santa Cruz 1:200 
ARL13B Connecting cilium ab83879 Rabbit IgG Abcam 1:500 
Bassoon 
presynaptic 
protein of 
ribbon synapses 
VAM-PS003 Mouse IgG2aκ Stressgen Biotechnologies 1:100 
BCAN ECM ab111719 Rabbit IgG Abcam 1:50 
CD44 ECM ab119348 Rat IgG2b Abcam 1:100 
Collagen IV ECM ab6586 Rabbit IgG Abcam 1:100 
Cone 
Arrestin Cone IS NBP2-41249 Rabbit IgG Novus Biologicals 1:100 
CRALBP RPE & Muller cells ab15051 Mouse IgG1 Abcam 1:100 
CRX postmitotic photoreceptors 
H00001406-
M02 Mouse IgG2a Abnova 1:200 
CRYAA Lens - Mouse IgG1 
Provided by Prof. 
Roy Quinlan 
Durham University, UK 
1:50 
CtBP2 Synaptic Ribbons 612044 Mouse IgG1 BD Biosciences 1:100 
Donkey 
anti-goat 
IgG 
IMPG2-Isotype 
Control 
705-005-147-
JIR Donkey IgG Jackson ImmunoResearch 1:1300 
Donkey 
anti-rabbit 
IgG 
BCAN-Isotype 
Control 
711-005-152-
JIR Donkey IgG Jackson ImmunoResearch 
1:65 
Collagen IV-
Isotype Control 1:130 
IMPG1-Isotype 
Control 1:260 
FN1 ECM sc-8422 Mouse IgG1 Santa Cruz Biotechnology 1:20 
Goat anti-
mouse IgG1 
FN1-Isotype 
Control NB7508 Goat IgG1 Novus Biologicals 1:100 
Goat anti-
mouse IgM 
VCAN-Isotype 
Control NB7494 Goat IgM Novus Biologicals 1:100 
Goat anti-
rat IgG2b 
CD44-Isotype 
Control NB7127 Goat IgG2b Novus Biologicals 1:100 
Gαt1 Photoreceptors outer segment sc-389 Rabbit IgG Santa Cruz 1:200 
HAPLN1 ECM 9/30/8-A-4 mAb Mouse IgG2b 
Developmental Studies 
Hybridoma Bank 1:50 
HuC/D 
amacrine and 
retinal ganglion 
cells 
A21271 Mouse IgG2b Invitrogen 1:200 
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Table 2-1: List of antibodies used for labelling cells for immunohistological analysis, 
continued. 
Antibody Tissue Cat. No. Host Antibody Isotype Source Dilution 
Hyaluronic 
Acid ECM ab53842 Sheep IgG Abcam 1:100 
IMPG1 ECM Ab113493 Rabbit IgG Abcam 1:100 
IMPG2 ECM sc-103232 Goat IgG Santa Cruz Biotechnology 1:200 
KI-67 
nuclear expression in 
proliferative cells 
during late G1, S, G2 
and M phases of the 
cell cycle 
ab15580 Rabbit IgG Abcam 1:200 
NCAN ECM AF6508 Sheep IgG R&D Systems 1:100 
NRL post-mitotic rod precursors sc-374277 Mouse IgG1 Santa Cruz 1:200 
Opsin blue 
(OPN1SW) 
S cone 
photoreceptors AB5407 Rabbit IgG Millipore 1:200 
Opsin red/green 
(OPN1LW/MW) 
L/M cone 
photoreceptors AB5405 Rabbit IgG Millipore  1:200 
Pan Heparan 
Sulfate ECM 370255-1 Mouse IgMκ Amsbio 1:20 
PAX6 neural progenitors, retinal progenitors ab78545 Mouse IgG1 Abcam 1:200 
PKCα Bipolar cells 610107 Mouse IgG2b BD Biosciences 1:200 
PROX1 Horizontal & Amacrine cells AB5475 Rabbit IgG Millipore 1:1000 
RBP3 IPM 14352-1-AP Rabbit IgG ProteinTech 1:100 
RBPMS retinal ganglion cells 1830-RBPMS Rabbit IgG PhosphoSolutions 1:1000 
Recoverin 
photoreceptors and 
midget OFF bipolar 
cells 
AB5585 Rabbit IgG Millipore 1:1000 
RetP1 
(Rhodopsin) Rod photoreceptors O4886 Mouse IgG1 Sigma 1:200 
RPE65 RPE cells ab13826 Mouse IgG1 Abcam 1:100 
RXRγ post-mitotic cone precursors sc-555 Rabbit IgG Santa Cruz 1:200 
Sox1 
neuroectodermal 
tissue, lens vesicle 
and neural epithelium 
of adjacent 
diencephalon 
4194 Rabbit IgG Cell Signaling Technology 1:200 
SPARC ECM ab14174 Rabbit IgG Abcam 1:100 
Syntaxin presynaptic plasma membrane S0664 Mouse IgG1 Sigma 1:200 
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Table 2-1: List of antibodies used for labelling cells for immunohistological analysis, 
continued. 
Antibody Tissue Cat. No. Host Antibody Isotype Source Dilution 
VCAN ECM MABT161 Mouse IgM Millipore 1:100 
vGlut1 
synaptic terminals of 
photoreceptors and bipolar 
cells 
AB5905 Guinea Pig N/A Millipore 1:1000 
VSX2 retinal progenitor cells & bipolar cells 
HPA003436-
100UL Rabbit IgG Sigma 1:50 
WGA inner/outer segments of rods/cones W11261 N/A N/A Invetrogen 1:1000 
 
 
Table 2-2: List of fluorescently labelled secondary antibodies used for 
immunohistological analysis. 
Antibody Cat. No. Host Antibody Isotype Source Dilution 
anti-donkey  
DyLight 488 SA5-10062 Rabbit IgG Life Technologies 
1:800 
anti-goat Cy3 305-165-003 Rabbit IgG Jackson ImmunoResearch 
anti-guinea pig Cy3 AP108C Goat IgG Millipore 
anti-mouse Alexa 488 A11001 Goat IgG Life Technologies 
anti-rabbit Alexa 488 111-545-003-JIR Goat IgG Jackson ImmunoResearch 
anti-rabbit Alexa 647 111-605-144-JIR Goat IgG Jackson ImmunoResearch 
anti-rabbit Cy3 111-165-003-JIR Goat IgG Jackson ImmunoResearch 
anti-sheep Alexa 488 A-11015 Donkey IgG Invitrogen 1:500 
 
2.2.2. IHC using cryostat sections (retinal organoids) 
Cryostat frozen sections were rinsed three times (3 minutes each) in PBS and 
incubated in blocking solution (10 % normal goat serum, 0.3 % Triton-X-100 in PBS) for one 
hour at RT in a humidified chamber. Antibody diluent solution was prepared (1 % bovine 
serum albumin (BSA), 0.3 % Triton–X-100 in PBS) and used to dilute all antibodies. Tissue 
sections were incubated with primary antibodies (Table 2-1) overnight at 4°C in a humidified 
chamber. After three washing steps (7 minutes each) in antibody diluent, sections were 
incubated with the appropriate fluorescently-labelled secondary antibodies (Table 2-2) at RT 
for 1.5 hours in a dark humidified chamber. Afterwards, sections were washed three times (10 
minutes each) in PBS and mounted with Vectashield containing Hoechst. Cover-slip was 
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applied on each slide, sealed with nail polish and left to dry in a dark box before storage at 
4°C. 
2.3. RPE conditioned medium  
RPE conditioned medium (CM) was collected every day from mature (8 months old) 
RPE monolayers (Trans-epithelial resistance; TER>250Ω) derived from hESC and hiPSC 
cultured in DMEM:F12 medium (Life Technologies, UK) supplemented with 2% B27 (Gibco, 
UK) & 1% N2 (Gibco, UK). The RPE cells density was 100,000 cells/ cm2 and the cells were 
provided by Ms. Adriana Buskin and Dr. Dean Hallam (Lako’s group, Newcastle University). 
The collected CM was centrifuged at 1000 rpm for 4 minutes to remove cellular material and 
prevent mixing between cell lines. Then, CM was diluted in 1:3.5 ratio before being added to 
the cells and filtered using vacuum filtration kit with pore size of 0.22 µm (TPP, UK).  
2.4. Decellularised RPE (dRPE) & neural retina (dRetina) 
Master student Martin Kiening has performed the RPE & retinal decellularisation 
procedures from four bovine eyes following a protocol indicated by Medberry et al., 2013 
(Medberry et al., 2013). RPE & neural retina were isolated from four adult bovine eyes 
freshly collected from the abattoir within one hour after slaughter. Using curved scissors, the 
muscle surrounding the eye was removed and the eyeball was hemisected to remove the 
cornea and vitreous humour. The retina was peeled very gently from the RPE using a 
microspatula and immersed into phosphate buffer saline (PBS, Sigma-Aldrich, UK). Then, 
the RPE was isolated and transferred into PBS. The isolated tissues (RPE/retina) were washed 
twice with PBS on orbital shaker at 60 rpm for 5 minutes followed by a decellularisation steps. 
The RPE and retinal decellularisation procedures were performed following a protocol 
indicated by Medberry et al., 2013 (Medberry et al., 2013). 
2.5. ECMs and DNA quantification 
Master student Martin Kiening performed a group of colorimetric assays to quantify 
the amount of collagen, glycosaminoglycan (GAGs), hyaluronic Acid and DNA content in the 
decellularised RPE and neural retinae, and compared to the native RPE and neural retinae. 
The concentration of these components was also determined in the RPE conditioned medium 
and compared to a control-RPE medium. 
2.5.1. Hydroxyproline assay 
Hydroxyproline assay kit (BioVision, K555-100) was used to quantify the amount of 
collagen. Hydroxyproline is a common amino acid found in collagen and formed by post-
translational modification of proline. As indicated in manufacturer’s protocol, samples 
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(10µl/sample) were transferred to 96-well plate with flat bottom (TTP, UK) and incubated 
with Chloramine T reagent (100µl/well) at RT for 5 minutes. Then, 100 µl of p-
Dimethylaminobenzaldehyde (DMAB) reagent was added to each reaction well and incubated 
at 60ºC for 90 minutes before the absorbance was measured at 560 nm in a plate reader 
(Varioskan LUX, Thermo Fisher Scientific, UK). Each sample was run in triplicate and the 
average absorbance value was calculated. The background value was corrected against a 
blank value and the concertation of each sample was determined against a standard 
Hydroxyproline sample (supplied with kit).  
2.5.2. Dimethylmethylene blue assay (DMMB) 
GAGs concentration was measured using dimethylmethylene blue assay (DMMB) that 
involves a changing in the absorbance spectrum after the formation of the GAG-DMMB 
complex. The DMMB regent was prepared and contained the following: 16 mg DMMB in 1 L 
double-distilled water containing 3.04 g glycine, 1.6 g NaCl and 95 ml of 0.1 M Acetic Acid. 
The pH of the solution was 3.0 and all the DMMB components were from (Sigma-Aldrich, 
UK). 20µl of each sample was transferred to a 96-well plate with flat bottom and incubated 
with DMMB reagent (200µl/sample) for 5 second. Then, the absorbance value was read 
immediately at 525 nm using Varioskan LUX plate reader. The average value was calculated, 
corrected against a blank and the concentration was determined against a standard chondroitin 
4-sulfate from bovine (Sigma-Aldrich, UK). The concentration of Hyaluronic acid could not 
be measured using DMMB assay becaause it only reacts with GAGs chain sulfated group. 
Therefore, turbidimetric measurement assay was used to measure the concentration of 
Hyaluronic acid. 
2.5.3. Turbidimetric measurement of Hyaluronic Acid 
Hyaluronic Acid is another ECM component that was quantified using a turbidimetric 
protocol indicated by Di Ferrante, 1956 based on the formation of insoluble complex between 
Cetyltrimethylammonium bromide (CTAB; Sigma-Aldrich, H6269-100G) and the isolated 
acid mucopolysaccharides (Di Ferrante, 1956). The samples were diluted (1:1 ratio) in acetate 
buffer (0.2M Acetic acid, 0.15M NaCl, pH 6.0). Then, 100µl of the solution (triplicate/sample) 
was transferred to 96-well plate and incubated at 37.5oC for 15 minutes. Then, 200µl of 
CTAB reagent (2.5 g of CTAB dissolved in 100ml of 2% NaOH) was added per well and the 
plate incubated at RT on a plate shaker (300 rpm) for 30 seconds before the absorbance was 
read at 405 nm using Varioskan LUX plate reader. The absorbance mean value was calculated 
and corrected against blank. Then, the concentration of Hyaluronic acid was determined 
against a standard Hyaluronic acid sodium salt from Streptococcus equi (Sigma-Aldrich, UK).  
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2.5.4. Laminin Quantification 
The quantification of Laminin in the native and decellularised RPE and neural retina 
was performed using a bovine Laminin enzyme-linked immunosorbent assay (Laminin-
ELISA) kit (Amsbio, UK) according to the manufacturer’s protocol. In brief, Laminin-ELISA 
is based on competitive ELISA in which the colorimetric signal is inversely proportional to 
the concentration of Laminin in the sample. The samples were incubated in 96 well-plate pre-
coated with polyclonal anti-Laminin antibody conjugated with horseradish peroxidase (HRP) 
for one hour followed by five washing steps. Then, the wells were incubated with a substrate 
for HRP enzyme. The enzyme-substrate reaction formed a blue colour and a stopping solution 
was added to stop the reaction before spectrophotometrically measuring the colour intensity at 
450nm using Varioskan LUX plate reader. The mean absorbance value was calculated and the 
concentration of Laminin was determined against a standard Laminin (supplied with the kit). 
Since CM PRE was collected from human cells, Laminin quantification in normal and CM 
RPE was performed on a different ELISA kit from human (Aviva Systems Biology, UK) 
following the manufacturer’s protocol. The kit principle is based on standard sandwich 
ELISA in which the colorimetric signal is proportional to the concentration of Laminin in the 
sample. The absorbance was measured as above. 
2.5.5. DNA Quantification  
The cellular DNA content was measured using Hoechst fluorometric assay following a 
protocol indicated by Rago et al., 1990  (Rago et al., 1990). The samples were diluted (1:1 
ratio) in TNE buffer (10 mM Tris, 2 M NaCl, 1 mM EDTA, pH 7.4) contained 20 µg/ml of 
Hoechst 33258 (Life Technologies, UK). Then, 200µl of the solution (triplicate/sample) was 
transferred to 96-well plate. The fluorescence intensity was proportional to the amount of 
DNA in the sample and was measured at 460 nm using Varioskan LUX plate reader. Then, 
the concentration was determined against a DNA standard from calf thymes (Sigma-Aldrich, 
UK).  
 
2.6. Human Pluripotent Stem Cells differentiation to retinal organoids 
Retinal organoids were generated from two different cell lines: hiPSCs derived from 
adult fibroblasts (SB-Ad3) (Melguizo-Sanchis et al., 2018) and human embryonic stem cells 
(H9, Wicell, USA). Stem Cells were expanded in mTeSR™1 (StemCell Technologies, UK) at 
37°C and 5% CO2 on 6 well plates pre-coated with Low Growth Factor Matrigel (Corning, 
UK) (Figure 2-1). The retinal organoids were generated following the method described in 
Mellough et al., 2015 (Mellough et al., 2015) with the addition of ROCK inhibitor (Y-27632 
dihydrochloride, Sigma, UK) (10 µM) for the first 48 hours of differentiation (Figure 2-2 & 
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Table 2-3). Further modifications include the addition of 10% Fetal Calf Serum (Life 
Technologies, UK), T3 (40 ng/ml; Sigma-Aldrich UK), Taurine (0.1 mM; Sigma-Aldrich UK) 
& Retinoic Acid (0.5 µM; Sigma-Aldrich UK) from day 18 of differentiation. After 18 days 
of differentiation the cells were divided into 4 groups with different cultural conditions: 
Control, RPE CM, decel NR (10 µg/ml) and decel RPE (10 µg/ml) (Figure 2-2). Retinal 
organoids were collected on day 35, 90 and 150 for qRT-PCR and IHC. For IHC, the 
organoids were fixed in 4% PFA for 20 minutes, followed by three washes in PBS, then 
overnight cryoprotection in 30% sucrose (Sigma, UK) in PBS before embedding in Optimal 
cutting temperature (OCT) medium (Cellpath, UK) and freezing at -20°C. Afterward, 10µm 
cryostat (Leica Cm1860) sections were collected onto Superfrost Plus slides and stored at -
20°C in slide boxes prior to immunostaining. For qRT-PCR retinal organoids were collected, 
washed with PBS and immediately frozen at -80°C. The total number of retinal organoids 
with phase bright neuroepithelium, neuroepithelium with RPE or only RPE was counted for 
each experimental condition using a bright field microscope AxioVert (Zeiss, Germany). 
 
Figure 2-1: Undifferentiated H9 (hESCs) & SB-Ad3 (hiPSCs), cultured on 6-well plate 
coated with Matrigel. Scale bar =20 μm, (P = passage number). 
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Figure 2-2: Illustrated diagram showing 4 different conditions for differentiating hESCs 
(H9) & hiPSCs (SB-Ad3) into retinal organoids. 
 
 
 
Table 2-3: A list of 4 different cultural conditions for differentiating hESCs (H9) & 
hiPSCs (SB-Ad3) into retinal linages. 
Days of 
Differentiation Group Conditions 
0 - 18 All Groups Basic Medium+ KO serum (Gibco , UK) + IGF-1 (Sigma, UK) 
18 - 37 
Control Basic Medium+ FCS+ Retinoic Acid (RA)+ Taurine + T3+ IGF-1 
RPE CM Basic Medium+ FCS+ RPE condition media+ RA+ Taurine + T3+ IGF-1 
Decel NR Basic Medium+ FCS+ decellularised neural retina+ RA+ Taurine+ T3+ IGF-1 
Decel RPE Basic Medium+ FCS+ decellularised RPE + RA+ Taurine + T3 + IGF-1 
37 - 150 
Control Basic Medium+ FCS+ RA + Taurine + T3+ IGF-1+ N2 (Gibco , UK) 
RPE CM Basic Medium+ FCS+ RPE condition media+ RA+ Taurine + T3+ IGF-1+ N2 
Decel NR Basic Medium+ FCS+ decellularised neural retina+ RA+ Taurine+ T3+ IGF-1+ N2 
Decel RPE Basic Medium+ FCS+ decellularised RPE + RA+ Taurine + T3 + IGF-1+ N2 
Note: Basic Medium include: DMEM:F12 (with L-Glutamine) + B27 supplement 
(Gibco , UK) + MEM Non-Essential Amino Acids (Gibco , UK) + Penicillin-Streptomycin 
(100 U/ml, Gibco , UK).  
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2.7. Blocking IMPG1 and CD44 cellular receptors in retinal organoids  
The role of IMPG1 and CD44 in photoreceptor differentiation was investigated using 
blocking antibodies to IMPG1 (Abcam, UK) and CD44 (Abcam, UK). The antibodies were 
added (10 μg/ml) to retinal organoid culture medium (Control group) at day 90 and 150 of the 
differentiation process. After 14 days in culture, the effects of IMPG1 and CD44 receptor 
inhibition was assessed and compared to a control group which was incubated with (10 μg/ml) 
non-specific control IgG blocking antibody (Jackson ImmunoResearch, USA). The 
morphology of the retinal organoids was examined using a bright field microscope AxioVert 
(Zeiss, Germany). 
 
2.8. Image capture and analysis 
Images were captured using an Axio Imager upright microscope with Apotome (Zeiss, 
Germany) structured illumination fluorescence using 20x objective and 40x oil objective 
operated with AxioVision software. A range of fluorescent filters were used to cover several 
dyes including Hoechst, Cy3 and Alexa 488. Tissue sections of two biological replicates of 
developing human retina and three biological replicates of adult retinae and pluripotent stem 
cell derived retinal organoids were analysed. Each biological replicate of day 35, 90 and 150 
retinal organoids included 10-15 organoids per group. Final images are presented as a 
maximum projection and adjusted for brightness and contrast in Adobe Photoshop (Adobe 
Systems). 
2.8.1. Image Quantification 
Cell image analysis was performed by Dr. Yuchun Ding (Newcastle University, UK) 
and the cells were quantitatively analysed in the microscopy data using MATLAB software. 
The data was presented as image segmentation through Hysteresis thresholding technique to 
segment the cells and filter out any noise background from the images (Zimmer et al., 2002). 
Furthermore, artefacts were removed manually because they may compromise the accuracy of 
the analysis. Using measuring property of MATLAB (regionprops), all the pixels of each 
image were represented as single region in order to extract the information about each cell 
including the size, average intensity value and length. After obtaining the final segmentation 
information, the total size and the percentage of the positive cells were calculated and 
exported as excel file for further analysis. 
The quantification and analyses of synaptic markers, Bassoon and CtBP2, were 
performed by Dr. Birthe Hilgen (Newcastle University, UK) using ImageJ (NIH, Bethesda, 
MD). For hESCs, 5-7 individual organoids per group and for hiPSCs, 3 individual organoids 
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per group were analysed. All images were taken with the same exposure time and three 
squares (500 x 500 pixel) to cover the whole retinal structure were validated in each organoid 
image. Plaque counts and median intensity were calculated automatically by ImageJ using an 
intensity threshold (Renyi Entropy) to ensure an accurate count with same conditions for all 
groups. All results were further analysed using Microsoft Excel and Prism (GraphPad, USA). 
 
2.9. RNA isolation  
15-20 retinal organoids were homogenised using Precellys lysing kit (CK28R) (Bertin 
Technology, UK) and dissociated with RNA lysing buffer provided by RNA extraction kit, 
RNeasy Plus Mini Kit (Qiagen, UK). Manufacturer’s protocol was followed which included 
passing the cell lysate into two different columns: gDNA eliminator column and RNeasy spin 
column. The final RNA product were re-suspended in nuclease-free water and stored in -80oC 
or used for cDNA synthesis, immediately.   
  
2.10. Reverse Transcription 
The concentration of RNA samples was measured using NanoDrop 2000 
Spectrophotometer (Thermo FisherScientific, UK). Following manufacturer’s instructions, 
500 ng of extracted RNA was reverse transcribed into cDNA using random primers  of 
Precision nanoScript 2 Reverse Transcription kit (RT-nanoScript2, Primerdesign, UK). 
  
2.11. Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) 
  Quantitative reverse transcription polymerase chain reaction (qRT- PCR) was 
performed on three biological replicates of H9 and SB-Ad3 cell lines and adult human retina 
as control. Every reaction contained 5 µl of PrecisionPLUS Master Mix with SYBRgreen, 1 
µl of cDNA sample, 3 µl of nuclease-free water, 1 µl of primers (10 µM) (Table 2-4). 384 
wells plates were run on Applied Biosystem Quant Studio 7 Real-Time PCR System (Life 
Technologies, UK). The cycling protocol consisted of hot-start enzyme activation at 95oC for 
2 minutes, followed by 40 cycles of denaturation at 95oC for 15 seconds, annealing/extension 
at 60oC for 1 minute, and denaturation at 95oC for 1 minute. Following amplification, a melt-
curve analysis was performed from 60oC to 90oC with increments every 10 seconds. Each 
sample was run in triplicate and the average threshold cycle (CT) value was determined. 
mRNA level was normalised to GAPDH using ∆∆CT method.  
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Table 2-4:  Primers used for qRT-PCR analysis. 
Gene Forward Primer (Sequence (5'->3')) 
Reverse Primer 
(Sequence (5'->3')) 
NCBI 
Reference 
Sequence 
BCAN AGGAGGCGACAAACTTCGC AAAAGCGCGGTCCTCTGA NM_198427.1 
FN1 GGTGGAAGTGTGATCCCGTC CAGGACCACTTGAGCTTGGAT NM_212482.2 
GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG 
NM_00125679
9.2 
IMPG1 GCTAGCAGGAAAGTCCCAACT GTGGAGCTTGAGCCATCTTTT NM_001563.3 
OPSINLW GCCTACTTTGCCAAAAGTGC GATGAGACCTCCGTTTTGGA NM_020061 
RBP3 AGATCATGCACACGGATGCC AGCCATAGCGTTCACCTACA NM_002900.2 
RCVRN TTCAAGGAGTACGTCATCGCC GATGGTCCCGTTACCGTCC NM_002903 
RHO TTTGGAGGGCTTCTTTGCCA CCTCGGGGATGTACCTGGAC NM_000539.3 
VCAN TGTTAATCGTGTGGGCCATGA AGAAGCTGTCTGGCTGGTTG NM_004385.4 
CRX GTGAGGAGGTGGCTCTGAAG CTGCTGTTTCTGCTGCTGTC NM_000554 
MATH5 CCCTAAATTTGGGCAAGTGAAGA CAAAGCAACTCACGTGCAATC NM_145178 
 
 
2.12. Electrophysiological recordings 
Electrophysiological recordings and analyses of the results were performed by Dr. 
Gerrit Hilgen (Newcastle University, UK) as follow: 24 hours prior to electrophysiological 
recordings, 9-cis retinal (10nM; Sigma Aldrich, UK) was added to the incubation medium. 
Organoids were transferred to 34°C artificial cerebrospinal fluid (aCSF) containing the 
following (in mM): 118 NaCl, 25 NaHCO3, 1 NaH2 PO4, 3 KCl, 1 MgCl2, 2 CaCl2, 10 
glucose, 0.5 l-Glutamine and 0.01 9-cis-retinal. Organoids were opened longitudinally and 
placed, with the presumed RGC layer facing down on the electrodes, onto the 4096 channel 
multielectrode array (MEA), flattened with a translucent polyester membrane filter (Sterlitech 
Corp., Kent, WA, USA). The organoids were allowed to settle for at least 2 hours. Recordings 
were performed on the BioCam4096 MEA platform with BioChips 4096S+ (3Brain GmbH, 
Lanquart, Switzerland), integrating 4096 square microelectrodes in a 64x64 array 
configuration.  
Light stimuli were projected as described previously (Hilgen et al., 2017a). Broad 
white (high photopic) light pulses (WLP, 200 ms, 217 µW/cm2 irradiance, 1Hz) were flashed 
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for 5 min onto the organoids following recording spontaneous activity in the dark for 5 min. 
Sustained broad blue light stimulation was also used (SBL, 2 min darkness, 2 min SBL, 2 min 
darkness), same irradiance as WLP), to evoke responses from intrinsically photosensitive 
RGCs (ipRGCs). The drug cGMP (8-Bromoguanosine 3’,5’-cyclic monophosphate, Sigma-
Aldrich, MO) was puffed in the recording chamber (final concentration: 100µM) and activity 
was recorded continuously for 4 minutes, starting at 2 minutes before the puff. 
To reliably extract spikes from the raw traces, quantile-based event detection was used 
(Muthmann et al., 2015). Single-unit spikes were sorted using an automated spike sorting 
method for dense, large-scale recordings (Hilgen et al., 2017b). Statistical significance 
(unpaired t-test) and firing rate analyses were evaluated by using MATLAB (Mathworks, MA) 
and Prism (GraphPad, CA). RGCs were considered responsive if they show at least 25% 
increase or decrease in spiking activity during 30 seconds after WLP onset compared to a 
similar time window before the light was turned on. For each cell, all spikes occurring during 
these two time windows were counted and the mean % change (±SEM) in activity between 
windows was calculated. All RGCs respond to WLP. To single out ipRGCs, additional 
analysis of their responses to SBL was performed, taking into account that photoreceptor-
driven responses are relatively transient, and therefore stop after a while, whereas intrinsic 
light responses in ipRGCs are sustained (and generally have a slower onset). Hence, RGCs 
were classified as ipRGCs if they still exhibited significantly higher firing rate 30-60 s after 
the onset of the SBL stimulus. All other RGCs were analysed for the WLP protocol 
(photoreceptor-driven responses).   
 
2.13. Transmission Electron Microscopy 
Cells were fixed with 2% glutaraldehyde and kept at 4°C. TEM including all the cell 
processing was performed at Newcastle University Electron Microscopy Research Services, 
Ultrathin sections were stained with heavy metal salts (uranyl acetate and lead citrate) and 
imaged on a Philips CM100 TEM (Philips, Japan). 
 
2.14. Measurements of neuroepithelium thickness 
Bright filed images of retinal organoids were taken using a bright field microscope AxioVert 
(Zeiss, Germany). Morphology of day 90 and 150 retinal organoids were assessed in culture 
at day 7, 10 and 14 of anti-IMPG1 and anti-CD44 treated groups compared to control. A total 
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of three biological replicates (n=3) were assessed from each hESCs- and hiPSCs- derived 
retinal organoids. Measurements of neuroepithelium thickness (a phase bright area typically 
found at the peripheral side of retinal organoids) were performed using (ImageJ, USA) in day 
90 and day 150 retinal organoids (Figure 2-3). A scaling system was set for all images of the 
organoids based on a scaling bar of 100 µm and fine lines were drawn from the apical edge 
toward the centre of the organoids at different sides to measure the neuroepithelium thickness 
in µm. A total of 25 measurements (5 measurements / organoid) were taken from each group 
(control, anti-IMPG1 and anti-CD44) and the neuroepithelium thickness were measured at 
three time point (day 7, 10 and 14) of the incubation period.   
 
 
Figure 2-3: Measurements of Neuroepithelium thickness in retinal organoids. 
Illustrated figure showing how the thickness of neuroepithelium was measured in the retinal 
organoids. (A) Bright field images were taken for the retinal organoids and a standard scale 
was set for measurements based on a 100 µm scale bar. (B) Bright filed Neuroepithelium area 
was identified on the apical side of the organoids (the area circled in red is an example of the 
organoid neuroepithelium. (C) 5 measurements were taken per organoid by drawing 5 lines 
(red) at different areas of the same organoid using (ImageJ, USA).     
 
   
2.15. Lipofectamine RNAiMAX Transfection 
Small interfering RNA (siRNA) studies were performed to validate the specificity of 
some antibodies used in IHC including fibronectin, brevican versican and IMPG1, where not 
enough evidence in the literature was found. Lipofectamine RNAiMAX reagent (Invitrogen, 
UK) was used to transfect stealth siRNA (Table 2-5) into undifferentiated hESCs (fibronectin: 
FN1, versican: VCAN and brevican: BCAN) and hESC- derived retinal organoids at day 150 
(IMPG1) following the manufacturer’s protocol. In brief, Lipofectamine is used for siRNA-
mediated gene knockdown experiments on variable types of cells. It is a lipid-based 
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transfection in which the cationic lipid formulation of Lipofectamine binds to the siRNA and 
delivers it into the cell cytoplasm. One day before transfection cells were plated on 6-well 
plate (for qPCR analysis) and 4-well slide chambers (for IHC; Thermo Fisher, UK) coated 
with Low Growth Factor Matrigel (Corning, UK). The cells were incubated with growth 
medium without antibiotic and allowed to grow to reach 40-50% confluency at the time of the 
transfection. Opti-MEM Reduced Serum Medium (Gibco, UK) was used to prepare a mixture 
of RNAi duplex-Lipofectamine RNAiMAX complex was prepared and a final concertation of 
10 nM for each siRNA was added per well/chamber. The cells were incubated 48 hours at 
37°C in a CO2 incubator and medium was changed after 16 hours. Afterward, the medium was 
removed and the cells were washed in PBS before collection for qPCR and IHC analysis. All 
siRNA samples were compared to siRNA negative control (Thermo Fisher, UK).  
Table 2-5: List of siRNAs used in transfection study 
Gene  siRNA Forward Primer  (Sequence (5'->3')) 
siRNA Reverse Primer 
(Sequence (5'->3')) 
UniGene 
Reference 
ID 
BCAN GGGCCAACUGUAUGCAGCCUGGGAU AUCCCAGGCUGCAUACAGUUGGCCC Hs.516904 
FN1 GCAGUGGCUGAAGACACAAGGAAAU AUUUCCUUGUGUCUUCAGCCACUGC Hs.203717 
IMPG1 GGUUCCAUAUCUACGAUCCAAUCUU AAGAUUGGAUCGUAGAUAUGGAACC Hs.590893 
VCAN CGGAGGCACCUGUUAUCCUACUGAA UUCAGUAGGAUAACAGGUGCCUCCG Hs.643801 
 
2.16. Statistical Analyses 
All statistical tests were performed using Prism software (GraphPad, USA). The standard 
errors of all means (SEM) were calculated. Statistical significance of differences was tested 
with two-tailed Student’s t-test for paired samples for neuroepithelium thickness and cell 
image quantitation or a One-way ANOVA for qRT-PCR and the quantification of synaptic 
marker proteins. Asterisk = p-value < 0.05, two asterisks = P-value < 0.01, three asterisks = P-
value <0.001, four asterisks = P-value <0.0001. 
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Chapter 3. Expression of extracellular matrix in adult mouse and monkey 
retina and adult and developing human retina 
 
3.1. Introduction 
The extracellular matrix (ECM) is the non-cellular component of all tissues. It consists 
of proteins, water and polysaccharides (Frantz et al., 2010) and varies in composition from 
one tissue to the next (Frantz et al., 2010). The ECM acts as a structural support that facilities 
cell adhesion via integrins and other adhesion molecules which mediate signalling pathways 
essential for cell proliferation, migration and differentiation (Streuli, 2009; Fournier et al., 
2012; Moreno-Layseca and Streuli, 2014). It also provides biochemical and biomechanical 
cues that are essential for tissue morphogenesis (Frantz et al., 2010).  
Various studies of rat, mouse, chicken and human retina (Popp et al., 2004; Hausman, 
2007; Inoue et al., 2009; Clark et al., 2011; Keenan et al., 2012; Kwan, 2014) have shown 
that the localisation of ECM molecules varies between developmental stages (Keenan et al., 
2012) and species (Clark et al., 2011). For example, versican has been identified in the nerve 
fibres and the inner plexiform layer of the embryonic chicken retina, while in adult chicken it 
has been found in photoreceptor layer and BrM (Keenan et al., 2012). Hyaluronic acid is 
found in the IPM of adult chicken retina (Inoue et al., 2009) but in adult human retina 
hyaluronic acid is widely distributed throughout the whole retina (Clark et al., 2011).  During 
retinal development, different ECM molecules including fibronectin, collagen IV and 
laminins are required for optic cup morphogenesis (Kwan, 2014). For example, removal of 
the surface ectoderm and disruption of the surrounding ECM with collagenase resulted in the 
curvature of the optic vesicle at early stages of invagination and inhibition of subsequent 
invagination and optic cup formation (Oltean et al., 2016). Another study has demonstrated 
that blocking the interaction of rat retinal progenitor cells with laminin β2 in vitro reduced the 
fraction of cells that express rhodopsin, suggesting that this laminin could be important for 
rod photoreceptor differentiation (Hunter et al., 1992). Knockdown of laminin β2 also results 
in abnormal elongation of photoreceptor outer segments, abnormal electroretinogram, and 
atypical synaptic formation of rod photoreceptors and apoptosis in mice (Libby et al., 1999).  
Collagen IV, laminin and fibronectin are the main ECM components of the basement 
membranes including BrM and the ILM (Hausman, 2007; Kwan, 2014). Basement 
membranes are essential for structural support, cellular adhesion, differentiation, proliferation, 
migration and intercellular communication (LeBleu et al., 2007). Roy et al. reported a direct 
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link between increased expression of fibronectin at the mRNA level and the thickening of 
BrM in rat animal models of diabetic retinopathy (Roy et al., 2003). Inhibition of fibronectin 
assembly in vitro prevented collagen IV accumulation and thus could be a contributor to the 
development of fibrotic disease in age-related macular degeneration (Miller et al., 2017). 
Mutations in collagen IV genes (COL4A3, COL4A4, or COL4A5) were also reported in Alport 
syndrome (characterised by corneal scarring, temporal retinal thinning, giant macular hole, 
and maculopathy) patients and mice with ocular anterior segment dysgenesis (Bai et al., 2009; 
Savige et al., 2015). 
The IPM is a highly organised structure that surrounds the inner and outer segments of 
the photoreceptor cells, and lies between the photoreceptors and the RPE (Ishikawa et al., 
2015). It has several prominent functions including: regulating retinoid transport; maintenance 
of the photoreceptor-specific microenvironment; cellular interactions; and retinal adhesion to 
the RPE (Ishikawa et al., 2015). A major component of the IPM is hyaluronic acid, a large 
non-sulfated linear polysaccharide of (1-β-4) D-glucuronic acid and (1-β-3) N-acetyl-D-
glucosamine (Ishikawa et al., 2015). Hyaluronic acid is expressed throughout the human 
retina and is known to bind several other IPM-specific ECM components including hyalectins, 
IMPG1 and IMPG2, forming a scaffold that fills the IPM (Inoue et al., 2009; Mellough et al., 
2014; Mouw et al., 2014; Ishikawa et al., 2015).  
Brevican and versican are members of the hyalectins family which has been shown to 
play an important role in maintaining adhesion between the RPE and neurosensory retina as 
well as BrM (Keenan et al., 2012). They can bind to hyaluronic acid from their N-terminal 
region and are involved in the development of the central nervous system (Popp et al., 2004). 
IMPG1 & IMPG2 are unique proteoglycans found in the IPM and shown to be involved in the 
development and maintenance of the photoreceptors, in mice and human (Acharya et al., 1998; 
Kuehn and Hageman, 1999; Chen et al., 2003). IMPG1 mutations were reported in 
Vitelliform macular dystrophies leading to impaired metabolism of the IPM and the 
accumulation of Vitelliform deposits in the sub-retinal space (Manes et al., 2013). A splice 
mutation in the versican gene (VCAN, heterozygous c.9265 + 1G > A nucleotide change in 
intron 8) was reported in Wagner syndrome patients with retinal detachment (Rothschild et al., 
2013), whilst mutations in IMPG2 cause progressive degeneration of the photoreceptors, 
leading to autosomal dominant retinitis pigmentosa (Bandah-Rozenfeld et al., 2010; Manes et 
al., 2013). CD44 acts as the primary receptor for hyaluronic acid and also allows adhesion to 
other ECMs such as Versican, Brevican and Aggrecan (Brun et al., 2003; Dicker et al., 2014). 
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It interacts with the glycosaminoglycans (GAGs) of IMPG1 and may participate in retinal 
adhesion (Kuehn et al., 2000).  
Given that human retina develops largely in utero, it is imperative to understand the 
expression of ECM components during retinal ontogenesis, in order to use this knowledge to 
improve the differentiation of pluripotent stem cells to retinal organoids and understand the 
role of various ECM components in retinal development and disease (Clark et al., 2011; 
Keenan et al., 2012). To date, there has been limited detailed analysis of ECM component 
distribution during human retinal development and so the functional importance of ECM in 
retinal ontogenesis is poorly understood (Reinhard et al., 2015). Preceding any experiment to 
study the ECM components during human retinal development, it is important to investigate 
their expressions in adult human retina. However, the ECM composition may change in 
retinae obtained from elderly as retinal changes occur with aging. Therefore, there is a need to 
find animal models such as mouse and monkey that are similar to humans in term of ECM 
expression.  
 
3.2. Aims 
The first aim of this chapter was to investigate the expression of several ECM 
components (Fibronectin, Collagen IV, Versican, Brevican, Neurocan, Aggrecan, Hyaluronic 
Acid, HAPLN1, IMPG1, IMPG2, pan-HS and SPARC) in adult mouse, monkey and human 
retinae so that important ECM expressions in the IPM and BrM can be identified which may 
be important for outer retinal development, in vivo.  A further aim was to determine the 
temporal and spatial expression of these ECM components during human retinal 
morphogenesis using IHC in order to identify components associated with the development of 
the outer retina that could potentially enhance the photoreceptor development in vitro.   
 
3.3. Results 
The expression data obtained from this study are largely IHC and such a validation of 
antibody specificity is an important consideration. To address this, widely used controls for 
IHC were employed including: (i) omission of primary antibodies (Figure 3-1); (ii) 
replacement of primary antibodies with isotype controls (for collagen IV, fibronectin, 
brevican, versican, IMPG1, IMPG2 and CD44) (figure 3-2); (iii) usage of antibodies that 
have been widely published and validated in other studies. For example, the IMPG2 antibody 
used in this study was validated through incubation with pre-immune serum and shown to be 
expressed in the IPM of human retina by Acharya et al. (Acharya et al., 2000). In addition, 
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the collagen IV antibody used in this study showed a similar expression in BrM of pig retina 
(Miura et al., 2010) and the size of CD44 protein detected with the same antibody used in this 
study was confirmed by western immunoblotting by Enkhjargal et al. (Enkhjargal et al., 
2017). 
 
Figure 3-1: Immunostaining of secondary antibody controls in adult mouse and monkey 
retinae, adult and developing human retinae and retinal organoids derived from hESCs.   
Different secondary antibodies (anti-mouse (IgG) Alexa Fluor 488, anti-rabbit (IgG) Cy3, and 
anti-goat (IgG) Cy3) were used to differentiate non-specific background signals in tested 
tissues: adult mouse retina (A), adult monkey retina (B), adult human retina (C) and human 
developing retina (19 PCW) (D). Scale bars = 20μm. 
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Figure 3-2: Immunostaining of isotype controls to ECM antibodies in adult mouse and 
monkey retinae, adult and developing human retinae. 
Isotype controls matching primary antibodies isotypes were used to differentiate non-specific 
binding of immunoglobulin to tested tissues: adult mouse retina (A), adult monkey retina (B), 
adult human retina (C) and human developing retina (19 PCW) (D). Scale bars = 20μm. 
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3.3.1. Distribution of basement membrane glycoproteins in adult mouse, monkey and 
human retinae  
In order to understand retinal ECM composition in adult retina, IHC was performed on 
adult mouse, monkey and human retinae. Fibronectin and collagen IV were expressed in BrM 
in adult mouse, monkey and human retinae (Figure 3-3). Fibronectin was also expressed in 
the ILM in all three species (Figure 3-3). Fibronectin and collagen IV expression around 
blood vessels was also observed in monkey (fibronectin) and human adult retina (collagen IV). 
Collagen IV has also moderate staining in the INL, IPL and GCL layers in adult human retina 
(Figure 3-3).   
 
Figure 3-3: Immunostaining of fibronectin (FN1) and collagen IV (Col4A1) in adult 
mouse, monkey and human retina.  
Antibody labelling with and without Hoechst (Hoe) are shown. FN1 and Col4A1 were 
expressed in BrM in all species. FN1 was also expressed in the ILM. Stars indicate FN1 and 
Col4A1 expression around blood vessels. Scale bars = 20μm.  
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3.3.2. Distribution of hyalectins and hyaluronan in adult mouse, monkey and human 
retinae  
Aggrecan, versican, brevican and neurocan are members of the hyalectins family that contain 
binding domains to hyaluronic acid (Mouw et al., 2014). Versican expression was conserved 
across adult mouse, monkey and human retinae (Figure 3-4) with strong expression around 
the outer segments of the photoreceptors, and partially co-localised with the IPM marker, 
(Retinol Binding Protein 3) RBP3 (Figure 3-4). Versican was faintly expressed in other 
retinal layers of mouse, monkey and adult human retina (INL and GCL in mouse; ONL and 
INL in monkey; ONL, INL and GCL in human retina). The expression of Brevican varied 
between all three species; showing expression in the RPE, around outer and inner segments of 
photoreceptors, outer plexiform layer, INL and GCL in adult mouse retinae, all retinal layers 
except outer segment in adult monkey retinae, and the INL, IPL and GCL in adult human 
retinae (Figure 3-4).  
 
Figure 3-4: Expression of Versican (VCAN) & Brevican (BCAN) in adult mouse, 
monkey and human retina.  
Antibody labelling with and without Hoechst (Hoe) are shown. Smaller boxes show double 
labelling of Versican with RBP3 in the human retina. Scale bars = 20μm.  
 
Neurocan was expressed in the plexiform layers (OPL & IPL) with moderate 
expression in the INL and GCL layers in the adult mouse, monkey and human retinae (Figure 
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3-5). Aggrecan expression varied between the three species. It was expressed in several layers 
including RPE, around IS, INL and GCL in mouse retinae. In monkey retina, aggrecan 
expression was observed in RPE and all retinal layers (Figure 3-5). However, strong immuno-
reactivity of aggrecan was only detected in BrM in adult human retinae (Figure 3-5).  
 
Figure 3-5: Expression of Neurocan (NCAN) & Aggrecan (ACAN) in adult mouse, 
monkey and human retina.  
Antibody labelling with and without Hoechst (Hoe) are shown. Scale bars = 20μm.  
 
The expression of hyaluronic acid was observed throughout the retina of all three 
species: strong staining was detected in the OPL, INL and GCL and moderate staining in the 
RPE layer, around IS, and IPL in mouse retinae; moderate staining in the RPE, OPL, INL, IPL 
and GCL layers in monkey retinae; and strong expression the ONL and moderate staining in the 
OPL, INL, IPL and GCL layers in human retinae (Figure 3-6). HAPLN1 is a cartilage link 
protein that stabilise the interactions between hyalectins and Hyaluronic Acid (Keenan et al., 
2012). Strong immuno-reactivity of HAPLN1 was detected around OS in adult monkey and 
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human retinae (Figure 3-6). HAPLN1 was also expressed in the RPE and GCL in adult human 
retina. However, different expression of HAPLN1 was detected in adult mouse retina 
including: strong expression in the INL and GCL; and moderate in the ONL (Figure 3-6). 
 
Figure 3-6: Expression of Hyaluronic Acid (HA) & Hyaluronan and proteoglycan link 
protein 1 (HAPLN1) in adult mouse, monkey and human retina.  
Antibody labelling with and without Hoechst (Hoe) are shown. Scale bars = 20μm.  
 
3.3.3. Distribution of photoreceptors specific ECM and other ECM components in adult 
mouse, monkey and human retinae  
The expression profiles of IMPG1 & IMPG2 were conserved across the three species 
examined (Figure 3-7). Remarkably, both IMPG1 and IMPG2 were strongly expressed 
around the outer segments of the photoreceptors in the adult human and monkey retina 
(Figure 3-7), however, expression around both inner and outer segments was observed in the 
mouse retina (Figure 3-7). In adult human retina, IMPG1 was expressed in the rod 
photoreceptor outer segments as shown by co-expression with the rod marker Rhodopsin 
(Figure 3-7). It was not possible to perform co-immunostaining of IMPG1 with the cone 
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markers (OPN1MW/LW) because the antibodies were raised in the same species, however the 
widespread expression of IMPG1 immunostaining in the outer segments indicates that these 
may include cone photoreceptors too (Figure 3-7). IMPG2 expression did not co-localise 
with Rhodopsin or opsin staining, thus indicating that IMPG2 is expressed around but not in 
the outer segments themselves.  
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The anti-Pan Heparan Sulfate antibody (pan-HS, 10E4) identifies a common N-
sulfated epitope within HS that facilitates the determination of the overall distribution of HS 
in the retina (Clark et al., 2011). Pan-HS expression was differently widespread throughout 
the retinae of the three species: strong expression in the INL and moderate staining in the RPE, 
around IS, ONL and GCL layers in mouse retina; strong expression in the RPE and GCL, and 
moderate staining in the ONL, OPL, INL and IPL layers in monkey retina; RPE, ONL, OPL, 
INL and GCL layers (strong expression in the GCL) in human retina (Figure 3-8). SPARC 
expression was also different between the three species: strong in the INL and GCL, and 
moderate in the RPE layer, IS, and OPL in mouse retina; moderate expression in the ONL, 
INL and GCL layers in monkey retina; and strong expression in the INL and GCL, and 
moderate in the OPL and IPL in adult human retina (Figure 3-8).  
 
Figure 3-8: Expression of Pan Heparan Sulfate (Pan-HS) & Secreted protein acidic and 
rich cysteine (SPARC) in adult mouse, monkey and human retina.  
Antibody labelling with and without Hoechst (Hoe) are shown. Scale bars = 20μm.  
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3.3.4. Distribution of basement membrane glycoproteins in developing human retina 
Collagen IV and fibronectin are two major components of the basement membranes. 
Collagen IV was expressed in the choroid and BrM during the 6 -19 PCW (Figure 3-9A). 
This result was further corroborated by adjacent expression of the RPE marker, RPE65 
(Figure 3-9C). Collagen IV was also expressed in the hyaloid artery and lens capsule during 
the 6 PCW suggesting that it might play an important role in their development. Faint 
expression of collagen IV was also detected in the RPE, Outer Neuroblastic Zone (ONZ), 
Inner Plexiform Layer (IPL) and Inner Neuroblastic Zone (INZ) across all stages (Figure 3-
9A). The expression pattern of collagen IV was consistent with the expression observed in 
adult human retina described in the previous section.  
Fibronectin was expressed in BrM during the 12-19 PCW (Figure 3-9B). In addition, 
expression was detected in the ILM in the 17 PCW and in the Choroid in 14-19 PCW (Figure 
3-9B). The expression pattern of fibronectin in BrM and ILM was consistent with the 
expression observed in adult human retina. Double staining of fibronectin with collagen IV 
confirmed that both of these ECM components were expressed in BrM, although in different 
parts with fibronectin localised more basally than collagen IV (Figure 3-9D).  
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3.3.5. Distribution of hyalectins and hyaluronan in developing human retina 
The expression of brevican was observed throughout the retina (ONZ, IPL and INZ) 
across all developmental stages (Figure 3-10A). Strong expression of brevican was detected 
around developing photoreceptors (Figure 3-10C, inset)  and in the emerging space between 
the RPE and ONZ, often referred as the IPM, during the 12-19 PCW (Figure 3-10A). 
Brevican was also detected in the surface ectoderm in 6 PCW and in the neural retina at 6 and 
8 PCW (Figure 3-10A). Versican was expressed throughout the retina and strongly expressed 
around the developing photoreceptors and IPM during the 12-17 PCW (Figure 3-10B). Co-
expression studies indicated that brevican and versican were both expressed in the developing 
IPM; however their expression did not overlap entirely (Figure 3-10C). Versican expression 
did, however, overlap with the IPM marker RBP3 and was located above Recoverin-positive 
labelled photoreceptors (Figure 3-10D), thus corresponding with the expression observed in 
adult human retina. 
 
Neurocan was strongly expressed in the IPL and ILM in 17-19 PCW (Figure 3-11A). 
Neurocan expression was not detected until 12 PCW in the IPL layer (Figure 3-11A), and its 
expression pattern in IPL was consistent with the expression previously observed in adult 
human retina. Expression of aggrecan was throughout the retina across all developmental 
stages with stronger expression in INZ than other layers (Figure 3-11B). Aggrecan was also 
expressed in the lens capsule in 6 PCW and dorsal-nasal gradient of the retina in 8 PCW 
(Figure 3-11B).  
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The expression of hyaluronic acid was throughout the retina across all developmental 
stages with stronger expression in the developing IPM (Figure 3-12A). Co-expression of 
hyaluronic acid with RBP3 (IPM marker) was observed in 14 PCW (Figure 3-12C). 
HAPLN1 was strongly expressed in BrM and INZ across all developmental stages (Figure 3-
12B). It was also expressed in the lens capsule in 6 PCW. As illustrated in Figure 3-12D, 
tissue was double labelled with HAPLN1 and SOX1 (lens marker) or RBPMS (retinal 
ganglion cells marker) to confirm the localisation of HAPLN1. Co-expression of HAPLN1 
with RBPMS was observed in 17 PCW suggesting that HAPLN1 was expressed in retinal 
ganglion cells (Figure 3-12D). Moreover, the distinct lens morphology in 6 PCW and using 
SOX1 in staining indicated that HAPLN1 was expressed in the lens capsule (Figure 3-12D). 
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3.3.6. Distribution of photoreceptors specific ECM and other ECM components in 
developing human retina 
Strong expression of IMPG1 was observed around the developing photoreceptors and 
emerging IPM during the 12-19 PCW (Figure 3-13A). This was confirmed by the co-
expression of IMPG1 with versican (Figure 3-13C). IMPG1 expression was also detected 
across the neural retina from the 6-19 PCW. Co-expression of IMPG1 with CRYAA (a lens-
specific marker) was observed in the lens in 6 PCW suggesting that IMPG1 might be 
important for lens development (Figure 3-13C). IMPG2 expression was not detected until the 
17 PCW (Figure 3-13B). Co-expression of IMPG2 with Recoverin in the ONZ was observed 
in 19 PCW suggesting that IMPG2 is expressed by the developing photoreceptors (Figure 3-
13D). Co-expression of IMPG2 with RBP3 was also found in the developing IPM, thus 
corroborating the expression observed in the adult human retina (data not shown).  
 
Pan-HS was expressed throughout the retina across all developmental stages (Figure 
3-14A). Pan-HS was also expressed in the lens capsule in 6 PCW. This result was further 
investigated by double staining Pan-HS with SOX1 (Figure 3-14C). The distinct lens 
morphology in 6 PCW and using SOX1 in staining indicated that Pan-HS was expressed in 
the lens capsule. SPARC was not expressed until 17 PCW with strong expression in INZ and 
ILM (Figure 3-14B).  
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3.3.7. Distribution of cluster of differentiation 44 (CD44) in human developing retina 
As mentioned previously, CD44 acts as the primary receptor for hyaluronic acid and 
interacts with other ECMs such as versican, brevican, aggrecan and IMPG1. It was, therefore, 
important to investigate CD44 expression in the developing human retina. CD44 was found to 
be expressed in the ONZ & INZ during the later stages of human retinal development studied 
including 16-19 PCW (Figure 3-15A). No immunostaining of CD44 was detected in retinal 
sections from the 6 until the 14 PCW (Figure 3-15A). Strong expression of CD44 was also 
observed in the developing IPM in 16-19 PCW as revealed by the co-localisation with RBP3 
(Figure 3-15B).  
 
75 | P a g e  
 
 Fi
gu
re
  3
-1
5:
 E
xp
re
ss
io
n 
of
 c
lu
st
er
 o
f d
iff
er
en
tia
tio
n 
44
 (C
D
44
) i
n 
th
e 
hu
m
an
 e
m
br
yo
ni
c 
an
d 
fo
et
al
 e
ye
. 
(A
) S
ag
itt
al
 se
ct
io
ns
 th
ro
ug
h 
th
e 
de
ve
lo
pi
ng
 h
um
an
 e
ye
 sh
ow
in
g 
an
tib
od
y 
la
be
lli
ng
 w
ith
 a
nd
 w
ith
ou
t H
oe
ch
st
 (H
oe
) d
ur
in
g 
th
e 
6-
19
 P
C
W
. 
Sc
al
e 
ba
r =
20
 µ
m
. A
rr
ow
s i
nd
ic
at
e 
C
D
44
 e
xp
re
ss
io
ns
 in
 IP
M
. (
B
) T
is
su
e 
la
be
lle
d 
w
ith
 C
D
44
 a
nd
 R
B
P3
 in
 1
6 
PC
W
. S
ca
le
 b
ar
 =
20
 µ
m
. 
76 | P a g e  
 
3.4. Discussion 
In this study the expression of several ECM components in adult mouse and monkey 
retinae, developing and adult human retinae was investigated (for summary of key ECM 
expression, please see Figure 3-16). The results of this study demonstrate that different ECM 
components have distinct distribution patterns throughout the adult retina of different species 
(Clark et al., 2011). Collagen IV was expressed in BrM, while Fibronectin was expressed in 
BrM and ILM, consistent with the expression previously observed in adult rat (Chen et al., 
2009). Preceding any experimental work to mimic the specific IPM environment, it is 
essential to understand the composition of the IPM during human retinal organogenesis. 
Expression studies were performed to map the differential distribution of proteoglycan core 
proteins and their associated GAGs in sections of adult mouse and monkey retinae, 
developing and adult human retinae.  
 
Figure 3-16: Illustrated diagram showing a summary of key ECM expression in human 
developing retina; and adult human, monkey and mouse retinae. 
Colour shades indicate intensity level of fluorescent expression for different ECMs.   
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Hyaluronic Acid was found to be widely distributed in the human developing retina 
and the adult retina of mouse, monkey and human. This was consistent with the result 
reported by Clark et al. showing the expression throughout the retina of adult human (Clark et 
al., 2011). Hyaluronic Acid is secreted from the apical side of the RPE and plays important 
role in the survival of the photoreceptors by binding to PEDF, a growth factor required for the 
avascularity of the IPM and survival of photoreceptors (Becerra et al., 2008; Broadhead et al., 
2010; Ishikawa et al., 2015). Co-expression study of hyaluronic acid with RBP3 in the IPM of 
human developing retina suggested that it may play a role in the development of IPM. 
Versican was previously reported in the IPM in adult chick (Zako et al., 1997). The data 
obtained in the current study corroborate this published report and also demonstrate conserved 
expression of versican in the IPM of adult human, mouse and monkey retina. In the 
developing human retina, versican expression surrounded the developing photoreceptors 
between the RPE and ONZ, an area which likely develops into the future IPM. The 
localisation of versican in the IPM was confirmed by co-expression with interphotoreceptor 
retinoid binding protein (IRBP/ RBP3), the most abundant protein in the IPM (Stenkamp et 
al., 2005).  
Brevican expression was also detected the developing IPM in human developing 
retina. Although co-expression study showed that brevican and versican expression did not 
overlap, it indicated that both were expressed in the developing IPM of human developing 
retina. Brevican expression in the IPM was consistent with data reported by Keenan et al. 
showing it is expressed in the IPM of adult human retina (Keenan et al., 2012). Neurocan 
expression was detected in the IPL layer of human developing retina, and its expression was 
consistent with the expression previously observed in postnatal rat retina (Inatani and 
Tanihara, 2002). Although aggrecan expression varied between the three species studied, it 
was only detected in BrM of adult human retina. This expression pattern was similar to a 
result reported by Keenan et al. illustrating strong expression of aggrecan in BrM of the adult 
human retinae (Keenan et al., 2012). Aggrecan was also expressed in the lens capsule and 
dorsal-nasal gradient in human developing retina, suggesting it might play a role in the 
development of the lens and retinal ganglion cells during optic cup morphogenesis.  
HAPLN1 is a cartilage link protein that maintains the interactions between hyalectins 
and hyaluronic acid (Keenan et al., 2012). The expression pattern of HAPLN1 in adult human 
and monkey retina is similar to what Keenan et al. reported that it was observed in the IPM of 
adult human retina (Keenan et al., 2012). HAPLN1 was expressed differently in mouse tissue 
suggesting that significant species-specific differences exist for this protein, although 
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expression around the inner segments and in the ONL suggests an important role of HAPLN1 
for photoreceptor. HAPLN1 was also expressed in the lens capsule of human developing 
retina suggesting that it might play an essential role in the lens development. 
IMPG1 and IMPG2 are two specific ECM components that are secreted by the 
photoreceptors into the IPM (Acharya et al., 1998; Acharya et al., 2000). The results of this 
study demonstrated expression of these two ECMs in the IPM in human developing tissue, 
with IMPG1 detected earlier and IMPG2 expressed at later stages of development, which may 
suggest a role for IMPG1 in early photoreceptor development and IMPG2 in photoreceptor 
maturation. Conserved expression of both ECMs was also detected in the IPM of the adult 
retinae in the three species studied suggesting an important role in IPM formation and 
photoreceptors development. Furthermore these data support the clinical phenotype of 
Vitelliform Macular Dystrophy caused by IMPG1 mutations and is characterised by impaired 
metabolism of photoreceptors in the macula region due to the loss of IPM (Manes et al., 
2013). 
Pan-HS was expressed throughout the retina of all species. This finding is similar to a 
recent report that demonstrated pan-HS expression throughout the retina of adult human 
(Clark et al., 2011). SPARC expression varied between the three species studied and was 
expressed at later stages of human developing retina. Several studies have demonstrated that 
CD44 is a multi-domain protein that spans the plasma membrane of the cell and acts as a 
receptor for Hyaluronic Acid and other ECMs such as versican, brevican and aggrecan (Brun 
et al., 2003; Dicker et al., 2014). CD44 can also interact with the GAGs of IMPG1 and may 
participate in retinal adhesion (Kuehn et al., 2000). The data obtained in this study indicated 
that CD44 was expressed in the IPM from the 16 PCW of human development, suggesting 
that CD44 may play an important role in the development of the photoreceptors. The results 
of this study and those published by Nishina et al., 1997 indicated that CD44 expression was 
also found in the longitudinal fibres that extend from the inner to the outer limiting membrane 
and the surface of Müller cells at later stages of human retinal development (19 PCW) 
(Nishina et al., 1997). 
IHC was the technique for investigating the expression of ECM components. The 
interpretation of fluorescence microscopy of tissues obtained from elderly individuals might 
be difficult due to the presence of the auto-fluorescent pigment lipofuscin (Schnell et al., 1999) 
which is a lipid/protein aggregate resulting from autophagocytosed oxidised cellular 
components and which accumulates throughout life in the RPE (Boulton and Dayhaw-Barker, 
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2001; Terman and Brunk, 2004; Petty et al., 2010). The presence of this auto-fluorescence in 
the visible spectrum can complicate the use of conventional immunofluorescence microscopy 
to localise molecules in the tissue sections and to distinguish specific labelling from that of 
lipofuscin (Schnell et al., 1999; Boulton and Dayhaw-Barker, 2001; Petty et al., 2010). 
Therefore, auto-fluorescence was experienced in most of the tissues used. To overcome this 
issue, tissue sections were stained with Sudan Black with the aim of quenching and reducing 
endogenous fluorescence of retinal tissue (Petty et al., 2010). This was successfully achieved 
in staining most of the tissues used in most mouse, monkey and human embryonic tissue. 
However, endogenous fluorescence was still present in the RPE of the adult human tissue that 
could be due to the age of the donors as lipofuscin can occupy up to 19 % of the cells 
cytoplasmic volume by 80 years of age (Boulton and Dayhaw-Barker, 2001). In addition, 
based on the fact that human retinal tissue were collected from elderly individuals, there 
might be changes occur to the ECM composition that in BrM (Booij et al., 2010) and the 
retina (Al-Ubaidi et al., 2013). To overcome this issue, ECM composition was also 
investigated in animal models that are similar to human in term of ECM composition and 
retinal structure.      
 
3.5. Conclusion 
In summary, the data presented in this chapter indicate a well conserved expression for 
Collagen IV and Fibronectin in BrM and BrM/ILM in adult and developing human retinae, 
and a well conserved expression for Versican, Brevican, IMPG1 and IMPG2 in the IPM of 
adult and developing human retinae. Therefore, these key ECM components were selected for 
further experiments described in the following chapter. 
 
Note: The content, data and figures in this chapter were used in a recently published original article 
(Felemban et al., 2018) published in Acta Biomaterialia Journal (See appendices): “Extracellular 
matrix expression in human pluripotent stem cell-derived retinal organoids recapitulates retinogenesis 
in vivo and reveals an important role for IMPG1 and CD44 in the development of photoreceptors and 
interphotoreceptor matrix”.  
 
80 | P a g e  
 
 
 
 
Chapter 4 
  
81 | P a g e  
 
Chapter 4. ECM expression in hESC- and hiPSC-derived retinal organoids 
and the role of IMPG1 and CD44 in the development of photoreceptors and 
interphotoreceptor matrix 
 
4.1. Introduction 
The final impact of many forms of retinal diseases is the loss of photoreceptors, a 
specialised type of photosensitive neurons that are capable of photo-transduction, and/or the 
underlying retinal pigmented epithelium (RPE) (Zhong et al., 2014). No treatments currently 
exist to restore lost photoreceptor cells and the accompanying vision loss which occurs in 
many retinal diseases. Thus there is a pressing need to generate a source of functional 
photoreceptors and RPE, the underlying tissue which is essential for photoreceptor function 
and viability, for disease modelling and transplantation. The retina is a prime system within 
which to test the development of cell transplantation therapies due to the relative accessibility 
of the eye that permits local delivery of cells with minimum risk of systemic consequences. 
Pluripotent stem cells including human embryonic stem cells (hESCs) and induced 
pluripotent stem cells (hiPSCs) provide great tools for modelling retinal disorders, 
understanding human fetal ontogenesis or as therapeutic agents; because of their ability to 
proliferate indefinitely and to differentiate into multiple tissue including retinal linages 
(Mellough et al., 2014). In the last few years several groups have demonstrated the generation 
of pluripotent stem cell derived retinal organoids which contain multiple retinal cells types, 
respond to electrophysiological stimuli (Meyer et al., 2011; Nakano et al., 2012; Zhong et al., 
2014; Kuwahara et al., 2015; Mellough et al., 2015; Gonzalez-Cordero et al., 2017; Wahlin et 
al., 2017; Hallam et al., 2018) and engraft within the degenerate retinae (Shirai et al., 2016; 
Waldron et al., 2018). Such organoid cultures provide an extremely useful tool for large scale 
pharmacology and toxicology testing, understanding human retinal development, and 
dissecting the role of individual genes during this process. As such, it is important to ensure 
that in vitro pluripotent stem cell models are similar counterparts to the retinal tissue in vivo. 
A number of reports have shown that various aspects of the retinal development can 
be recapitulated in vitro through the differentiation of hESCs and hiPSCs into retinal 
organoids (Meyer et al., 2011; Mellough et al., 2012; Nakano et al., 2012; Mellough et al., 
2014; Zhong et al., 2014; Gonzalez-Cordero et al., 2017; Welby et al., 2017) which contain 
the key retinal cells types and respond to electrophysiological cues. The ECM plays an 
important role in controlling the behaviour of stem cells including self-renewal and 
differentiation (Keung et al., 2012). In vivo, the ECM plays major roles in several cellular 
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processes during retinal development such differentiation, proliferation, migration, adhesion, 
guidance and axonal growth (Reinhard et al., 2015).  This process can be enhanced by ECM 
supplementation, in vitro (Boucherie et al., 2013). For example, the addition of Matrigel, a 
complex ECM which is rich in basement membrane components, to the media was shown to 
promote hESC self-organisation into retinal organoids under 3D culture conditions 
(Boucherie et al., 2013), whilst addition of laminin-111 encouraged differentiation of hESC 
and iPSC to RPE (Gong et al., 2008; Rowland et al., 2013). Sasai et al. have demonstrated 
that the addition of laminin and entactin to 3D culture promoted the formation of self-
organising optic cups from mouse ESCs (Eiraku et al., 2011; Kuwahara et al., 2015).  
Given the potential of using pluripotent stem cells to model various aspects of retinal 
morphogenesis, it is essential to study the expression of ECM components during the 
differentiation of hESC and hiPSC into retinal organoids and to understand the role of several 
ECM components in retinal development.   
 
4.2. Aims 
In the previous chapter, the expression of several ECM components in adult mouse and 
monkey retina, developing and adult human retina was studied. The aim of this chapter was to 
investigate the expression of key ECM components (Fibronectin, Collagen IV, Versican, 
Brevican, IMPG1 and IMPG2) and their functions in retinal organoids derived from hESCs 
and hiPSCs.  
 
 4.3. Results 
In order to validate the antibody specificity used to study the ECM expression in 
retinal organoids, several approaches was applied including: omission of primary antibodies 
(Figure 4-1A), replacement of primary antibodies with isotype controls (Figure 4-1B) and 
usage of antibodies that have been widely published and validated in other studies. For some 
antibodies (Fibronectin, Brevican, Versican and IMPG1) where not enough evidence in the 
literature was found, siRNA studies were performed and showed in all cases a corresponding 
decrease in gene and protein expression using qRT-PCR and immunocytochemistry (Figure 
4-2). 
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Figure 4-2: siRNA study of ECM protein and gene expression 
(A) qRT-PCR study showing a decrease in the mRNA expression upon transfection of 
(Fibronectin: FN1, Versican: VCAN and Brevican: BCAN) siRNAs in hESCs. IMPG1 was not 
expressed in hESCs, hence siRNA was performed in day 90 retinal organoids. (B) Hoechst 
(Hoe) control and siRNA transfection of FN1, VCAN and BCAN in hESCs, and IMPG1 in 
day 90 retinal organoids showing a reduction in the ECMs expression after the transfection. 
n=3, error bars = SEM. * p-value < 0.05, *** p-value <0.001. 
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4.3.1. ECM expression during differentiation of hESC and hiPSC to laminated retina 
Retinal organoids were generated from hESCs (H9) and hiPSCs (SB-Ad3) following a 
differentiation protocol which was previously described (Mellough et al., 2015), with a few 
modifications (previously mentioned in Chapter 2, section 2.6). The development of retinal 
progenitors and their maturation over time was assessed using a combination of specific 
markers (Figure 4-3 and 4-4). VSX2, a marker of retinal progenitor cells, was expressed in 
the apical region of retinal organoids of days 35 and 90 of differentiation (Figure 4-3). 
Amacrine and RGCs (detected by the expression of HuC/D) were located in the basal layer 
(toward the centre of the retinal organoids) (Figure 4-3). The development of photoreceptors 
was assessed using antibodies to CRX and Recoverin. CRX, a post-mitotic photoreceptor 
marker, was expressed throughout the retinal organoids with strong expression towards the 
apical region of the organoid as the photoreceptors developed over time (Figure 4-3). Strong 
expression of Recoverin, a photoreceptors and midget OFF bipolar cells, was observed at the 
most apical side of the organoids at days 90 and 150 (Figure 4-3). At day 150, there was no 
overlap between VSX2 and CRX expression (Figure 4-3). PAX6 and VSX2 co-
immunostaining showed that bright VSX2 and bright PAX6 expressing cells did not overlap 
(Figure 4-4A), indicating that high VSX2 and high PAX6 expression in the putative inner 
nuclear layer of day 150 retinal organoids most likely marks the emerging bipolar and 
amacrine/horizontal cells respectively, corroborating data published by Volkner et al. 
(Volkner et al., 2016). Nonetheless, within the retinal organoids, some cells were found with 
low PAX6 and low VSX2 expression which most likely mark the remaining proliferating 
retinal progenitor cells (Figure 4-4A), also shown by Ki67 expression (Figure 4-4A). At day 
150, other cell types including amacrine, horizontal, bipolar and Muller glial cells were 
observed through immunostaining with AP2α, Prox1, CRLABP (Figure 4-4A) in addition to 
the expression of presynaptic marker (Syntaxin shown to be expressed in the presynaptic 
terminals of photoreceptor and horizontal cells), vGlut1 (expressed in photoreceptor and 
bipolar cell terminals) and photoreceptor connecting cilia marker, ARL13B (Figure 4-4A). At 
day 150, the expression of Rhodopsin was observed in cell bodies and IS/OS like segments 
(Figure 4-4A) in a similar pattern reported by Gonzalez-Cordero et al. recently (Gonzalez-
Cordero et al., 2017). The expression of cone markers (Cone Arrestin and long/medium 
wavelength Opsin) was assessed from day 150; however a typical expression pattern in cell 
bodies and IS/OS like segments was only observed from day 200 onwards (Figure 4-4B).  
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Figure 4-3: Expression of retinal markers during the differentiation of hESC to 
laminated retina. 
H9-derived retinal organoid sections showing the development of retinal progenitors and their 
maturation over time using retinal markers: VSX2, HuC/D, CRX and Recoverin. 
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Figure 4-4: Immunostaining of day 150 retinal organoids (hESC) with retinal lineage 
markers.  
(A) Sections through retinal organoids at day 150 showing labelling with retinal markers 
including: PAX6 & VSX2, Ki67, CRALBP, Rhodopsin, Recoverin & vGlut1, Prox1, 
ARL13B, Syntaxin, AP2α with or without Hoechst. (B) Sections through retinal organoids 
showing double labelling of Hoechst with Cone Arrestin, OPN1MW/LW (day 150 & 200) & 
with Cone Arrestin, OPN1MW/LW & CRX (day 270). 
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Immunostaining with antibodies against the selected ECM components indicated that 
Fibronectin was expressed throughout the 3D retinal organoids during the entire period of 
differentiation in both hESC- and hiPSC-derived retinal organoids (Figure 4-5 and Figure 4-
6). On day 35, the strongest expression of Fibronectin was observed on the basal side of the 
organoids, whilst at day 90 and 150, the strongest expression was at the apical edge. The 
expression of Collagen IV was detected in the basement membrane on the luminal side of 
both hESC- and hiPSC-derived retinal organoids (Figure 4-5 and Figure 4-6). 
 
Versican was expressed throughout the retinal organoids with strong apical expression 
at all stages of differentiation. Furthermore, Versican expression at the most apical edge of the 
organoid co-localised with RBP3 in both hESC- and hiPSC-derived retinae at day 150 and 
120 of differentiation respectively (Figure 4-5C and Figure 4-6C), indicating expression in 
the emerging IPM and corroborating data obtained from developing and adult human retinae. 
A similar analysis in the hESC- and hiPSC-derived retinal organoids showed highest 
expression of Brevican in the apical layer consisting of photoreceptors marked by the CRX 
expression at days 90 and 150 of differentiation (Figure 4-5B, C and Figure 4-6B, C). At day 
35, faint expression of Brevican was only detected in hESC-derived retinal organoids (Figure 
4-5A and Figure 4-6A). 
 
The expression of IMPG1 in retinal organoids was first evident on day 90, with strong 
apical expression at day 150 (around the developing IPM and adjacent to the photoreceptors 
marked by CRX) suggesting that IMPG1 might have a significant role in the development and 
maturation of photoreceptors in vitro (Figure 4-5C). IMPG1 expression in hiPSC-derived 
retinal sections was only observed from day 120, suggesting potential differences between 
hESC and hiPSC in the kinetics of differentiation and/or IMPG1 expression (Figure 4-5 and 
Figure 4-6). In contrast, IMPG2 was not detected at all stages of hESC and hiPSC retinal 
differentiation tested, suggesting that it might be expressed at later stages of the 
differentiation process that have not been studied herein. Similar to IMPG1, CD44 expression 
started at day 90 in the retinal organoids with broad expression throughout neural retinal 
tissue and a strong punctate-like pattern in the apical layer where Recoverin staining was 
strongly detected (Figure 4-7A-C). Co-immunostaining showed CD44 co-expression with 
IPM marker RBP3 (Figure 4-7D). Collectively, these data indicate that Versican, Brevican, 
IMPG1 and CD44 were expressed in the IPM of human pluripotent stem cells derived retinal 
organoids and recapitulate the expression observed in human developing retina.  
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Figure 4-5: Expression of selected ECM components during the differentiation of hESC 
to laminated retina.  
(A-C) H9-derived retinal organoid sections showing Fibronectin, Collagen IV, Versican, 
Brevican, IMPG1 and IMPG2 antibody labelling with and without Hoechst on day 35 (A), 
day 90 and (B), day 150 (C). Scale bars =20 μm.  
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Figure 4-6: Expression of ECM components in hiPSC derived retinal organoids.  
(A-C) Sections through retinal organoids showing Fibronectin, Collagen IV, Versican, 
Brevican, IMPG1 and IMPG2 antibody labelling with and without Hoechst in differentiated 
SB-Ad3, day 35 (A), day 90 (B), day 120 (C). Scale bars =20 μm.  
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Figure 4-7: Expression of CD44 in human pluripotent stem cell derived retinal 
organoids.  
(A-C) Sections through retinal organoids showing double labelling of CD44 with Recoverin, 
with and without Hoechst (Hoe) in differentiated H9 (day 35, 90 and150). (D) Double 
labelling of CD44 with RBP3 in retinal organoid section at day 150 of differentiation. Scale 
bars =20 μm.  
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4.3.2. IMPG1 & CD44 receptors mediated effect on photoreceptors development -Day 90 of 
differentiation 
In order to investigate the functional role of IMPG1 and CD44 in photoreceptor 
differentiation, blocking antibodies to IMPG1 and CD44 were added to retinal organoid 
culture medium at day 90 and 150 of the differentiation process. IMPG1 antibody blocks the 
extracellular cell binding domain (SEA domain) of the receptor, while CD44 blocks the LINK 
domain on the cell membrane (Brun et al., 2003; Vigetti et al., 2008). Treated groups were 
compared to a control group. After 14 days of incubation of retinal organoids at day 90 of 
differentiation with IMPG1 and CD44 blocking antibody, thinning of the phase bright 
neuroepithelium typically found at the periphery of retinal organoids, was observed in the 
group treated with IMPG1 antibody only (Figure 4-8). 
 
Figure 4-8: Effect of IMPG1 and CD44 blocking on neuroepithelium thickness in day 90 
retinal organoids 
Measurements of neuroepithelium thickness in retinal organoids at day 7, 10 and 14 of anti-
IMPG1 and anti-CD44 treated groups compared to control. n=3, error bars = SEM. *** p-
value <0.001. 
 
 
After 14 days in culture, the effects of IMPG1 and CD44 receptor inhibition at day 90 
of differentiation were assessed using qRT-PCR and IHC with retinal markers including 
Recoverin (photoreceptor marker), ARL13B (marker for connecting cilia) and RBP3 (IPM 
marker) to determine any effect on photoreceptors and/or IPM development (Figure 4-9 and 
4-10). The expression of RCVRN (Recoverin; Figure 4-9A) and the number of Recoverin 
positive cells (Figure 4-9B and Figure 4-10B) were significantly reduced upon blocking of 
IMPG1 at day 90 of differentiation. The expression of photoreceptor connecting cilia, 
ARL13B was also significantly reduced upon blocking of IMPG1 function (Figure 4-10B), 
however no changes in RBP3 expression were observed (Figure 4-9A and Figure 4-10B), 
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suggesting that IMPG1 plays a role in the development and emergence of photoreceptors, but 
not IPM formation at this developmental time point. Blocking of CD44 had no impact on the 
gene or protein expression of photoreceptor, connecting cilia or IPM markers at this time 
point (Figure 4-9 and Figure 4-10C). 
 
 
Figure 4-9:  Blocking of IMPG1 and CD44 function in retinal organoids (day 90-104).  
(A) qRT-PCR study showing the expression of RCVRN and RBP3 in blocked retinal 
organoids (day 104). (B) Quantification of Recoverin immune-positive cells in blocked retinal 
organoids (day 104). n=3, error bars = SEM. ** p-value < 0.01. 
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4.3.3. IMPG1 & CD44 receptors mediated effect on photoreceptors and IPM development -
Day 150 of differentiation 
At day 150 of differentiation, thinning of the neuroepithelium was observed in both CD44 and 
IMPG1 treated groups after 14 days of incubation with blocking antibodies (Figure 4-11). 
The effects of IMPG1 and CD44 receptor inhibition at day 150 of differentiation were 
assessed using qRT-PCR and IHC with retinal markers including Recoverin (photoreceptor 
marker), Rhodopsin (rod marker), OPN1LW (cone marker), WGA (cone and rod inner and 
outer segment marker), ARL13B (marker for connecting cilia) and RBP3 (IPM marker) to 
determine any effect on photoreceptors and/or IPM development (Figure 4-12 and 4-13). No 
cone markers for immunostaining analysis were included due to their emergence from day 
200 onwards as mentioned previously (Section 4.3.1.).  
Blocking of IMPG1 action at day 150 led to a significant reduction in the expression 
of RCVRN and the number of Recoverin positive cells within the retinal organoids (Figure 4-
12 and Figure 4-13B). The expression of the cone marker (OPN1LW) was downregulated 
only in the IMPG1 blocked group (Figure 4-12A), although it was difficult to assess cones 
expression at the protein level given the later and typical emergence (from day 200) of this 
cell type. The expression of Rhodopsin (RHO) and the number of Rhodopsin immune-positive 
cells were reduced upon IMPG1 and CD44 blocking (Figure 4-12 and Figure 4-13B, C). In 
addition, the typical pattern of Rhodopsin immunostaining was lost in CD44 and IMGP1 
blocked groups (Figure 4-13B, C), instead a punctate pattern at the surface of retinal 
organoids was observed. Immunostaining with the cone and rod inner/ outer segment marker 
WGA showed a significant reduction in the IMPG1 and less so in the CD44 blocked group, 
suggesting that blocking the function of these two ECM components interferes with the 
development of photoreceptor inner/outer segments at different extent (Figure 4-13B, C). 
Furthermore, the expression of photoreceptor connecting cilia (ARL13B) and IPM (RBP3) 
markers was significantly reduced in the IMPG1 treated group (Figure 4-13B), indicating an 
important role for this protein in cilia and IPM formation. ARL13B and RBP3 
immunostaining were also reduced in the CD44 blocked group, but less so when compared to 
the IMPG1 treated group (Figure 4-13C). Collectively, these data suggest that IMPG1 and 
CD44 play an important role in the development of photoreceptors, their inner and outer 
segments, connecting cilia and IPM, with IMPG1 having an earlier and more significant 
impact than CD44. 
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Figure 4-11: Effect of IMPG1 and CD44 blocking on neuroepithelium thickness in day 
150 retinal organoids 
(A) Bright field images of retinal organoids (day150-164) treated with IMPG1 and CD44 
blocking antibodies, compared to treatment with a non-specific IgG antibody control. Scale 
bars =100 μm. (B) Measurements of neuroepithelium thickness (NE; highlighted by red lines) 
in retinal organoids (day 150) in culture at day 7, 10 and 14 of anti-IMPG1 and anti-CD44 
treated groups compared to control. n=3, error bars = SEM. ** p-value < 0.01, *** p-value 
<0.001, **** p-value <0.0001. 
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Figure 4-12: Blocking of IMPG1 function in retinal organoids (day 150-164).  
(A) qRT-PCR study showing the mRNA expression of RCVRN, OPN1LW and RHO in retinal 
organoids (day 164). (B) Quantification of Recoverin (RCVRN) and Rhodopsin (RHO) 
immuno-positive cells in blocked retinal organoids (day 164). n=3, error bars = SEM. * p-
value < 0.05, ** p-value < 0.01, **** p-value <0.0001. 
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4.4. Discussion 
Since the seminal discovery of Eiraku and Sasai in 2011 on generation of 3D retinal 
organoids from mouse ESC, multiple protocols have been developed and optimised for both 
human and mouse pluripotent stem cells (Jayakody et al., 2015). The initial stages of 
differentiation protocols that encompass formation of neural progenitors vary between 
different published methods and include manipulation of IGF-1 and Wnt and TGFβ/activin 
signalling pathway (Jayakody et al., 2015; Mellough et al., 2015). The second and longer 
stages of differentiation protocols that encompasses the formation of retinal progenitors, 
photoreceptor precursors and mature photoreceptors within a laminated structure are more 
similar to each other and in most cases include the addition of fetal calf serum, taurine and 
retinoic acid. The differentiation method in this study was based on a previous publication 
which highlighted enhanced formation of eye and optic cup like structures from hESC by the 
addition of IGF-1 (Mellough et al., 2015). To obtain laminated retinal organoids with high 
efficiency from both hESC and hiPSC, this protocol was optimised through the addition of 
fetal calf serum, retinoic acid, taurine and tri-iodothyronine (T3) from day 18 of 
differentiation. The data (discussed in more detail in Chapter 5, sections 5.3 & 5.4) indicate 
that this optimised differentiation protocol results in formation of laminated retinal organoids 
which contain all key retinal cell types, form synaptic connections and respond to light. In 
view of these results, this differentiation protocol was used for the ECM studies described 
herein. 
In this study the expression of key ECM components in retinal organoids derived from 
hESC and hiPSC was investigated (for summary of ECM expression, please see Figure 4-14). 
Fibronectin was expressed in the basal layer of the organoids at early stages of differentiation 
and later the expression changed to become in the apical layer. The expression of Collagen IV 
was observed in the luminal side of the organoids and corporate a similar result reported by 
Kuwahara et al. showing the formation of Collagen IV in the luminal side of the hESCs-
derived retinal epithelium (Kuwahara et al., 2015). In the examined organoids generated from 
pluripotent stem cells, Versican was expressed in the most apical side of the organoids, an 
area which likely develops into the future IPM. The localisation of Versican in the IPM was 
confirmed by co-expression with (IRBP/ RBP3), the most abundant protein in the IPM 
(Stenkamp et al., 2005). Similarly, Brevican and IMPG1 were also expressed in the apical 
layer of the organoids. IMPG2 was not expressed in retinal organoids until the last time point 
examined (day 150). This, however, does correspond well with expression in developing 
human retina, where IMPG2 expression was observed only from 17 PCW.  
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The expression of key ECM components was very similar between hESC- and hiPSC-
derived organoids (Figure 4-14). However, Brevican and IMPG1 were detected earlier 
(Brevican at day 35 and IMPG1 at day 90) in hESC-derived organoids than hiPSCs, 
suggesting potential differences between hESC and hiPSC in the differentiation kinetics 
and/or ECM expression. Moreover, the expression of Versican, Brevican, IMPG1 and CD44 
in the apical side of the organoids (developing IPM) was similar to the expression observed in 
human developing retina. For example, IMPG1 was detected in the developing IPM of human 
developing retina at 12 PCW which correspond with the expression observed in the apical 
side (developing IPM) of day 90 retinal organoids. Another example, strong expression of 
CD44 was detected in the developing IPM at day 150 organoids which recapitulate the 
expression in human developing retina from 16 PCW.   
 
Figure 4-14: Illustrated diagram showing a summary of selected ECM expression 
during the differentiation of hESCs and hiPSCs to retinal organoids. 
Collagen IV was detected in the basal layer (luminal side) of the organoids. Fibronectin was expressed 
thought the organoids with strong expression toward the apical layer. Brevican, Versican and IMPG1 
were strongly expressed in the IPM in the most apical side of the organoids. IMPG2 was not detected 
until the last time point examined. Colour shades indicate intensity level of fluorescent expression for 
different ECMs.  
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Following studying the expression of key ECM components in the retinal organoids, it 
was clear that their expression in the organoids recapitulates human retinal development in 
vivo. In addition, the expression of IMPG1 and CD44 was first detected in day 90 retinal 
organoids and became strong in day 150 organoids. Therefore, it was important to perform 
blocking studies at these time points (day 90 & 150) in order to examine the functional role of 
these ECMs on retinal development, in vitro. At day 90 of differentiation, blocking the action 
of IMPG1 affected the expression of photoreceptors and connecting cilia but not IPM markers, 
suggesting important role for IMPG1 in the emergence of the photoreceptors at this time point. 
Blocking the action of CD44 in day 90 retinal organoids had no impacts on the expression of 
photoreceptor, connecting cilia and IPM markers. The study also indicated that inhibition of 
CD44 and IMPG1 in day 150 retinal organoids had a negative impact on the development of 
photoreceptors and IPM formation (Figure 4-15).  
 
Figure 4-15: Illustrated diagram surmising the effect of blocking IMPG1 and CD44 
receptors in retinal organoids. 
Blocking antibodies against IMPG1 and CD44 were added to culture medium containing retinal 
organoid at day 150 of the differentiation process for 14 days. IMPG1 antibody blocked the 
extracellular cell binding domain (SEA domain) of the receptor, and CD44 blocked the LINK domain 
on the cell membrane. Inhibition of IMPG1 and CD44 negatively affected photoreceptor 
development, their inner and outer segments, connecting cilia and IPM formation. Although, 
IMPG1 acts earlier and having more significant effect on development than CD44. 
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Blocking the function of IMPG1 in day 150 retinal organoids indicated that IMPG1 
plays an important role in the development of photoreceptors as well as formation of their 
inner/outer segments, connecting cilia and IPM (Figure 4-15). Furthermore these data support 
the clinical phenotype of Vitelliform Macular Dystrophy caused by IMPG1 mutations and is 
characterised by impaired metabolism of photoreceptors in the macula region due to the loss 
of IPM (Manes et al., 2013). Several studies have demonstrated that CD44 is a multi-domain 
protein that spans the plasma membrane of the cell and acts as a receptor for Hyaluronic acid 
and other ECMs such as Versican, Brevican and Aggrecan (Brun et al., 2003; Dicker et al., 
2014). CD44 can also interact with the GAGs of IMPG1 and may participate in retinal 
adhesion (Kuehn et al., 2000). In retinal organoids, strong expression of CD44 was observed 
in the apical layer where the IPM develops, suggesting that CD44 may play an important role 
in the development of the photoreceptors. The results of this study and those published by 
Nishina et al., 1997 indicated that CD44 expression was also found in the longitudinal fibres 
that extend from the inner to the outer limiting membrane and the surface of Müller cells at 
later stages of human retinal development (19 PCW) (Nishina et al., 1997). Blocking of the 
CD44 receptor in day 150 retinal organoids resulted in a reduction in the number of rod 
photoreceptors within the retinal organoids as well as the expression of connecting cilia 
marker (ARL13B) and IPM marker (RBP3) (Figure 4-15). Collectively these data suggest 
that IMPG1 & CD44 may play an important role in the development of photoreceptors, in 
addition to being involved in formation of photoreceptor connecting cilia and IPM. 
4.5. Conclusion  
In summary, Retinal organoids were successfully generated from pluripotent stem 
cells. The expression of key ECM components (Collagen IV, Fibronectin, Brevican, Versican, 
IMPG1, IMPG2 and CD44) was examined in the retinal organoids found to recapitulate 
human retinal development, in vivo. Collagen IV and Fibronectin were expressed in Bruch’s 
membrane; whereas Brevican, Versican, IMPG1 and CD44 in the developing IPM. 
Furthermore, the study highlights an essential role for IMPG1 and CD44 in the development 
of photoreceptors, their inner and outer segments, connecting cilia and IPM, with IMPG1 
having an earlier and more significant impact than CD44. Future work will endeavour to 
investigate whether manipulation of the ECM can accelerate and enhance retinal development 
in vitro so that effective cell replacement therapies for retinal diseases may be realised. 
Note: The content, data and figures in this chapter were used in a recently published original article 
(Felemban et al., 2018) published in Acta Biomaterialia Journal (See appendices): “Extracellular 
matrix expression in human pluripotent stem cell-derived retinal organoids recapitulates retinogenesis 
in vivo and reveals an important role for IMPG1 and CD44 in the development of photoreceptors and 
interphotoreceptor matrix”.   
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Chapter 5. Investigating the impact of exogenous ECM manipulation on 
hESC and hiPSC differentiation towards 3D laminated retina 
 
5.1. Introduction 
Human pluripotent stem cells (hPSCs) can be differentiated into retinal organoids to 
study inherited and age related retinal dystrophies, to screen new drugs and to use them in 
tissue transplantation. In the last decade, seminal discoveries made by Sasai’s group have led 
to the in vitro generation of retinal organoids containing major retinal cell types such as 
photoreceptors, Muller glia and other retinal neurons organized in laminar structures from 
murine, primate and human embryonic stem cells and induced pluripotent stem cells (Eiraku 
and Sasai, 2011; Eiraku et al., 2011; Nakano et al., 2012; Assawachananont et al., 2014; 
Kuwahara et al., 2015; Takata et al., 2017). Since then, multiple studies modified Sasai’s 
protocol to enhance culturing outcomes (Gonzalez-Cordero et al., 2013; Assawachananont et 
al., 2014; Völkner et al., 2016). However, current differentiation protocols are impeded by 
some challenges. For example,  the differentiation process is lengthy, requiring 150-300 days 
and often unable to generate correct proportions of all retinal cell-types especially those 
located in the inner nuclear layer (Llonch et al., 2018). Other challenges in this field are the 
failure to establish correct synaptic connections (Llonch et al., 2018), although the expression 
of some synaptic proteins have been reported (Zhong et al., 2014), inability to maintain 
mature photoreceptor cells that resemble the native counterparts in both structure and function 
and light response (Meyer et al., 2011; Nakano et al., 2012; Zhong et al., 2014; Kuwahara et 
al., 2015; Gonzalez-Cordero et al., 2017; Wahlin et al., 2017). Although light responses were 
reported by Zhong et al., they were from a limited number of photoreceptors (2 out of 13 
randomly selected cells) (Zhong et al., 2014). Another study has reported immature light 
responses in retinal organoids that resemble early light responses recorded from retinal 
ganglion cells in mouse developing retina (Hallam et al., 2018). Many groups have also 
reported the generation of RPE cells (Zhong et al., 2014; Kaewkhaw et al., 2015; Lowe et al., 
2016; Wahlin et al., 2017), but not all the cells were able to interact with neural retina (NR) as 
in vivo and were not fully organised on the apical side of the retinal organoid. It has been 
shown in mouse retina in vivo and in vitro that the RPE is important for retinal lamination, 
spatial reorganisation and the differentiation of the photoreceptors (Raymond and Jackson, 
1995; German et al., 2008). 
In vivo, RPE cells and its associated basement membrane are known to release many 
extracellular molecules (ECMs) that help to maintain retinal integrity such as laminin, 
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collagen and hyaluronic acid (Aisenbrey et al., 2006; Clark et al., 2011; Keenan et al., 2012). 
This is corroborated by in vitro proteomic studies which have shown the secretion of 
numerous trophic factors and ECMs including fibronectin, collagen and laminin (Kolomeyer 
et al., 2011) from foetal and adult RPE into the culture media. The biological effect of the 
RPE secreted factors is reflected in enhanced proliferation, neurite outgrowth and 
differentiation of the photoreceptors isolated from neonatal rat retina and co-cultured with 
RPE conditioned medium (CM) (Gaur et al., 1992), enhanced RPE differentiation from 
human embryonic stem cells (hESCs) (Hsiung et al., 2015) and human adipose tissue-derived 
mesenchymal stromal cells (Zhang et al., 2017). Kolomeyer et al. indicated that porcine retina 
cultured in RPE CM significantly decreases the thinning of outer nuclear layer, photoreceptor 
axon retraction and retinal death compared to basal medium (Kolomeyer et al., 2013), 
supporting the presence of key factors in RPE CM which support photoreceptor viability in in 
vitro culture conditions. Another study reported that co-culturing rat neural retina with RPE 
cells in vitro promotes the attachment of the photoreceptors, axon’s growth and migration of 
their cell bodies toward the RPE cells as well as photoreceptors development by increasing 
the synthesis of rhodopsin (German et al., 2008). Given the close interactions of RPE with 
NR, co-culture of these two cell types has been used to support the maintenance of neural 
retina in a novel organotypic culture model (Kaempf et al., 2008). For example, Kaempf et al. 
indicated that co-culture of adult porcine neural retina with choroid-RPE explant in vitro 
enhanced the maintenance of the retina by reducing apoptosis in the all nuclear cell layers, 
decreasing gliosis and increasing glutamate synthetase compared to retina cultured alone 
(Kaempf et al., 2008).     
In addition to secreted factors provided in CM and direct co-culture of several cell 
types, tissue decellularisation has been put forward as a useful method for providing the 
necessary biochemical and biophysical features of cellular niches that are needed to promote 
progenitor and stem cell differentiation and engraftment (Ott et al., 2008; Ott et al., 2010; 
Petersen et al., 2010; Baptista et al., 2011; Song et al., 2013; De Waele et al., 2015; Chirco et 
al., 2017; Sun et al., 2018). Tissue decellularisation is a process of removing the cellular 
materials from a tissue so that only the extracellular matrix (ECM) components remain 
(Chirco et al., 2017). This process preserves the architecture and integrity of the ECM which 
can be used as an additional culture media supplement or as a scaffold to support cell 
engraftment and differentiation as well as a source of biochemical and biophysical cues for 
the cells that reside within it (Chirco et al., 2017). To date, decellularised ECM (dECM) has 
been successfully achieved and utilised from many tissues including heart, liver, lung, kidney 
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and brain (Ott et al., 2008; Ott et al., 2010; Petersen et al., 2010; Baptista et al., 2011; Song et 
al., 2013; De Waele et al., 2015; Sun et al., 2018). For example, culturing hESCs on 
decellularised rhesus monkey kidney and lung sections enhanced the expression of kidney and 
lung markers, respectively (Agmon and Christman, 2016). Zhang et al. has also reported that 
dECM from rat liver enhanced the differentiation of adipose derived mesenchymal stem cell 
into hepatic cells (Zhang and Dong, 2015). Several groups have also performed 
decellularisation of tissues in the eye including cornea, retina, Bruch’s membrane and RPE 
(Tezel et al., 2004; Ponce Márquez et al., 2009; Kundu et al., 2016; Chirco et al., 2017; Ji et 
al., 2018; Singh et al., 2018). More recently, dECM has been prepared from RPE and neural 
retina and shown to contain several ECMs [such as collagen, laminin sulfated 
glycosaminoglycans, hyaluronic acid, and growth factors including basic fibroblastic growth 
factor (bFGF), epidermal growth factor (EGF), nerve growth factor (NGF) and pigment 
epithelium derived factor (PEDF)] that play a significant role in the development and 
maturation of the retina and photoreceptors (Kundu et al., 2016; Chirco et al., 2017). Kundu 
et al. showed that decellularised neural retina from bovine eye promoted the attachment, 
proliferation and differentiation of human retinal progenitor cells in vitro (Kundu et al., 2016).  
To investigate whether direct contact or only secreted factors (indirect) were needed to 
direct differentiation of retinal progenitor cells (RPCs) from hESCs, Amirpour et al. 
compared between direct and indirect RPE co-cultured with hESC-derived retinal progenitor 
cells differentiation system into photoreceptors (Amirpour et al., 2013) and found that the 
expression of photoreceptor mature markers like arrestin was only increased in direct co-
culture (cell-cell contact) comparing to the indirect system (Amirpour et al., 2013). This result 
suggests that the expression of late photoreceptor markers can be enhanced through seeding 
retinal progenitor cells on RPE cells, in vitro. However, none of these studies tested the 
impacts of these supplementations on retinal organoids developed in 3D culture systems 
which recapitulate retinal development in vivo.  
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5.2. Aims 
In the previous chapter, the functional role of key ECM components in the differentiation 
of hPSC-derived retinal organoids was investigated via blocking the action of CD44 and IMPG1. 
The aim of this chapter is to investigate the impact of culture supplementation with RPE CM, 
decellularised ECM from adult bovine neural retina (decel NR) and RPE (decel RPE) on the 
differentiation of pluripotent stem cells (PSCs) to retinal organoids in order to enhance the 
current differentiation protocol by manipulating the ECM microenvironment to improve the 
development of retinal organoids and their responses to electrophysiological stimuli, in vitro.  
5.3. Results 
The work in this chapter was performed jointly with Dr. Birthe Hilgen (Newcastle 
University, UK). 
5.3.1. ECMs composition in CM RPE, decel NR & decel RPE  
Engineering a natural substrate that can promote pluripotent stem cells differentiation 
into retinal cells could be essential for the successful generation of retinal organoids, in vitro. 
The ECM has been shown to provide a biomimetic microenvironment with essential cues for 
retinal differentiation in culture (Kundu et al., 2016). In order to examine the role of ECM on 
the differentiation of pluripotent stem cells into retinal organoids, neural retina and RPE tissue 
were extracted and decellularised by the Master student (Martin Kiening) from adult bovine 
eye following a protocol reported by Medberry et al. (Medberry et al., 2013). The RPE CM 
was collected from polarised RPE cells (8 months old; TER>250Ω) derived from hESCs. 
ECM components (collagen, laminin, GAGs and HA) were quantified and compared to RPE 
medium and native tissue of bovine retina and RPE, respectively (Table 5-1). 
Table 5-1: DNA and ECM composition in RPE normal and conditioned medium (RPE 
CM), native and decellularised neural retina and RPE (decel NR) and (decel RPE). 
 DNA Collagen Laminin GAGs Hyaluronic Acid 
Ratio  
(collagen:laminin:
GAGs:HA) 
RPE Medium 
(µg/ml) - 
0.5 ± 
0.0001767 
0.00017 ± 
0.00001085 0 
2.937 ± 
0.04582 2941:1:0:17276 
RPE CM 
(µg/ml) - 
1.7 ± 
0.0001146 
0.00233 ± 
0.00001668 
0.06358 ± 
0.01387 
3.333 ± 
0.1212 730:1:27:1430 
Native Retina 
(µg/mg of tissue 
dry weight) 
110.
5 
1.999 ± 
0.4285 
0.00327 ± 
0.009366 
8.667 ± 
0.1115 
43.43 ± 
1.403 611:1:2650:13281 
Decel NR 
(µg/mg of tissue 
dry weight) 
8.5 0.9496 ± 0.1731 
0.00051 ± 
0.01372 
3.661 ± 
0.5228 
8.81 ± 
0.9633 1862:1:7178:17275 
Native RPE 
(µg/mg of tissue 
dry weight) 
21.7
1 1.999 ± 0.0 
0.00547 ± 
0.01 
21.42 ± 
0.1115 
32.95 ± 
0.001171 365:1:3916:6024 
Decel RPE 
(µg/mg of tissue 
dry weight) 
4.3 0.5998 ± 0.1731 
0.00228 ± 
0.008868 
14.58 ± 
0.4238 
13.05 ± 
0.1315 263:1:6395:5724 
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To confirm the successes of the decellularisation process, the DNA content was 
assessed in NR and RPE samples. These results indicated 8.5 and 4.3 µg/mg of initial dry 
weight of NR and RPE, respectively (Figure 5-1 and Table 5-1) which was significantly 
lower than the amount of DNA in the native tissues (Figure 5-1 and Table 5-1) indicating 
that the bulk of cellular material was removed after the decellularisation process from the 
native retina (~92%) and RPE (~80.5%). This result was similar to the one reported by Kundu 
et al., 2016 where (~94%) of cellular material was removed after the decellularisation of NR 
from bovine eyes (Kundu et al., 2016), but higher than the amount of DNA reported by 
Medberry and his group (0.0379 µg/mg of initial dry weight of tissue) (Crapo et al., 2012). 
 
Figure 5-1: Cellular material composition of native and decel NR and RPE. 
DNA content (µg/mg of dry tissue). Data is shown as mean ± SEM, n = 3. Differences were 
considered statistically significant at ***p < 0.001 and ****p < 0.0001.  
 
All analysed ECM components (collagen, laminin, GAGs and HA) significantly 
increased in the CM RPE compared to the normal RPE medium (Figure 5-2 and Table 5-1). 
Opposite results were found for the native retina after decellularisation, revealing a decrease 
of all analysed ECM components in the decel NR compared to the native retina (Figure 5-3 
and Table 5-1). Similar to decel NR, the ECM components in the decel RPE were reduced 
compared to the native RPE after decellularisation (Figure 5-4 and Table 5-1). The ratio 
between the ECM components before and after the decellularisation was changed for all 
ECMs except laminin. Together these results indicate that some of the ECM components 
(collagen, sulfated GAGs & HA) were lost during the decellularisation procedures while 
removing the majority of cellular material. Kundu et al.  has also reported that  some of the 
ECMs  were lost after the decellularisation procedures and the ECMs concentration in the 
decel NR was 79 ± 13 µg collagen/mg, 21.3 ± 8 µg sGAG/mg, and 15.14 ± 0.22 µg HA/mg of 
tissue dry weight (Kundu et al., 2016). 
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Figure 5-2: ECM composition of RPE normal and conditioned medium (CM RPE). 
Collagen, laminin, sulfated GAGs and hyaluronic acid content (µg/ml of medium). Data is 
shown as mean ± SEM, n = 3. Differences were considered statistically significant at *p < 
0.05 and ****p < 0.0001.  
 
Figure 5-3: ECM composition of native and decellularised neural retina (decel NR). 
Collagen, laminin, sulfated GAGs and hyaluronic acid content (µg/mg of dry retina). Data is 
shown as mean ± SEM, n = 3. Differences were considered statistically significant at ***p < 
0.001 and ****p < 0.0001.  
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Figure 5-4: ECM composition of native and decellularised RPE (decel RPE). 
Collagen, laminin, sulfated GAGs and hyaluronic acid content (µg/mg of dry RPE). Data is 
shown as mean ± SEM, n = 3. Differences were considered statistically significant at **p < 
0.01 and ****p < 0.0001.  
 
 
 
 
5.3.2. Effects of ECM supplementation on early/middle retinal differentiation 
Retinal organoids were generated from hESCs and hiPSCs in four culture systems 
including: control culture system from previously published protocol (Dorgau et al., 2018; 
Felemban et al., 2018), and media supplemented with CM RPE, decel NR or decel RPE. The 
impacts of each ECM supplementation were assessed using IHC for specific markers of 
retinal developmental at three time points during the differentiation process: early (day 35), 
middle (day 90) and later stages of retinal differentiation (day 150). In addition, semi-
quantitative analysis of positive cells for distinct key retinal marker was performed to validate 
the effect of each ECM supplementation on the differentiation process.  
 At early stages of differentiation (day 35), a thick layer of retinal progenitor cells, 
expressing VSX2, was found on the apical edge of retinal organoids generated from hESCs 
(Figure 5-5) and hiPSCs (Figure 5-6) in all four culture conditions. Recoverin-positive 
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photoreceptors and HuC/D- positive amacrine/ganglion cells were observed in the centre 
region of retinal organoids in all culture conditions (Figure 5-5 and Figure 5-6). 
 
Figure 5-5: Characterisation of hESC-derived retinal organoids at day 35 of 
differentiation. 
(A-D) Sections through retinal organoids at day 35 showing immunofluorescence labelling 
with retinal markers including: VSX2, CRX, Recoverin (Recov) and HuC/D with Hoechst 
(Hoe) in four culture systems: control (A), CM RPE (B), decel NR (C) and decel RPE (D). 
Scale bars =20 μm. 
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Figure 5-6: Characterisation of hiPSCs-derived retinal organoids at day 35 of 
differentiation. 
(A-D) Sections through retinal organoids at day 35 showing immunofluorescence labelling 
with retinal markers including: VSX2, CRX, Recoverin (Recov) and HuC/D with Hoechst 
(Hoe) in four culture systems: control (A), CM RPE (B), decel NR (C) and decel RPE (D). 
Scale bars =20 μm. 
 
CRX, a marker for post-mitotic photoreceptors, was expressed across the entire neural 
retina of both cell lines in all culture conditions, marking some positive cells in the centre as 
well as the apical edge of the organoids where retinal progenitor cells are located (Figure 5-5 
and Figure 5-6). Cell quantification analysis of retinal progenitor cells (VSX2), 
photoreceptors (CRX and Recoverin) and amacrine/ganglion cells (HuC/D) revealed no 
significant differences between all conditions (Figure 5-7). These data correspond with 
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morphological observations which showed similar percentage of organoids that had 
developed neural retina with or without RPE (or RPE only) across different culture conditions 
at day 35 of the differentiation process (Figure 5-8).  
 
Figure 5-7: Cell quantification of retinal markers in day 35 retinal organoids derived 
from hESCs & hiPSCs. 
(A-D) Schematic charts showing semi-quantitative measurements of the retinal markers: 
VSX2 (A), CRX (B), Recoverin (C) and HuC/D (D) in day 35 hPSC-derived retinal organoids. 
Data is shown as mean ± SEM, n=6-8 (average of hESCs + hiPSCs).  
 
In comparison to day 35, a massive increase in the percentage of retinal organoids 
containing neural retinal structures with or without RPE was observed at day 90 of 
differentiation in all conditions of both cell lines, except for decel RPE condition of hESC-
derived retinal organoids (Figure 5-8). Interestingly, in this culture condition, retinal 
organoids had developed less structures of neural retina without RPE (p<0.001) and more 
structures of neural retina containing RPE (p<0.01) compared to control conditions (Figure 5-
8B), suggesting that the addition of decel PRE supplementation may have a beneficial effect 
on the development of neural retina with RPE.    
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 At middle stages of retinal differentiation (day 90), a thick layer of VSX2-positive 
retinal progenitor cells was still found in all culture conditions but a remarkable increase in 
the number of photoreceptors and amacrine/ganglion cells was observed compared to early 
stages of differentiation (day 35) in both cell lines and all conditions (Figure 5-9 and Figure 
5-10).  
 
Figure 5-9: Characterisation of hESC-derived retinal organoids at day 90 of 
differentiation. 
(A-D) Sections through retinal organoids at day 90 showing immunofluorescence labelling 
with retinal markers including: VSX2, CRX, Recoverin (Recov), HuC/D, NRL and RXR with 
Hoechst (Hoe) in four culture systems: control (A), CM RPE (B), decel NR (C) and decel 
RPE (D). Stars indicate cellular debris in NRL staining. Scale bars =20 μm.  
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Figure 5-10: Characterisation of hiPSC-derived retinal organoids at day 90 of 
differentiation. 
(A-D) Sections through retinal organoids at day 90 showing immunofluorescence labelling 
with retinal markers including: VSX2, CRX, Recoverin (Recov), HuC/D, NRL and RXR with 
Hoechst (Hoe) in four culture systems: control (A), CM RPE (B), decel NR (C) and decel 
RPE (D). Stars indicate cellular debris in NRL staining. Scale bars =20 μm. 
 
The majority of HuC/D-positive amacrine/ganglion cells were observed in the centre 
of the retinal organoids rather than across the neural retina in both cell lines (Figure 5-9 and 
Figure 5-10). A thin layer of photoreceptors, co-expressing CRX and Recoverin, was found 
at the apical edge of the organoids; however CRX- and Recoverin-photoreceptor precursors 
were also found across the organoids and accumulated in the centre (Figure 5-9 and Figure 
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5-10). The expression of NRL and RXRγ, markers for post-mitotic rod and cone precursors 
respectively, were expressed at day 90 of differentiation with slightly different distribution 
pattern. NRL-positive cells were mainly located at the apical edge of the organoids whereas 
RXRγ-expressing cells were found across the neural retina in both cell lines and all conditions 
(Figure 5-9 and Figure 5-10). In addition, there were less NRL-expressing rod precursors 
than RXRγ-positive cone precursors which were confirmed by cell quantification analysis 
(Figure 5-11). The cell quantification analysis showed no significant differences in retinal 
progenitor cells (VSX2), amacrine/ganglion cells (HuC/D), photoreceptors (CRX and 
Recoverin), rod (NRL) and cone (RXRγ) precursors between all conditions in both cell lines 
(Figure 5-11).  In summary, these data indicate that supplementation of CM RPE, decel NR 
and decel RPE in culture media had no effect on retinal development at early and/or middle 
stages of the differentiation process.  
 
 
Figure 5-11: Cell quantification of retinal markers in day 90 retinal organoids derived 
from hESCs & hiPSCs. 
(A-F) Schematic charts showing semi-quantitative measurements of the retinal markers: 
VSX2 (A), CRX (B), Recoverin (C), HuC/D (D), NRL (E) and RXRγ (F) in day 90 hPSC-
derived retinal organoids. Data is shown as mean ± SEM, n=6-8 (average of hESCs + 
hiPSCs). 
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5.3.3. ECM supplementation improves retinal differentiation at later stages 
To assess the development and confirm that retinal organoids contain all retinal cell-
types during later stages of the differentiation process (day 150), more specific retinal markers 
were used in IHC analysis and TEM was performed in all culture conditions. In addition, cell 
quantification analysis and qRT-PCR were carried out to evaluate any differences between 
individual ECM supplementation conditions.  
 At later stages of retinal differentiation (Day 150), the number of retinal structures, the 
bright phase neuroepithelium on the apical side of organoids, increased slightly in both cell 
lines and all conditions compared to day 90 of the differentiation process (Figure 5-8B,D). 
Moreover, a remarkable increase of retinal structures with RPE was observed in all conditions 
of hESCs in contrast to early stages of differentiation (Figure 5-8B). In line with this, there 
were significantly more retinal structures with RPE (p<0.05) and subsequently less without 
RPE (p<0.01) in the decel RPE condition compared to control condition (Figure 5-8B).  
IHC analysis revealed a thick layer of photoreceptors, detected by CRX and Recoverin, 
on the apical side of retinal organoids in all conditions (Figure 5-12, 5-13, 5-14 and Figure 
5-15), indicating the formation of outer nuclear layer (ONL). Moreover, in culture all 
conditions higher magnifications of Recoverin-positive cells displayed nice morphological 
features of photoreceptors possessing a connecting cilium, labelled with ARL13B, and 
developing outer segments (OS) as demonstrated by Gαt1 immunoreactivity (Figure 5-12, 5-
13, 5-14 and Figure 5-15).  
Although qRT-PCR studies and cell quantification analyses failed to show any 
differences in gene expression of CRX and RCVRN as well as the number of Crx- and 
Recoverin-positive photoreceptors in all culture conditions (Figure 5-16), the next step was to 
examine in more detail the expression of both photoreceptor types, rods and cones, in retinal 
organoids. In general, the two photoreceptor types were found in all conditions of hPSC-
derived retinal organoids at day 150 of differentiation (Figure 5-12, 5-13, 5-14 and Figure 5-
15). Rods, detected by Rhodopsin, were evenly distributed across the developing ONL of the 
organoids in all conditions (Figure 5-12, 5-13, 5-14 and Figure 5-15). Higher magnifications 
highlighted typical rod morphology in detail as shown in Figure 5-12, 5-13, 5-14 and Figure 
5-15.  
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Figure 5-12: Characterisation of hESC-derived retinal organoids at day 150 of differentiation. 
(A-B) Sections through retinal organoids at day 150 showing immunofluorescence labelling with 
retinal markers including: CRX, Recoverin (Recov), HuC/D, Gαt1, OPN1LW/MW, OPN1SW, 
Rhodopsin (Rho), ARL13B, Syntaxin, PKCα, Prox1, AP2α and CRALBP with or without Hoechst 
(Hoe) in four culture systems: control (A), CM RPE (B). Stars indicate cellular debris in organoids. 
Scale bars =20 μm.  
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Figure 5-13: Characterisation of hESC-derived retinal organoids at day 150 of differentiation. 
(A-B) Sections through retinal organoids at day 150 showing immunofluorescence labelling with 
retinal markers including: CRX, Recoverin (Recov), HuC/D, Gαt1, OPN1LW/MW, OPN1SW, 
Rhodopsin (Rho), ARL13B, Syntaxin, PKCα, Prox1, AP2α and CRALBP with or without Hoechst 
(Hoe) in four culture systems: decel NR (A) and decel RPE (B). Stars indicate cellular debris in 
organoids. Scale bars =20 μm.  
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 Figure 5-14: Characterisation of hiPSC-derived retinal organoids at day 150 of differentiation. 
(A-B) Sections through retinal organoids at day 150 showing immunofluorescence labelling with 
retinal markers including: CRX, Recoverin (Recov), HuC/D, Gαt1, OPN1LW/MW, OPN1SW, 
Rhodopsin (Rho), ARL13B, Syntaxin, PKCα, Prox1, AP2α and CRALBP with or without Hoechst 
(Hoe) in four culture systems: control (A), CM RPE (B). Scale bars =20 μm.  
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 Figure 5-15: Characterisation of hiPSC-derived retinal organoids at day 150 of differentiation. 
(A-B) Sections through retinal organoids at day 150 showing immunofluorescence labelling with 
retinal markers including: CRX, Recoverin (Recov), HuC/D, Gαt1, OPN1LW/MW, OPN1SW, 
Rhodopsin (Rho), ARL13B, Syntaxin, PKCα, Prox1, AP2α and CRALBP with or without Hoechst 
(Hoe) in four culture systems: decel NR (A) and decel RPE (B). Scale bars =20 μm.  
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Figure 5-16: Expression of retinal markers in day 150 retinal organoids derived from 
hESCs & hiPSCs. 
(A) Schematic charts showing qPCR study of retinal markers expression: CRX, RCVRN, 
MATH5 and RHO in day 150 retinal organoids in four culture systems. (B) Schematic charts 
showing semi-quantitative measurements of retinal markers: CRX, Recoverin, HuC/D and 
RHO in day 150 organoids. Data is shown as mean ± SEM, n=6-8 (average of hESCs + 
hiPSCs). Differences were considered statistically significant at *p < 0.05, **p < 0.01 and 
****p < 0.0001. 
 
qRT-PCR studies indicated a higher expression of RHO in the CM-RPE and decel 
RPE condition when compared to control condition (Figure 5-16A). These changes were 
confirmed by cell quantification analyses which revealed a significant increase in the number 
of rhodopsin-positive cells in CM-RPE and decel RPE condition when compared to control 
(Figure 5-16B). Furthermore, the higher expression of RHO could also be due to an increase 
in the production of the protein within the cells. This data suggests that the supplementation 
of CM-RPE and decel RPE improves the development of rods. In contrast to rod expression, 
the expression of long/middle wavelength (OPN1LW/MW) and short wavelength (OPN1SW) 
cones were found more sporadic within retinal organoids (Figure 5-12, 5-13, 5-14 and 
Figure 5-15), suggesting the beginning of opsin expression at this developmental stage. 
Nevertheless, both OPN1LW/MW and OPN1SW immunoreactivity-positive cells were found 
either at the apical side or in the centre of retinal organoids. In addition, higher magnifications 
of both cone types displayed the typical morphology at this time point of the differentiation 
process (Figure 5-12, 5-13, 5-14 and Figure 5-15). 
All other retinal cell-types (bipolar, horizontal, amacrine, ganglion and Müller cells) 
were found at day 150 of differentiation in retinal organoids derived from both cell lines and 
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in all conditions (Figure 5-12, 5-13, 5-14 and Figure 5-15). HuC/D-positive ganglion cells 
were mostly located in the centre of retinal organoids, forming a ganglion cell layer (GCL) 
(Figure 5-12, 5-13, 5-14 and Figure 5-15). This was seen in all conditions (Figure 5-12, 5-
13, 5-14 and Figure 5-15) without any differences in the MATH5 gene expression (Figure 5-
16A) or the percentage of HuC/D-positive cells as indicated by the cell quantification analysis 
(Figure 5-16B). Interestingly, horizontal cells detected by the marker protein Prox1 were 
found more towards the apical side of organoids while amacrine cells (Ap2α-labelled) were 
located more toward the centre of the organoids (Figure 5-12, 5-13, 5-14 and Figure 5-15), 
reflecting correct positions of both cell-types within the retinal organization. In all conditions 
Müller cells (CRALBP) are spanning through the whole retinal structure like known from the 
adult retina (Figure 5-12, 5-13, 5-14 and Figure 5-15).  
The development of mature RPE cells was confirmed by TEM analysis, showing 
polarized melanosomes [melanosomes are pigment granules where the synthesis, storage and 
transport of melanin pigments occur (Wasmeier et al., 2008); and called polarized because it 
is an essential feature for normal function of RPE cells that involve the polarization of Na,K 
ATPase to the apical membrane domain of RPE cells (Hu and Bok, 2001)] in decel RPE 
retinal organoids (Figure 5-17D). The TEM analysis also revealed the presence of organized 
photoreceptor-like ultrastructures such as photoreceptor OS, inner segments (IS), connecting 
cilium (cc) and basal body (bb) in all conditions (Figure 5-17A-D). In addition, an outer 
limiting membrane (OLM) was observed basal to the IS of developing mitochondria-rich 
photoreceptors in all culture conditions (Figure 5-17A-D). The development of other retinal 
cell types such as amacrine cells and Müller cells (indicated by the formation of 
neurofilaments) were also confirmed by TEM analysis (Figure 5-17B). Taken together, these 
results suggests that the supplementation of decel RPE has a positive impact on the 
development of RPE and rods, whereas the development of other retinal cell types including 
cones was not affected by the supplementation of CM RPE, decel NR or decel RPE at later 
stages of the differentiation.  
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Figure 5-17: Ultrastructural analysis of hPSC-derived retinal organoids using 
transmission electron microscopy. 
(A-D) Sections of retinal organoid derived from hPSCs showing ultrastructural analysis of 
photoreceptors in four different cultural conditions: control (A), CM RPE (B), decel NR (C) 
and decel RPE (D). Scale bars: 2µm, 10µm or 500µm. Abbreviations: AC: amacrine cells; bb: 
basal body; cc: connecting cilium; IS: photoreceptors inner segments; mt: mitochondria; M: 
melanosomes; NF: neurofilaments; OLM: outer limiting membrane; OS: photoreceptors outer 
segments; SV: synaptic vesicles.  
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5.3.4. Effect of ECM supplementation on the development of synapses and 
electrophysiology light responses 
Electrophysiological recordings and analyses of the results were performed by Prof. 
Evelyne Sernagor and Dr. Gerrit Hilgen (Newcastle University, UK). Also, quantification 
analyses of synaptic markers were performed by Dr. Birthe Hilgen (Newcastle University, 
UK). 
The previous results demonstrated that the retinal organoids derived from pluripotent 
stem cells in all culture conditions contained all retinal cell-types, forming different nuclear 
layers as in adult retina. However, the formation of correct synaptic connections between 
different cell-types, known as plexiform layers in adult retina (OPL and IPL), is still 
challenging in the retinal differentiation process (Llonch et al., 2018). IHC study was 
performed to investigate the effect of different ECM supplementations at day 150 of 
differentiation using more common synaptic marker proteins as well as ribbon synapse 
specific marker proteins.  
Syntaxin, a marker for the presynaptic plasma membrane, was found underneath the 
putative ONL of retinal organoids in all culture conditions at day 150 of differentiation 
(Figure 5-12, 5-13, 5-14 and Figure 5-15), indicating the formation of possible 
photoreceptor synapses. Ribbon synapse marker proteins (Bassoon and CtBP2) in 
combination with vGlut1, a marker for synaptic terminals of photoreceptors and bipolar cells, 
and Recoverin for photoreceptors were used to assess this in more detail. Bassoon and CtBP2 
puncta immunoreactivity were largely found below photoreceptor nuclei in retinal organoids 
derived from both cell lines in all conditions (Figure 5-18). Co-localisation of Bassoon or 
CtBP2 respectively with vGlut1 and Recoverin were observed at putative axons/axon 
terminals as highlighted by higher magnifications (Figure 5-18, insets). This suggests that 
photoreceptors might be able to form synaptic connections with second order neurons like 
bipolar or horizontal cells. In addition, a quantification of Bassoon and CtBP2 patches as well 
as the median intensity was performed to validate the impact of different ECM 
supplementations on the synapse formation.  
Bassoon-positive patches were significantly decreased in CM RPE and decel NR in 
hESC-derived retinal organoids while in hiPSCs they were significantly increased in decel 
NR compared to control condition (Figure 5-19A). This data suggest less putative 
photoreceptor synapses to be formed in CM RPE condition at day 150 of differentiation and 
potential differences between hESCs and hiPSCs. In contrast, immunoreactivity-positive 
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patches for CtBP2 were not affected by the different types of ECM supplementations in 
hESC-derived retinal organoids while in hiPSC-derived retinal organoids they were 
significantly increased in decel NR compare to control condition (Figure 5-19B), suggesting 
that decel NR condition promoted the formation of putative photoreceptor synapses and the 
expression of Bassoon and CtBP2 in hiPSC-derived retinal organoids. The protein expression 
of Bassoon and CtBP2 analysed by the median intensity quantification revealed an increase in 
hESC-derived retinal organoids of all culture conditions compared to the control condition 
(Figure 5-19C). This effect was slightly different in hiPSC-derived retinal organoids where 
the expression of Bassoon and CtBP2 significantly increased in CM RPE and decreased in 
decel NR and RPE (Figure 5-19D). These results indicate a higher protein expression of 
Bassoon and CtBP2 in both hESC- and hiPSC-derived retinal organoids in response to the 
three different ECM supplementations but CM RPE condition showed stronger effect. 
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Figure 5-18: Expression of synaptic markers in day 150 retinal organoids. 
Sections through day150 retinal organoid derived from hESCs (A-B) & hiPSCs (C-D) 
showing immunofluorescence labelling of retinal markers (vGlut1 & Recoverin; Recov) with 
synaptic markers (Bassoon or CtBP2). Small insets show higher magnification images of the 
organoid. Scale bars =20 μm. 
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Figure 5-19: Quantification of synaptic markers in day 150 retinal organoids derived 
from hESCs & hiPSCs. 
Schematic charts showing semi-quantitative measurements (A-B) and median intensity (C-D) 
of synaptic markers: Bassoon & CtBP2 in hPSC-derived day 150 retinal organoids. Data is 
shown as mean ± SEM, n=6-8. Differences were considered statistically significant at *p < 
0.05, **p < 0.01 and ****p < 0.0001. 
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To further investigate the formation of synaptic connections between retinal cell-types 
in hPSC-derived retinal organoids, Dr. Gerrit Hilgen performed multi-electrode recordings 
(MEA) for ganglion cells using strong light stimuli as well as the application of cyclic 
guanosine monophosphate (cGMP). Many presumed ON RGCs in retinal organoids derived 
from hESC and hiPSCs in control, CM-RPE, decel NR and decel RPE conditions at day 150 
of differentiation exhibited an increase in spiking activity when exposed to high intensity 
WLP stimuli. The spike raster plots (Figure 5-20A-D) show all ON responses for RGCS that 
responded at least with a 25% increase in spiking activity following WLP. Figure 5-20E 
illustrates the normalised mean change of spiking activity in all four conditions with a general 
increase in responsiveness of hESC- and hiPSC-derived retinal organoids in all conditions 
compared to their respective controls. However, the only conditions showing statistically 
significant increases were the decel NR and decel RPE in hiPSC-derived retinal organoids 
(Figure 5-20E). 
cGMP is a secondary messenger in the phototransduction cascade that gates Na+-
permeable channels in the outer segments of photoreceptors. Puffing 8-br-cGMP, a membrane 
permeable analogue of cGMP, in the recording chamber triggers Na+ influx and depolarises 
photoreceptors, thus mimicking the dark current. Organoid RGCs responding to the 8-br-
cGMP puff with increased spiking activity are thus presumed OFF RGCs (Figure 5-21A), 
whilst those exhibiting a decrease in activity after the puff are presumed ON RGCs (Figure 5-
21B). RGCs of the hESC-derived retinal organoids in decel NR and decel RPE groups 
showed the smallest change in activity for OFF (Figure 5-21A, left) and ON (Figure 5-21B, 
left) responses. In contrast, RGCs of the hiPSC-derived retinal organoids in control group 
showed the smallest change in activity for OFF (Figure 5-21A, right) and ON (Figure 5-21 
B, right) responses. In summary, these results show that all four conditions improve the light-
driven responses but decel NR and RPE conditions showed stronger effects. In contradiction, 
the effect of 8-br-cGMP was minimal in these two groups and the control conditions showed 
higher dynamics than the other conditions.  
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Figure 5-20: Light-driven spiking activity recorded from presumed ON RGCs in four 
different groups of 3D retinas derived either from hES (H9) or hiPSC (Ad3) cell lines at 
day 150 of differentiation. 
(A-D) Spike raster plots (SRPs) from RGCs of the different groups that showed a 25% 
increase in spiking activity during pulsed white light (WLP, see methods). In the raster plot, 
each small vertical bar indicates the time stamp of a spike, where each row represents a 
different RGC. The left half illustrates the activity before stimulus onset and, separated by the 
red line, the right half the activity when exposed to WLP. A) SRPs from H9 control group 
(left) and Ad3 control group (right). B) SRPs from H9 CM RPE group (left) and Ad3 CM 
RPE group (right). C) SRPs from H9 decel NR group (left) and Ad3 decel NR group (right). 
D) SRPs from H9 decel RPE group (left) and Ad3 decel RPE group (right).  E) The change of 
activity before and after stimulus onset was calculated for each RGC shown in A-D. An 
unpaired t-test was applied this data to estimate the difference between the control group to 
the other three groups. For better visualisation the means (+SEM) were normalised (as a 
fraction). Differences were considered statistically significant at *p < 0.05 and **p < 0.01. 
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Figure 5-21: Change of RGC spiking activity in four different groups of 3D retinas 
derived from hESC or hiPSC cell lines at Day 150 of differentiation.  
The change of activity after puffing 8-br-cGMP (final concentration 100 µM) compared to the 
activity before puffing was calculated for each RGC. RGCs that showed either a 25% increase 
(putative OFF RGCs) or decrease (putative ON RGCs) were considered as responsive. For 
better visualisation the means (+SEM) were normalised (as a fraction) within each cell line. A) 
Change of putative OFF RGC activity in H9 (left) and Ad3 (right) cell line groups. B) Change 
of putative ON RGC activity in H9 (left) and Ad3 (right) cell line groups. An unpaired t-test 
was applied this data to estimate the difference between the control group to the other three 
groups, differences were considered statistically significant at *p < 0.05. 
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5.4. Discussion 
The ECM of natural organs and tissues represents an essential material formed from 
highly complex proteins which provide many biological cues known to influence stem cells 
activity and function as well as differentiation, in vitro (Gong et al., 2008; Rowland et al., 
2013). Tissue specific ECM biomaterial may also provide micro-environments niches that 
recapitulate the in vivo milieu by possessing distinct properties and therefore provide a 
potential platform for enhancing tissue engineering and cellular functions in cultures to 
behave more similar to the original tissue, in vivo (Sackett et al., 2018). dECM has been 
utilised and studied from many tissues such as heart, liver, lung, kidney and brain to improve 
cellular differentiation (Ott et al., 2008; Ott et al., 2010; Petersen et al., 2010; Baptista et al., 
2011; Song et al., 2013; De Waele et al., 2015; Sun et al., 2018). In retina, dECM from 
bovine eyes promoted the differentiation of human retinal progenitor cells into photoreceptors 
by enhancing the expression of different markers such as retinal outer membrane-1 (ROM1), 
NRL and CRX (Kundu et al., 2016). In this study, media supplementations of CM RPE, decel 
NR and decel RPE containing natural ECM biomaterials was performed and the impacts of 
these different ECM supplementations on the differentiation of hPSCs into retinal organoids 
was investigated, in vitro. CM RPE and decel RPE media supplementations appear as good 
candidates to induce photoreceptors differentiation due to the anatomical relationship between 
the RPE and photoreceptors outer segments in the vertebrate eye (Gong et al., 2008). The data 
indicated a successful tissue decellularisation process which was achieved by removing the 
majority of cellular material. However, some of the ECM components were lost during the 
process which was also observed in other study (Kundu et al., 2016) suggesting that 
unavoidable reduction in the ECM content may occur during the decellularisation while 
removing a bulk of the cellular material and maintaining major components of the ECM niche. 
The ECM niches of the different media supplementations contained essential ECM 
components such as collagen, laminin, GAGs and hyaluronic acid. For example, Laminin was 
reported to enhance the differentiation of hPSCs into RPE (Rowland et al., 2013) or retinal 
progenitors into photoreceptors, in culture (Gong et al., 2008). Clark et al. reported that 
GAGs were major components of the ECM niche in adult human retina (Clark et al., 2011). 
Thus, each ECM component may have a better effect when it combined with other ECM 
components in one tissue specific ECM niche used as media supplements.   
 To examine the effect of different ECM supplementations, retinal organoids from 
hESCs and hiPSCs were generated and their structural and functional characterisations were 
assessed in term of containing all retinal layers and cell types, synapses formation and 
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electrophysiological responses. There was no significance effects of CM RPE, decel NR or 
decel RPE supplementation found at early and middle stages of retinal differentiation. 
Although several retinal markers including VSX2, HuC/D, CRX and Recoverin were 
expressed at early stages (day 35) of differentiation, no significant differences were found 
between the four culture condition suggesting that it might be early to observe the impact of 
ECM supplementations at this time point of the differentiation process. This result correspond 
with data reported by Singh et al. showing the expression of retinal marker VSX2, HuC/D 
and recoverin at day 31 of culturing hESCs on ECM scaffold. At middle stages of the 
differentiation process, the percentage of retinal organoids containing morphological 
structures such as neural retina and/or RPE has increased as the organoids developed with 
time in all culture conditions except in decel RPE condition where the organoids developed 
more neural retinal structures containing RPE compared to the control condition suggesting a 
beneficial impact of decel RPE supplementation on the development of neural retina with 
RPE. This result corresponds with the data reported by McLenachan et al. showing that 
decellularised ECM from ARPE19-PRE cell lines can promote the differentiation of hiPSCs 
into RPE cells by increasing the number of pigmented colonies and the expression of RPE65, 
an RPE marker, suggesting that the ECM of decel RPE may contains signals that promote the 
differentiation of RPE cells from hPSCs (McLenachan et al., 2017).  Overall, the result 
indicated that the impact of different ECM niches in CM RPE, decel NR and RPE started to 
be observed at middle stages of the differentiation with the ECM niche of decel RPE 
promoted the differentiation of hPSCs into RPE cells, in vitro.   
 At later stage of the differentiation, the effect of ECM in decel RPE condition 
continued to promote the characterisation of retinal structures with RPE in the organoids at 
this stage of development as well. This was in line with the TEM analysis that showed 
polarized melanosomes in the organoids of decel RPE condition suggesting that the ECM in 
this supplementation can promote the development of mature RPE cells and correspond with 
the observation reported by McLenachan et al. (McLenachan et al., 2017). More distinct 
retinal layers such as ONL and GCL started to generate in the organoids in all conditions and 
morphological features of the photoreceptors maturation were developed such as IS, OS, and 
CC which were confirmed by IHC and TEM studies. These ultrastructures were similar to the 
ones reported by other studies (Gonzalez-Cordero et al., 2017; Hallam et al., 2018; Ovando-
Roche et al., 2018).  qRT-PCR and cell quantification studies indicated that RHO expression 
and the number of RHO-positive cells were higher in CM RPE and decel RPE compared to 
control condition. This corresponds with the study reported by German et al. showing that 
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RPE cells promoted the synthesis of rhodopsin from photoreceptors in culture (German et al., 
2008). Although many reports showed that the ECM of CM RPE or decel RPE can promote 
the characterisation of RPE cells or proliferation of photoreceptors (Gaur et al., 1992; Hsiung 
et al., 2015; McLenachan et al., 2017) , these data indicate that for the first time, the ECM of 
RPE CM and decel RPE promote the differentiation and maturation of hPSCs into rods in 
culture. All other retinal cell-types (cones, bipolar, horizontal, amacrine, ganglion and Müller 
cells) were developed and different ECM supplements had no significant effect on their 
development which was confirmed by IHC and TEM studies.  
 The generation of retinal organoids containing key retinal cell types from PSCs were 
reported by several studies (Eiraku and Sasai, 2011; Eiraku et al., 2011; Nakano et al., 2012; 
Assawachananont et al., 2014; Kuwahara et al., 2015; Takata et al., 2017). However, the 
formation of correct synaptic connections between different cell-types is still a remaining 
challenge in the field of retinal differentiation (Llonch et al., 2018). The retinal organoids in 
this study were able to generate synaptic connections between photoreceptors and second 
order neurons such as bipolar or horizontal cells. However, variable effects of ECM 
supplementations on synaptogenesis were observed during retinal organoid development. 
Less putative photoreceptor synapses, indicated by Bassoon expression, were formed in the 
CM RPE compared to control condition, while all three media supplementations indicated an 
increase in the synaptic markers, Bassoon and CtBP2, median intensity compared  to control 
condition with CM RPE condition showed stronger expression. These results suggest that the 
ECM niches in CM RPE may have better impacts on synaptogenesis than the decel NR and 
RPE during the differentiation process. To test the impacts of different ECM 
supplementations on the development of correct synaptic connections, electrophysiological 
light responses were performed and showed that decel NR and RPE conditions had more 
mediated the light-driven responses in the retinal organoids than control condition, in vitro. 
This result suggest that the ECM niches of decel NR and RPE may have essential role in 
mediating the correct synaptic connections and light responses in retinal organoids derived 
from hPSCs in culture.   
Together, the data highlighted a beneficial effect of ECM as a natural biomaterial for 
efficient generation of retinal organoids in culture. The data observed in this study also 
suggest an important role for the ECM niches in the RPE CM and decel RPE to promote the 
differentiation and maturation of hPSCs into rods photoreceptors; as well as a major impact of 
the ECM niche in the decel RPE to enhance the differentiation of hPSCs into RPE cells and 
promoting correct synaptic connections and light responses in culture.    
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5.5. Conclusion 
In summary, CM RPE, decel NR and decel RPE containing natural ECM biomaterials 
were successfully generated and used as media supplements for the development of retinal 
organoids from hPSCs, in vitro. The effects of these supplementations were assessed and 
found that they had no effect on the differentiation process during early and middle stages. 
However, at later stages of the differentiation process supplementation with CM RPE and 
decel RPE promoted the characterisation of RPE cells and maturation of rod photoreceptors. 
The different ECM supplements had variable effects on synaptogenesis and mediated 
electrophysiological light responses in retinal organoids in vitro. Together, the study 
highlights an important role for tissue specific ECM supplementation and may provide a 
potential platform for future studies to test tissue specific ECMs on the development of hPSCs 
into other various tissue systems so that effective tissue engineering and cell replacement 
therapies may be achieved. 
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Chapter 6. General Discussion & Future Work 
 
 6.1. General Discussion  
Retinal degeneration is a major cause of blindness in developed countries (Kong et al., 
2012). In 2017, world-wide estimates indicated that around 36 million people were blind and 
around 217 million were visually impaired which may have negative impacts on economy, 
educational opportunities and public health policies (Bourne et al., 2017). Retinal degenerated 
diseases are characterised by progressive visual decline that originates from dysfunction and 
loss of key retinal cells such as RPE (Ovando-Roche et al., 2018) and photoreceptor cells 
(Oner, 2018) which may leads to total blindness (Köberlein et al., 2013). The most common 
examples of retinal degeneration are: Age-related macular degeneration which accounts 8.7% 
of global blindness (Wong et al., 2014) and Retinitis pigmentosa which affects 1 in 4000 
individuals (Hamel, 2006). Although animal models may provide several important insights 
into retinal disorders, they often unable to recapitulate key aspects of human pathophysiology 
which may obscure full understanding of the molecular mechanisms underlying retinal 
dystrophy (Ovando-Roche et al., 2018). For example, the development of photoreceptors is 
less advanced in mouse than human at birth (Swaroop et al., 2010). All photoreceptors are 
generated prenatally in human, whereas in mice they are generated pre- and postnatally 
(Swaroop et al., 2010). There are also significant differences between the two species in term 
of the number, ratio and distribution of the photoreceptors (Saghizadeh et al., 2011). The 
human retina has a larger amount of cone cells (~5%) than the mouse retinal photoreceptors 
(~3% cone cells) (Fu and Yau, 2007) and it contains the fovea which is not present in the 
mouse (Sung and Chuang, 2010; Saghizadeh et al., 2011) . Moreover, human retina is 
trichromatic (has three types of cone photoreceptors), whereas mice are dichromats 
(Saghizadeh et al., 2011). Therefore, it is important to study the tissue of human eye rather 
than other species in retinal research.    
 hPSCs including hESCs and hiPSCs can be differentiated into retinal organoids which 
provide a potential tool to study inherited and age related retinal degenration, to screen new 
drugs and to use them in tissue transplantation (Singh et al., 2018). Several reports have 
shown that many aspects of the retinal development can be recapitulated in vitro through the 
differentiation of hPSCs into retinal organoids (Meyer et al., 2011; Mellough et al., 2012; 
Nakano et al., 2012; Mellough et al., 2014; Zhong et al., 2014; Gonzalez-Cordero et al., 2017; 
Welby et al., 2017) which contain majorretinal cells types and respond to electrophysiological 
signals. However, current differentiation protocols are impeded by some challenges in term of 
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the prolong time required for the differentiation, formation of fully mature retinal layers with 
correct synaptic connections and limited ability to respond to light cues (Llonch et al., 2018; 
Ovando-Roche et al., 2018). Therefore, to use these advances for optimal retinal disease 
modelling in vitro and cell transplantation, more studies are required to develop 
differentiation protocols that result in efficient generation of retinal cells and maintaining 
laminar architecture of the retina (Ovando-Roche et al., 2018).   
The ECM plays an important role in controlling the behaviour of stem cells including 
self-renewal and differentiation (Keung et al., 2012). In vivo, the ECM plays major roles in 
many cellular processes during retinal development such differentiation, proliferation, 
migration, adhesion, guidance and axonal growth (Reinhard et al., 2015). Given the 
significant roles of ECM in retinal development, it is important to understand the expression 
of ECM components during human retinal ontogenesis, in order to utilise this knowledge to 
improve the differentiation of hPSCs into retinal organoids and understand the role of various 
ECM components in retinal development and disease (Clark et al., 2011; Keenan et al., 2012). 
To date, there have been limited detailed studies for the distribution of ECM components 
during human retinal development and the functional importance of many of them is poorly 
understood (Reinhard et al., 2015). In this study, the expression of key ECM components was 
investigated to map the differential distribution of proteoglycan core proteins and their 
associated GAGs in sections from adult mouse and monkey retina, developing and adult 
human retina. The results demonstrate that different ECM components have distinct 
distribution patterns throughout the adult retina of different species and a well conserved 
expression pattern between adult and developing human retinae. Based on the expression data, 
ECM components expressed in the BrM or IPM, which play important roles in maintaining 
health and viability of the photoreceptors (Booij et al., 2010; Ishikawa et al., 2015), in adult 
and developing human retinae were selected for further studies as important candidates for 
outer retinal development, in vitro. Collagen IV and Fibronectin were conversely expressed in 
BrM and BrM & ILM respectively which was consistent with the expression previously 
observed in adult rat (Chen et al., 2009) while Versican, Brevican, IMPG1, IMPG2 and CD44 
were expressed in the IPM.     
The expression of these key ECM components including Collagen IV, Fibronectin, 
Versican, Brevican, IMPG1, IMPG2 and CD44 were further studied during the differentiation 
of retinal organoids which generated form hESCs and hiPSCs, in vitro. Collagen IV and 
Fibronectin were expressed in BrM; whereas Brevican, Versican, IMPG1 and CD44 in the 
developing IPM. The data indicated that the expression of these ECM components 
140 | P a g e  
 
recapitulates human retinal development, in vivo. For example, IMPG1 was detected in the 
developing IPM of human developing retina at 12 PCW which was in line with the expression 
observed in the apical side (developing IPM) of day 90 retinal organoids. IMPG2 was not 
expressed in retinal organoids until the last time point examined (day 150). This, however, 
does correspond well with expression in developing human retina, where IMPG2 expression 
was observed only from 17 PCW. Another example, strong expression of CD44 was detected 
in the developing IPM at day 150 organoids which recapitulate the expression in human 
developing retina from 16 PCW. 
After confirming that the expression of key ECM components in the retinal organoids 
in vitro recapitulates human retinal development in vivo, blocking studies were performed in 
order to examine the functional role of ECM on the differentiation of hPSC into retinal 
organoids. The action of IMPG1 and CD44 was blocked at day 90 and 150 of the 
differentiation, as their expression started at these time points, by incubating the organoids 
with blocking antibodies for 14 days in culture. At day 90 of differentiation, blocking the 
action of IMPG1 reduced the expression of photoreceptors and connecting cilia but not IPM 
markers while blocking CD44 had no impacts on the expression of these markers, suggesting 
important role for IMPG1 in the emergence of the photoreceptors at this time point. At day 
150 of differentiation, blocking the action of IMPG1 and CD44 caused changes in the 
morphological structures of the organoids by thinning of the neuroepithelium structure and 
disrupted the development of the photoreceptors, their inner and outer segments and IPM 
formation. Together, these data suggest that IMPG1 and CD44 play an important role in the 
development of photoreceptors, their inner and outer segments, connecting cilia and IPM. 
However, IMPG1 acts earlier and has more significant effect than CD44 on retinal 
development, in vitro. 
Publishes evidences suggest that the RPE and dECM from the RPE and neural retina 
contain several ECM components that are important for retinal development and synaptic 
formation between various retinal cell types (Aisenbrey et al., 2006; Clark et al., 2011; 
Kolomeyer et al., 2011; Keenan et al., 2012; Kundu et al., 2016). The functional role of ECM 
on the differentiation of hPSCs into retinal organoids was further investigated via 
supplementation of culture media with RPE conditioned medium, decellularised ECM of 
neural retina or RPE. The data indicated that these three ECM supplementations had no 
impacts on the development of hPSC-derived retinal organoids at early (day 35) and middle 
stages (day 90) of the differentiation process. However, at later stages of differentiation (day 
150) supplementation with decel RPE promoted the characterisation of RPE cells and the 
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maturation of rod photoreceptors, suggesting that the ECM of this supplement may contain 
essential cues for the development of these two cell types. This corresponds with the study 
reported by German et al. showing that RPE cells promoted the synthesis of rhodopsin from 
photoreceptors in culture (German et al., 2008). Supplementation with decel NR and RPE had 
positive impacts on mediating the light-driven responses in the retinal organoids, in vitro. 
Together, the study highlights an important role for tissue specific ECM supplementation and 
may provide a potential platform for future studies to test tissue specific ECMs on the 
development of hPSCs into other various tissue systems so that effective tissue engineering 
and cell replacement therapies may be achieved. 
 
6.2. General Conclusion 
In summary, the study highlights a conserved expression of ECMs between human 
adult and developing retinae and retinal organoids as well as an important role for IMPG1 and 
CD44 in the development of photoreceptors, their inner and outer segments, connecting cilia 
and IPM; with IMPG1 acts earlier and has more significant effect than CD44 on retinal 
development, in vitro. Furthermore, the study identifies important role for ECM 
supplementation in retinal development in vitro. 
 
6.3. Future Work 
The work presented here investigated the expression and the functional roles of ECM 
on the development of retinal organoids, in vitro. However, the experimental approaches used 
to identify these roles were mainly based on studying the protein and gene expressions of 
various retinal markers as well as electrophysiological recording. Therefore, it may be 
important to further study the effect of ECM manipulation on various cellular signalling 
pathways such as Akt/PKB and the Erk pathways which are essential for cell proliferation 
(Streuli, 2009; Fournier et al., 2012; Moreno-Layseca and Streuli, 2014); ERK/MAPK 
pathway which plays important role in cell growth (Huang and Ingber, 1999); and Rho/ROCK 
pathway which is essential for cell polarity and migration (Brakebusch and Fassler, 2003). 
Although this study provided evidence that hPSC-derived retinal organoids were able to 
recapitulate ECM expression in vivo, develop all key retinal cell types in their correcting 
layers, and electrophysiologically respond to light; it is still not determined whether they able 
to incorporate in adult mammalian retina which can be examined via dissecting the retinal 
organoids to prepare a retinal sheet and transplant it in the subretinal space of retinal 
degenerative animal models as in a recent study by McLelland et al. (McLelland et al., 2018) . 
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The transplanted retinal sheet was able to integrate and grow within the host retina of retinal 
degenerative animal model, differentiate into different retinal cell types such as rods and 
cones as well as show functional connectivity through the formation of active synapses 
between the donor and host cells within the host IPL layer to improve visual function 
(McLelland et al., 2018). The improvement in the visual function was confirmed by 
electrophysiological recording that showed functional connections were made between the 
cells (McLelland et al., 2018). In summary, transplantation of hPSC-derived retinal organoids 
could improve visual function in retinal degenerative animal models so that effective retinal 
cell therapy may be realised. 
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Laminin γ3 plays an important role in 
retinal lamination, photoreceptor
organisation and ganglion cell
differentiation
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Abstract
Laminins are heterotrimeric glycoproteins of the extracellular matrix. Eleven different laminin chains have been
identified in vertebrates. They are ubiquitously expressed in the human body, with a distinct tissue distribution.
Laminin expression in neural retina and their functional role during human retinogenesis is still unknown. This study
investigated the laminin expression in human developing and adult retina, showing laminin α1, α5, β1, β2 and γ1 to
be predominantly expressed in Bruch’s membrane and the inner limiting membrane. Laminin-332 and laminin γ3
expression were mainly observed in the neural retina during retinal histogenesis. These expression patterns were
largely conserved in pluripotent stem cell-derived retinal organoids. Blocking of laminin γ3 function in retinal
organoids resulted in the disruption of laminar organisation and synapse formation, the loss of photoreceptor
organisation and retinal ganglion cells. Our data demonstrate a unique temporal and spatial expression for laminins
and reveal a novel role for laminin γ3 during human retinogenesis.
Introduction
The extracellular matrix (ECM) is a non-cellular
structure that is present in all tissues and can be divided
into two separate types, the connective tissue matrix and
the basement membrane1. The ECM provides structural
support and promotes cellular functions including dif-
ferentiation, adhesion, migration, proliferation, axonal
growth and morphogenesis in many tissues1–4. Laminins
(Lam) are a family of heterotrimeric glycoproteins and
part of the ECM5. They are a major component of base-
ment membranes and are important for multiple biolo-
gical processes4,5. Laminins are composed of one α, one β
and one γ chain, and at present 11 different laminin
chains have been identified in vertebrates: five α, three β
and three γ chains6. These 11 laminin chains can assemble
into at least 16 different laminin isoforms, named
according to their trimer composition7. All isoforms have
a tissue-specific distribution6. Mutations in different
laminin chains are known to cause several congenital
diseases in human including eye abnormalities8–13.
Laminin functions have often been associated
with embryogenesis. For example, laminin-111 has been
shown to play an essential role in primitive ectoderm
differ- entiation14–16 and knockdowns of any individual
chain of laminin-111 result in lethality15,17,18. Laminin-
111 and other laminin chains play an important role
during optic cup morphogenesis and retinal
histogenesis19–21, photo- receptor structure and synapse
formation20,22,23, stability of the inner limiting
membrane (ILM)24 and retinal ganglion cell (RGC)
axonal growth25–29.
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